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SUMMARY 
It is vital for organisms to undergo cell division in order to survive, grow and 
produce offspring. Errors in this process can lead to uncontrolled cell division 
and diseases like cancer. During each cell cycle, duplicated DNA has to be 
equally distributed to the prospective daughter cells. The proteinaceous 
kinetochore structure is crucial for the attachment of microtubules from 
opposite spindle poles and thereby correct partitioning of the sister 
chromatids. Centromeres are epigenetically defined chromosomal regions 
which serve as platforms for the assembly of the kinetochore during mitosis.  
In humans, many efforts have been made to identify proteins present in 
centromeres and kinetochores. Also Drosophila melanogaster has proven its 
value in unraveling functional aspects of centromere biology. In this model 
organism, insights about centromeres are more readily obtained and can 
frequently be transferred to higher organisms. Still, only a very limited number 
of centromeric proteins is known in Drosophila, potentially owing to the lack of 
sequence conservation among functional orthologs.  
This study set out to identify novel proteins present at Drosophila 
centromeres. For this purpose, a constitutive centromere-bound protein, the 
centromeric histone H3 variant CID (centromere identifier) fused to a GFP-
tag, was used as bait for affinity purification followed by mass spectrometry 
analysis. Thereby, 94 potentially centromeric proteins were identified that co-
purified with GFP-tagged CID. Subsequent immunolocalization studies of 32 
factors revealed centromeric localizations for nine factors and fourteen 
additional proteins localizing to the nucleus. The depletion of three factors, 
namely CG2051, a histone acetyltransferase, CG14480 and Hyd, in 
Drosophila cells by RNAi led to elevated mitotic errors. Unlike the known 
centromere proteins CENP-C and Cal1, neither of the investigated factors 
influenced centromere loading of CID as assessed by quantitative 
microscopy. On the contrary, depletion of three factors, CG6227, REG and 
Hyd, caused elevated levels of centromeric CID-GFP, pointing to an 
involvement in inhibition of CID deposition. This, together with the finding that 
CID mono-ubiquitination was lost when hyd amounts were reduced, 
suggested that Hyd, a putative E3 ubiquitin ligase, might be implicated in 
control of CID stability. Cell cycle analysis indicated that reduction of known 
centromeric factors like CENP-C, Cal1 and CID arrested cells in S-phase 
while none of the other tested factors led to severe alterations. In sum, this 
study provides a comprehensive analysis of Drosophila melanogaster 
centromeric protein composition.  
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ZUSAMMENFASSUNG 
Zellteilung ist ein essentieller Prozess für Organismen, um überleben, 
wachsen und sich fortzupflanzen zu können. Fehler, die dabei auftreten, 
können zu unkontrollierter Zellteilung und somit Krankheiten wie Krebs 
führen. In jedem Zellzyklus muss die duplizierte DNA gleichmäßig auf die 
künftigen Tochterzellen verteilt werden. Die proteinhaltige Kinetochorstruktur 
ist wichtig für die korrekte Aufteilung der Schwesterchromatiden, da 
Mikrotubuli von den gegenüberliegenden Spindelpolen dort binden. 
Zentromere sind epigenetisch definierte Chromosomenregionen, die während 
der Mitose die Basis für den Kinetochoraufbau bilden.  
In humanen Zellen wurden diverse Studien durchgeführt, um Zentromer- und 
Kinetochorproteine zu identifizieren. Auch Drosophila melanogaster hat sich 
als gutes Modellsystem bestätigt, um funktionelle Prozesse der 
Zentromerbiologie zu entdecken. Erkenntnisse durch Genprodukt-
reduzierungen können hier einfacher gewonnen und oft auch auf höher 
entwickelte Organismen übertragen werden. In Drosophila ist jedoch nur eine 
sehr begrenzte Anzahl an Zentromerproteinen bekannt, vermutlich wegen 
einer fehlenden Konservierung der Orthologen.  
In dieser Studie sollten neue Zentromerproteine von Drosophila identifiziert 
werden. Zu diesem Zweck wurde eine Affinitätsaufreinigung der GFP-
getaggten zentromerischen Histon H3-Variante CID (centromere identifier) mit 
anschließender massenspektrometrischer Analyse durchgeführt. Dabei 
wurden 94 Proteine im Komplex mit CID-GFP gefunden. Anschließend 
wurden 32 dieser Faktoren mittels Immunfluoreszenz auf ihre Zelllokalisation 
überprüft und dabei neun zentromerische Lokalisationen sowie 14 
kernlokalisierende Faktoren gefunden. Bei Depletion dreier Faktoren, nämlich 
CG2051, einer Histonacetyltransferase, CG14480 und Hyd, durch RNA-
Interferenz reicherten sich mitotische Fehler in Zellen an. Quantitative 
Mikroskopie zeigte, dass Reduktion der Zentromerproteine CENP-C und Cal1 
zu vermindertem CID-GFP-Einbau in Zentromeren führt. Kein anderer Faktor 
zeigte diesen Effekt, jedoch resultierte CG6227-, REG- und Hyd-
Verminderung in vermehrtem CID-GFP an Zentromeren. Normalerweise sind 
diese Faktoren also offensichtlich an der Eindämmung von CID-Einbau 
beteiligt. Reduzierung von hyd, einer putativen E3-Ubiquitinligase, führte zu 
Rückgang von CID-Monoubiquitinierung. Diese Erkenntnisse deuten auf eine 
Regulation der CID-Stabilität durch Hyd hin. Verringerung von CENP-C, Cal1 
und CID führte zu S-Phase-Arrest der Zellen, während bei keinem anderen 
getesteten Kandidaten eine Zellzyklusbeeinflussung beobachtet wurde. 
Zusammengenommen bietet diese Studie eine umfassende Analyse des 
Proteinaufbaus von Drosophila melanogaster-Zentromeren.  
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1 INTRODUCTION 
1.1 Cell division and aberrations 
More than 100 years ago, Theodor Boveri, a developmental biologist working 
with sea urchin in Würzburg, observed that chromosomal aneuploidies have 
deleterious effects to cells (Boveri 1902). These incorrect chromosome 
numbers in the two generated cells can result from missegregation of the two 
sister chromatids in mitosis or meiosis. In 1914, he proposed that these 
abnormalities might lead to establishment of malignant cancers (Boveri 1914). 
These facts show that the process of cell division in general and chromosome 
distribution and its participating factors in particular has been intensively 
studied since decades as it is a crucial process in biology. Since Boveri's first 
proposal of cancerogenesis due to chromosomal aneuploidies, it has been 
confirmed in many cases (reviewed in Fang and Zhang 2011). Nevertheless, 
the molecular mechanisms leading to these aberrations are still not fully 
understood. Unraveling these functions can lead to hints about how to control 
the deleterious chromosome missegregations.  
During mitotic cell division, one mother cell divides into two daughter cells. 
With the few exceptions of asymmetric divisions, these daughters are identical 
to the mother cell. To maintain this identity, the DNA content of the mother cell 
has to be duplicated before division. The process of cell division is separated 
into different stages of a so-called cell cycle (figure 1.1). Replication of DNA 
happens in the synthesis or S-phase of the cell cycle. Before and after DNA 
synthesis, gap phases are taking place, called G1- and G2-phase. All three 
phases together are termed interphase. After G2-phase, cells enter mitosis 
(M-phase), which is divided into five different stages: prophase, 
prometaphase, metaphase, anaphase and telophase. Cytokinesis follows 
mitosis, where the cytoplasm is separated. If cells are differentiated and do 
not undergo division anymore, their status is termed G0.  
INTRODUCTION 
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In prophase of mitosis, chromosomes are starting to condensate and the 
nuclear membrane is dissolving. Centrosomes, which are microtubule 
organizing centers (MTOCs), are duplicated and move to opposite sides of 
the cell where the future spindle poles will be located. In prometaphase, 
microtubules (MTs) emerging from the centrosomes are either attaching to the 
kinetochore part (see chapter 1.2) of chromosomes (kinetochore 
microtubules), to a MT from the opposite pole (polar microtubules) or helping 
to anchor the MTOCs to the cell membrane (astral microtubules). In 
metaphase, condensed chromosomes are aligned in the metaphase plate 
such that the two kinetochores face the two opposite spindle poles. In 
anaphase, the two sister chromatids of one chromosome are actually getting 
separated and torn towards opposite spindle poles. This process is assisted 
by polar microtubules that are pushing the spindle poles further apart and 
kinesins at the kinetochore that help move the chromosomes towards the 
spindle pole along microtubules. In telophase, the nuclear membrane is 
forming again and the cleavage furrow between the prospective daughter 
Figure 1.1: Schematic of a cell cycle. Different phases with approximate durations are 
indicated by arrows. G1/G2/G0-phase: gap phases. S-phase: synthesis phase. M-phase: 
mitosis. Mitosis is subdivided in five different phases, shown with names and schematics in 
the figure. Brown: Centrosomes/Microtubule organizing centers. G1, S, and G2-phase 
together are also termed interphase.  
INTRODUCTION 
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cells is established. The cytoplasm is separated to two distinct cells by the 
process of cytokinesis, thus ending cell division.  
As mentioned, cell division is a critical process in cells and has to be well 
controlled. Therefore, different checkpoints exist during the cell cycle that can 
only be passed if all prerequisites for continuation are fulfilled. There are 
checkpoints at G1/S-phase transition, intra S-phase, at G2/M-transition and in 
M-phase of the cell cycle. If DNA is damaged, cells will arrest in late G1-, S- 
or G2-phase to allow for repair. The checkpoint in mitosis is also called 
spindle assembly checkpoint (SAC). Proteins of the SAC make sure that 
sister chromatids are only separated when all kinetochores are bound by 
microtubules, thereby preventing chromosomal aberrations (reviewed in 
Musacchio and Salmon 2007). Constituents of the kinetochore like PLK (Polo-
like kinase) and Zwilch are also members of the spindle assembly checkpoint.  
Mitosis is a cell cycle phase regulated by posttranslational modifications of 
proteins: for example, (de)phosphorylation of cyclin dependent kinases 
(CDKs) and cyclins. The CDK1/Cyclin B complex phosphorylates Aurora B 
kinase, Polo-like kinase (PLK) and APC/C (anaphase promoting 
complex/cyclosome) during mitosis. Once phosphorylated, APC/C associates 
with Cdc20 to become an active E3 ubiquitin ligase, which targets its 
substrates for proteasome-mediated degradation. In this way, the APC/C 
ubiquitinates Cyclin B after the spindle assembly checkpoint is passed and 
thus indirectly terminates the mitotic phosphorylations. Other APC/C 
dependent ubiquitination events together with PLK-dependent 
phosphorylations are required to inactivate Securin and Shugoshin. Thereby, 
Separase becomes active to cleave Cohesin, which triggers chromatid 
separation (reviewed in Kim and Yu 2011, Jeong and Yang 2013). 
Additionally, acetylation of Cyclin A has been determined as a prerequisite for 
its ubiquitination by the APC/C complex and its subsequent degradation by 
the proteasome (Mateo, Vidal-Laliena et al. 2010), adding acetylations to the 
list of posttranslational modifications implicated in control of mitotic 
progression. 
Since each cell originates from another cell ("omnis cellula e cellula", Rudolf 
Virchow), cell division is a process important for an organism to stay alive, 
reproduce, grow, specialize and inherit traits. Each cell division is prone to 
errors. These can appear on different layers of cell division: either during DNA 
replication, which is a tightly controlled mechanism, or when chromatids of 
chromosomes are separated to the two cell poles. Errors in the latter process 
result in chromosomal aberrations which can cause diseases like cancer if 
cells start to proliferate in an unregulated manner. Therefore, detailed 
INTRODUCTION 
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understanding of cell division processes is crucial and prominent players in 
cell division are centromeres and kinetochores.  
1.2 Centromeres and kinetochores 
Centromeres have different appearances. In the most abundant one, when 
chromosomes are metacentric and monocentric, they can be seen as a 
primary constriction in the middle section of condensed mitotic chromosomes, 
making condensed chromosomes adapt an X-shaped structure. Centromeres 
of monocentric chromosomes can be located at different positions on the 
chromosome: if they are placed more towards one end of a chromatid, they 
are termed acrocentric; if they are placed right at the end, chromosomes are 
telocentric. The model organism used in this work, the fruit fly Drosophila 
melanogaster, possesses four monocentric chromosomes with the Y, 2nd and 
3rd chromosome being metacentric and the X and 4th chromosome telocentric.  
Three different kinds of centromeres are described. The chromosomes of the 
budding yeast Saccharomyces cerevisiae (S. cerevisiae) have point 
centromeres, which are constituted by one positioned nucleosome spanning 
around 120 bp of centromere-identity conferring DNA (Furuyama and Biggins 
2007). Most other organisms harbor regional centromeres that comprise 
larger areas of chromatin. Regional centromeres are not very similar in length 
of underlying DNA: it can reach from 40 to 100 kb in the fission yeast 
Schizosaccharomyces pombe (S. pombe) to around 400 kb in Drosophila 
melanogaster or 10 Mb in humans (reviewed in Cleveland, Mao et al. 2003). A 
third type of centromeres can be found on holocentric chromosomes detected 
in a wide range of organisms found throughout the animal and plant kingdom 
(Melters, Paliulis et al. 2012) where centromeres are spread over the whole 
chromosome.  
Centromeres build the platform for assembly of kinetochores, a proteinaceous 
structure only present throughout mitosis. Kinetochores are the site on 
chromosomes where microtubules attach during mitosis. Electron microscopy 
analysis and molecular studies revealed that kinetochores are made up of 
four different protein layers on both sister chromatids (figure 1.2). First, and 
innermost, there are proteins of the inner centromere, also termed the 
chromosomal passenger complex (CPC), colored in orange in figure 1.2. In 
mammalian cells, the CPC is comprised of the Aurora B kinase, INCENP, 
Survivin and Borealin. The second layer is represented by centromeric 
chromatin. It typically consists of the core histones H3, H4, H2A and H2B (see 
chapter 1.3), interspersed by nucleosomes containing the centromere-specific 
INTRODUCTION 
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histone H3 variant CENP-A (centromeric protein A) (Blower, Sullivan et al. 
2002). Proteins of the centromeric chromatin are colored in violet in figure 1.2. 
The third layer is formed by proteins of the so-called constitutive centromere-
associated network (CCAN) or the inner kinetochore. In human, 16 different 
components of the CCAN are known that are also termed CENPs 
(summarized in Westermann and Schleiffer 2013). They are marked in bluish 
colors in figure 1.2. Forth, the outermost structure is composed by proteins of 
the outer kinetochore or KMN-network. KMN stands for Knl1 complex, Mis12 
complex and Ndc80 complex (reviewed in Varma and Salmon 2012). The 
different components are depicted in figure 1.2 in red/pink. Mostly the 
components of the Ndc80 complex interact with kinetochore microtubules.  
 
 
 
 
The four layers of the kinetochore are differently regulated during the cell 
cycle. The proteins of the chromosomal passenger complex and the outer 
kinetochore are only present at centromere regions during M-phase of the cell 
cycle. Constitutive centromere-associated network proteins as well as 
centromeric chromatin stay bound throughout the whole cell cycle. Since 
during cell division, histone content needs to be doubled for the two 
prospective daughter cells, synthesis of the majority of histone H3 and H4 is 
tightly regulated and coordinated with S-phase, when DNA is replicated 
(Heintz, Sive et al. 1983). During centromere replication, CENP-A is evenly 
Figure 1.2: Four layers of a human kinetochore. On the left, a schematic mono- and 
metacentric chromosome is depicted with kinetochores on both sister chromatids. On the 
right, an amplification of the kinetochore layers can be seen. Different layers with their 
components are indicated in different colors and the names of the layers mentioned on top. 
Black lines indicate kinetochore microtubules attaching to kinetochores in mitosis.  
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distributed to the two new daughter strands of DNA. It is, however, only in the 
following G1-phase, after cells already divided, that the CENP-A pools are 
filled up to the amount before cell division (Jansen, Black et al. 2007). Also, a 
CENP-A specific chaperone termed HJURP (Holliday junction recognition 
protein) is required for deposition (Foltz, Jansen et al. 2009).  
CENP-A has been discovered by staining cells with an antibody isolated from 
CREST (calcinosis, Raynaud's phenomenon, esophageal dysmotility, 
sclerodactyly, and telangiectasias) syndrome patients (Earnshaw and 
Rothfield 1985). The obtained signal was centromeric, thus the stained 
proteins were termed as CENPs A, B and C. Later it was found that CENP-A 
is part of nucleosomes, thereby a histone and a centromere-specific variant of 
histone H3 (Palmer, O'Day et al. 1987). Interestingly, this histone H3 variant 
specific for centromeres is present in all eukaryotes investigated so far 
(Henikoff and Dalal 2005). In this regard, CENP-A is an exception since 
CCAN proteins show very limited conservation compared to proteins of the 
chromosomal passenger complex or the outer kinetochore that are only 
temporarily bound to kinetochores during mitosis. Furthermore, the underlying 
DNA of centromeres is hardly conserved, sometimes even differing between 
individual chromosomes.  
These findings have led to the suggestion that centromere identity and 
function are not determined by DNA, but by protein composition. This is 
further underlined by experiments demonstrating that CENP-A (or centromere 
identifier (CID) in Drosophila) incorporation at ectopic sites creates fully 
functional centromeres onto which kinetochores assemble (Olszak, van Essen 
et al. 2011). These neocentromere kinetochores preferably form at 
heterochromatin borders, mirroring the situation of endogenous centromeres 
that are usually surrounded by pericentromeric heterochromatin (more on 
heterochromatin in chapter 1.3). Furthermore, if CID is targeted to a non-
centromeric chromatin site, it is both necessary and sufficient for centromere 
and kinetochore establishment and maintenance over many cell divisions 
(Mendiburo, Padeken et al. 2011). Neocentromere formation proofs that there 
is no dependency on underlying DNA sequence for establishment of 
functioning centromeres and kinetochores (reviewed in Burrack and Berman 
2012). Rather, it is believed that chromatin factors are responsible.  
1.3 Chromatin and epigenetics 
Chromatin describes the entity of DNA and associated factors like proteins or 
RNAs. DNA in a nucleus is always tightly associated with proteins. The most 
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abundant chromatin proteins are histone proteins. So-called "core" histones 
H2A, H2B, H3 and H4 are organized in octamers with two copies of each 
histone. When DNA is wrapped around this histone octamer 1.65 times 
(146 bp of DNA) (Luger, Mader et al. 1997), the resulting structure is called a 
nucleosome. Nucleosomes make up the first level of chromatin compaction 
and organization. A DNA fiber packed in nucleosomes forms a "beads-on-a-
string"-like structure with a diameter of 10 nm in vitro (Olins and Olins 1974). 
Another histone, histone H1, termed a "linker" histone since it binds DNA in 
between two nucleosomes (linker DNA), helps to condense chromatin to 
higher structures (reviewed in Happel and Doenecke 2009). In order to obtain 
condensed mitotic chromosomes, more levels of compaction are applied 
whose precise molecular appearance is still under debate (reviewed in 
Hansen 2012).  
Thus, chromatin helps packing DNA during interphase as well as in 
condensed metaphase chromosomes, but is also an important mediator of 
gene regulation. Almost each cell in a multicellular organism bears the same 
DNA, but their appearance is quite different, suggesting that genes are 
differentially regulated in diverse cell types. Already in 1928, two distinct 
chromatin states were described based on microscopic observations (Heitz 
1928): the less tightly packed euchromatin and more densely packed 
heterochromatin, while heterochromatin is subgrouped in constitutive and 
facultative heterochromatin. In general, DNA located in euchromatin is more 
easily accessible for regulatory factors like transcription factors or RNA 
polymerases and thus more active than the one in heterochromatin.  
Regulation of gene activity can be controlled by different so-called 
"epigenetic" mechanisms, with "epigenetic" describing all aspects of gene 
regulation that are not encoded in the DNA sequence but are inherited to the 
next generation during mitosis or meiosis. Figure 1.3 gives an overview about 
different epigenetic mechanisms.  
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Multiple regulatory factors were shown to mediate epigenetic processes. First, 
the position of nucleosomes can be shifted on DNA by nucleosome 
remodelers, which are often ATP-dependent (reviewed in Clapier and Cairns 
2009), making DNA more or less accessible for chromatin proteins. Second, 
DNA can be methylated on cytosines by DNA methyltransferases, leading to 
5-methylcytosine (5-mC), a "fifth DNA base". Methylated cytosines in CpG-
motifs located within promoters can cause binding of repressor proteins and 
thereby lead to inactivation of the corresponding gene. Additionally, 
5-hydroxymethylcytosine is generated from 5-mC, which can be converted to 
5-formylcytosine and 5-carboxycytosine, by action of ten-eleven-translocation 
(TET) enzymes (reviewed in Delatte and Fuks 2013). Third, non-coding RNAs 
(ncRNAs) are implicated for example in inactivation of the mammalian female 
X-chromosome by recruiting the histone modifying complex PRC2 (Zhao, Sun 
et al. 2008). Forth, histone proteins carry a multitude of different 
posttranslational modifications (PTMs), especially the N-terminal tails of 
histone H3 and H4 (see figure 1.4). These modifications, mainly acetylations, 
methylations, phosphorylations and ubiquitinations, are set by so-called 
Figure 1.3: "Epigenetic" mechanisms depicted schematically. Blue/yellow: Histone octamer. 
TF: transcription factor. MBD: Methyl binding domain protein. HDAC: Histone deacetylase. 
Green arrow: Active gene transcription. Red arrow: Inactive gene. Grey line: RNA. TFIID: 
Transcription factor IID. HP1: Heterochromatin protein 1. Yellow stars: DNA methylation. 
Stars and rectangles: histone modifications. Modified after Hahn, Dambacher et al. 2010. 
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"writer" proteins, removed by "erasers" and recognized by "readers". Histone 
PTMs translate into different activity states: on the one hand, they activate the 
underlying gene, like in general acetylations or trimethylation of histone 3 on 
lysine 4 (H3K4me3) present on promoters, by recruiting RNA polymerase II 
via transcription factor IID (TFIID) (Vermeulen, Mulder et al. 2007). On the 
other hand, they can repress gene activity for example by helping to enhance 
chromatin compaction through the recruitment of repressors like the polycomb 
repressive complexes PRC1 and PRC2. The latter mono-, di- and 
trimethylates histone 3 on lysine 27 (H3K27me1/2/3) by its subunits Ezh1 or 
Ezh2 (enhancer of zeste), and this mark can recruit repressive readers 
(reviewed in Simon and Kingston 2009). The existence of a "histone code" 
has been postulated, implying that combinations of various histone 
modifications lead to a certain regulatory outcome, rather than single 
modifications (Strahl and Allis 2000). Fifth, different chromatin compartments 
can contain distinct, specialized histone variants, a fact made use of in this 
work (chapter 1.6). Mammalian histone H3 has four main variants, H3.1, H3.2, 
H3.3 and CENP-A. The two replication-dependent variants H3.1 and H3.2 are 
only incorporated in chromatin during S-phase of the cell cycle when the 
demand for histone proteins is high. These canonical variants differ in only 
one amino acid. The replication-independent variant called replacement 
variant H3.3 is incorporated by a different mechanism throughout the cell 
cycle and differs by five amino acids to H3.1. In contrast, the sequence of the 
centromeric variant CENP-A substantially differs from the other H3 variants 
(reviewed in Biterge and Schneider 2014). Histone variants can alter the 
features of chromatin domains where they are incorporated, for example by 
carrying a distinct pattern of histone PTMs, destabilization of the nucleosome 
or by engaging in unique protein-protein interactions.  
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As introduced before, also centromeres and kinetochores execute their 
function and inheritance mostly by epigenetic mechanisms that are not 
encoded by the underlying DNA (with the exception of point centromeres). 
Centromeric chromatin has a distinct composition and is embedded in 
pericentromeric heterochromatin. Centromeres are in fact marked by a special 
pattern of histone modifications with high levels of the activating H3K4me2 
mark and a low level of acetylated H3 and H4, which is usually found at 
repressed chromatin. Pericentromeric heterochromatin surrounding 
centromeric chromatin is characterized by repressive H3K9me2/3 and 
hypoacetylated H3 and H4 (reviewed in Dunleavy, Pidoux et al. 2005). 
Recently, it has been shown that H4K20me1 is present in the CENP-A 
containing nucleosome in chicken and human cells and that it is necessary for 
kinetochore assembly (Hori, Shang et al. 2014).  
In this work, the centromeric histone variant CENP-A (or CID in Drosophila) 
was used as a bait to identify centromeric proteins of Drosophila 
melanogaster (see chapter 1.6). Therefore, the current status of research on 
Drosophila centromere proteins is now described.  
1.4 Centromeres in the model organism Drosophila melanogaster 
Centromeric DNA in different organisms is not well conserved and fast 
evolving (Henikoff, Ahmad et al. 2001). Therefore, also centromeric proteins 
differ substantially. Proteins of the chromosomal passenger complex as well 
as the outer kinetochore, which mediates binding to microtubules, however, 
are conserved throughout evolution. The H3 variant CENP-A and proteins of 
the constitutive centromere-associated network (CCAN) in contrast harbor 
Figure 1.4: Schematic of abundant posttranslational modifications on histone tails. Not 
included are modifications like crotonylation, proline isomerization, formylation, 
hydroxylation, deamination, ADP-ribosylation, β-N- acetylglucosamine, sumoylation.  
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considerable differences between organisms that complicate sequence-
homology based identification of the orthologs. Centromeric proteins known to 
date in Drosophila are hence limited to the more conserved proteins of the 
inner centromere (CPC) and outer kinetochore (KMN network). However, only 
one CCAN protein, CENP-C, was identified (table 1.1).  
 
Table 1.1: Centromere and kinetochore proteins identified in different species. Names of the 
histone H3 variant are highlighted in red. Proteins from humans and Drosophila are shaded in 
blue for better comparison. Modified after Perpelescu and Fukagawa 2011.  
Homo 
sapiens 
Gallus  
gallus 
Xenopus  
laevis 
C. 
elegans 
Drosophila 
melanogaster 
S.  
pombe 
S. 
cerevisiae 
CENP-A CENP-A CenH3 HCP3 CID Cnp1 Cse4 
CENP-B         
Abp1/Cbh1/
Cbh2   
CENP-C CENP-C CENP-C HCP4 CENP-C Cnp3 Mif2 
CENP-E CENP-E CENP-E   
CENP-meta/ 
CENP-ana   Mcm16 
CENP-F   CENP-F HCP1/2       
CENP-I CENP-I       Mis6 Ctf3 
CENP-K             
CENP-L CENP-L       Fta1   
CENP-M CENP-M       Mis17 Iml3 
CENP-N CENP-N       Mis15 Chl4 
CENP-O CENP-O       Mal2 Mcm21 
CENP-P CENP-P       Fta2 Ctf19 
CENP-Q CENP-Q       Fta7   
CENP-R CENP-R           
CENP-S CENP-S Apitd1     
SPBC2D10
.16 YOL86-A 
CENP-T CENP-T CENP-T     
SPBC800/
Cnp20   
CENP-U  CENP-50       Fta4   
CENP-W CENP-W           
CENP-X CENP-X           
CENP-Y             
HJURP   HJURP     Scm3 Scm3 
Mis18 Mis18       Mis18   
Mis18 Mis18       Mis18   
M18BP1 Knl2   knl-2       
RbAp48   rbbp4-a rba-1 
RbAp48 = 
CAF-1 Mis16 Msi1 
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Homo 
sapiens 
Gallus  
gallus 
Xenopus  
laevis 
C. 
elegans 
Drosophila 
melanogaster 
S.  
pombe 
S. 
cerevisiae 
RbAp46   Rbbp7     Mis16 Msi1 
hMis12 Mis12   MIS-12 CG18156 Mis12 Mtw1 
DSN1 Dsn1   KNL3   Dsn1/Mis13 Dsn1 
NNF1 Nnf1   KBP-1 
CG13434/ 
CG31658 Nnf1 Nnf1 
NSL1 Nsl1   KBP-2 CG1558 Nsl1/Mis14 Nsl1 
NDC80 
Ndc80/ 
Hec1 
 
NDC-80 CG9938-PA Ndc80 Ndc80 
NUF2 Nuf2  HIM-10 CG8902 Nuf2 Nuf2 
SPC24 Spc24 spc24 KBP-4   Spc24 Spc24 
SPC25 Spc25 spc25 KBP-3 CG7242 Spc25 Spc25 
KNL1 Knl1   KNL1 CG11451 Spc7 Spc105 
 
Recently, the homolog of the CENP-A chaperone HJURP in Drosophila 
melanogaster was identified to be chromosome alignment defect 1 (Cal1) 
(Chen, Dechassa et al. 2014). If targeted to a non-centromeric chromosomal 
region, Cal1 can recruit CID and lead to establishment of functioning 
kinetochores. These kinetochores can also be inherited. Furthermore, as 
mentioned earlier, the centromeric H3 variant is termed CID in Drosophila 
melanogaster, which stands for centromere identifier. It only bears around 
50 % similarity with the human CENP-A. Taken together, the knowledge 
about Drosophila centromere proteins is very limited as compared to human 
centromeres (figure 1.5).  
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Consistent with its heterochromatic environment, Drosophila centromeric DNA 
is replicated in late S-phase (Sullivan and Karpen 2001). However, newly 
synthesized CID is only incorporated in the G1-phase of the cell cycle (Lidsky, 
Sprenger et al. 2013). CENP-C and Cal1 are two proteins required for CID 
deposition (Erhardt, Mellone et al. 2008). Cal1 is binding to centromeres 
before newly synthesized CID is incorporated (Mellone, Grive et al. 2011). 
Although new CID is transiently accumulating at centromeres during M-phase, 
the full levels of centromeric CID present before cell division are only restored 
in G1-phase. These findings indicate that reconstitution of centromeric 
chromatin after replication is more complicated than presumed.  
Another interesting finding in Drosophila centromere biology was a model for 
regulation of centromere clustering (Padeken, Mendiburo et al. 2013). 
Centromere clustering is a phenomenon observed in various cell types: in 
theory, each chromosome contains one centromere or even two when its 
DNA has been duplicated during S-phase. As the Schneider cell subclone 
used in the study, L2-4 cells, harbors 13 chromosomes in total (two X, four 
2nd, four 3rd, two 4th and one 2L chromosome), 13 or 26 centromeres should 
Figure 1.5: Schematic of centromere and kinetochore proteins in Drosophila melanogaster. 
On the left, a schematic mono- and metacentric chromosome is depicted with kinetochores 
on both sister chromatids. On the right, an amplification of the kinetochore layers can be 
seen. Different layers with their components are indicated in different colors and the names 
of the layers mentioned on top. Black lines indicate kinetochore microtubules attaching to 
kinetochores in mitosis. 
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be distinguishable, respectively. However, usually only between 4-6 
centromere spots can be detected by microscopy. Centromeres in nuclei are 
thus clustering together. This clustering involves nucleoplasmin-like protein 
(NLP), Modulo and CTCF. Modulo is a nucleolar protein and anchors 
centromere clusters to the nucleolus. The role of this centromere clustering is 
not exactly clear; however, the study also showed that induction of 
centromere declustering by knockdown of any of the involved factors 
destabilizes pericentromeric heterochromatin. This causes re-activation of 
transposable elements usually silenced by pericentromeric heterochromatin 
and results in genomic instability such as DNA double-strand breaks, lagging 
chromosomes and anaphase bridges. Hence, centromere clustering seems to 
play an important role in chromatin regulation.  
Histone modifications on centromeric chromatin have been determined for 
Drosophila (Sullivan and Karpen 2004). For this, chromosomes were spread 
as fibers and incubated with modification-specific antibodies. It was found 
that, similar to human centromeres, CID-containing regions were enriched for 
H3K4me2 and some H3K9me2, but no acetylations on H3 or H4 or 
H3K4me3/H3K9me3 were detected. Thus, also in Drosophila, centromeric 
chromatin seems to be marked by both active and repressive histone 
modifications.  
1.5 Previous analyses on chromatin composition of centromeres 
The huge number of centromeric proteins known in humans partly derives 
from one affinity purification – mass spectrometry (AP-MS) study (Foltz, 
Jansen et al. 2006). The study made use of a TAP-tagged CENP-A 
expressing HeLa cell line on which purifications and subsequent identification 
of the enriched proteins by mass spectrometry analysis was performed. By 
that means, ten proteins could be newly designated to centromeres, termed 
CENP-K to CENP-T. Additionally, another AP-MS study, performed with an 
antibody directed against CENP-A in human HeLa cells, identified 34 proteins 
specifically associating with CENP-A (Obuse, Yang et al. 2004).  
In Drosophila, a screen was performed to determine factors involved in the 
establishment of the mitotic spindle (Goshima, Wollman et al. 2007). In this 
genome-wide high-throughput RNAi screen, spindle phenotypes were 
monitored by automated microscopy. Since also chromosome structure and 
alignment was one of the criteria screened for, centromeric proteins like CID 
and CENP-C were detected in the screen. Cal1 was identified for the first time 
here. Also proteins of the outer kinetochore layers resulted in erroneous 
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phenotypes, leading to first description of the homologs in Drosophila. 
Additionally, TAP-tagged, soluble Drosophila CID has been purified in order to 
identify the specific chaperone on unincorporated CID (Furuyama, Dalal et al. 
2006). The resulting complex was very simple: only CID, histone H4 and 
CAF-1 were determined, suggesting that CAF-1 might be the responsible 
chaperone for CID/H4-dimers. To date, no proteomic screen for centromeric 
composition in Drosophila is published. 
1.6 Aims of this thesis 
The fruit fly Drosophila melanogaster is a widely used model organism to 
unravel basic biological principles. The embryonically derived Schneider cell 
line is easy to manipulate by RNA interference (RNAi) (Elbashir, Harborth et 
al. 2001), thus enabling efficient screening for phenotypes. Some kinetochore 
proteins, like Aurora B kinase of the chromosomal passenger complex, have 
first been identified in Drosophila (Glover, Leibowitz et al. 1995). It is now 
clear that this protein has broad functions also in higher organisms including 
humans (Hochegger, Hegarat et al. 2013).  
Still, since centromeric DNA is fast evolving, members of the constitutive 
centromere-associated network are not conserved among different 
organisms. Information about these proteins lacks almost completely in 
Drosophila (chapter 1.4). Therefore, the goal of this work was to increase 
knowledge about the protein composition of centromeres in the model 
organism Drosophila melanogaster. In order to gain more insight into 
Drosophila centromere biology, the following questions were asked:  
1. What is the composition of the proteome present at Drosophila 
centromeres? 
2. Do the proteins interacting with CID localize to centromeres? Is their 
binding regulated in a cell cycle dependent fashion? 
3. What are possible functions of proteins present at Drosophila 
centromeres?  
To answer the first question, an AP-MS strategy, similar to the work used by 
Foltz et al. that discovered novel CENPs in human cells (Foltz, Jansen et al. 
2006), was chosen. For this purpose, CID was tagged with GFP. As 
introduced in chapter 1.2, this centromeric histone H3 variant is centromere-
bound throughout the whole cell cycle and therefore constitutes the ideal bait.  
Interactors determined by the AP-MS strategy were then confirmed by an 
independent assay. Immunofluorescence analysis was selected as it 
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determines localization of a factor in individual cells. Thereby, the localization 
can be easily monitored during different stages of the cell cycle. As introduced 
before (chapter 1.2), proteins belonging to different layers of the kinetochore 
structure show different binding behaviors during the cell cycle. Assessing if a 
factor is centromere-bound during interphase or specifically only during 
mitosis can help to closer identify its functions.  
Centromere-associated factors can have several potential functions, of which 
some should be tested for interesting factors here. First, centromere 
maintenance could be compromised when the amount of a respective factor is 
diminished by RNAi. Second, halftime of CID or other centromeric or cell cycle 
proteins could be impacted. Third, the cell cycle progression could be 
alternated. Fourth, it can be envisioned that deletion of centromeric proteins 
causes mitotic errors. Fifth, the establishment of the kinetochore layers during 
mitosis could be hampered.  
Answering these questions should help to make a big step forward to identify 
and characterize novel centromere-associated proteins in Drosophila 
melanogaster and thereby gain insight into processes that can lead to 
chromosomal aberrations.  
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2 RESULTS 
The goal of this work was to identify novel centromeric proteins in the model 
organism Drosophila melanogaster. Therefore, an affinity purification – mass 
spectrometry (AP-MS) strategy was applied (chapter 2.1-2.4). Selected 
candidates determined by this assay were re-analyzed by 
immunofluorescence analysis to check for centromeric localizations (chapter 
2.5). Furthermore, RNAi-mediated loss-of-function studies were conducted, 
addressing the potential requirement of centromere-localizing factors for CID 
incorporation in centromeres (chapter 2.6, 2.7), cell cycle progression 
(chapter 2.8) and centromeric architecture and function (chapter 2.9, 2.10). By 
this means, this work offers a comprehensive description of Drosophila 
melanogaster centromere composition and biology.  
2.1 Workflow for centromeric protein identification by AP-MS 
Figure 2.1 gives an overview of the experimental approach to isolate and 
identify centromeric proteins in D. mel. More detailed descriptions and 
explanations can be found in the respective chapters.  
 
Figure 2.1: Schematic workflow for AP-MS. Cells expressing GFP-tagged histone variants 
(bright green flag) were used to identify novel Drosophila centromeric proteins. Dark green 
ellipsoids, bands and circles constitute potential centromeric proteins. Blue symbols 
represent factors generally associated with chromatin as deduced from AP-MS experiments 
performed on H3.3-GFP expressing cell lines. Factors that are exclusively recovered in 
chromatin purifications from wildtype cells or that associate with the GFP-affinity matrix 
irrespective of the source of the soluble chromatin are depicted in grey. 
RESULTS 
32 
 
The proteomes of centromeric chromatin versus general chromatin were 
isolated in order to compare their compositions. For this purpose, D. mel 
Schneider cell lines expressing GFP-fusion proteins of the three Drosophila 
histone H3 variants CID, H3.2 and H3.3, respectively, were generated 
(chapter 2.2). CID is the centromere-specific H3 variant and its associated 
proteins can be compared to the ones in purifications of other H3 variants or 
wildtype chromatin. By that means, specific CID-GFP interacting proteins 
were assigned. Micrococcal nuclease (MNase) solubilized chromatin from 
large-scale cultures of the different cell lines was subjected to anti-GFP 
affinity purification (chapter 2.3). The isolated proteins were size-separated by 
denaturing gel electrophoresis. Histone H3 and H4 were excised individually 
and analyzed for posttranslational modifications (PTMs) (chapter 2.4.1). All 
other proteins contained in one lane were identified and quantified as 
described in chapter 2.4.2. Statistical analysis was utilized as a means to 
extract proteins that are most specific to centromeric chromatin (CID-GFP co-
purifying factors). This analysis revealed 94 potential centromere associated 
proteins (chapter 2.4.2). One third of these factors was checked for their 
cellular localization (chapter 2.5) and some also in other assays linked to 
centromere biology (chapter 2.6-2.10).  
2.2 Characterization of stable cell lines  
Before starting immunoprecipitations (IPs) and subsequent MS analysis, 
single steps of the workflow were set up, tested and optimized, starting with 
generation of cell lines to perform affinity purifications. To allow for 
comparable immunoprecipitation conditions, the three different histone 
variants CID, H3.2 and H3.3 of D. mel were fused to the same tag. A GFP tag 
was used as it provides a good means for IPs by commercially available GFP-
specific antibodies immobilized on beads (GFP-Traps). Moreover, this tag 
enables direct detection by fluorescence microscopy analysis.  
The stable cell lines were checked for protein levels of the exogenously 
expressed, tagged histone variants by Western blot (figure 2.2). CID-GFP 
levels were below the ones of endogenous CID, minimizing the risk of 
identifying binding partners of tagged variants as a result of overexpression 
(compare signal intensities for CID-GFP and endogenous CID in figure 2.2, 
lane one, lower panel). Because of the incomparable, low H3.2-GFP 
expression, results with this cell line were eliminated from downstream 
analysis.  
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Furthermore, localization of the tagged variants in the stable cell lines was 
determined by fluorescence microscopy (figure 2.3, 2.4). As expected, CID-
GFP signals showed a strong overlap with endogenous CID as determined by 
CID antibody staining. The CID antibody used here (7A2 subclone) does not 
detect the GFP-tagged CID protein, but only the endogenously expressed 
protein (figure 4.3). H3.2-GFP and H3.3-GFP showed the expected 
homogenous nuclear distribution. Figure 2.3 gives an impression of GFP-
tagged variant fluorescence levels, since here the settings are comparable 
between different panels. Confirming the Western blot results with a GFP 
antibody (figure 2.2), H3.3-GFP levels were higher than the ones of H3.2-
GFP. CID-GFP expression being less than the one of H3.3-GFP mirrors the in 
vivo situation, since CID is only present in the confined region of centromeres 
whereas H3.3-GFP can be incorporated throughout the genome. The cell 
lines therefore represent a good experimental system to identify proteins 
interacting with CID.  
Figure 2.2: Expression levels of tagged 
histone variants in stable cell lines used 
in this work. Western blots of MNase 
solubilized chromatin used for 
purifications. The appropriate sizes of 
the tagged or untagged proteins are 
indicated.  
RESULTS 
34 
 
 
Since expression levels are so different between the GFP-tagged histone 
variants, microscopic settings were adapted in order to avoid overexposure 
like for H3.3-GFP in figure 2.3. Figure 2.4 better demonstrates localization 
patterns of all variants.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Localization of GFP-tagged histone variants in stable cell lines. Scale bar 
corresponds to 3 µm. Maximum intensity projections of deconvolved images are shown. 
Blue: DNA stained with DAPI, green: GFP, red: CID.  
Figure 2.3: Image acquisition with identical hardware and software settings for comparing 
intensities confirms quantitative differences in GFP-variant expression levels. Scale bar 
corresponds to 3 µm. Maximum intensity projections of deconvolved images are shown. 
Blue: DNA stained with DAPI, green: GFP, red: CID.  
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2.3 Optimization of conditions for immunoprecipitation 
After confirming the suitability of the cell lines for affinity purifications, the right 
ratio of affinity-matrix amount to proteins was determined in small scale 
experiments (chapter 4.2.4) in order to advance purification conditions and to 
gain optimal results. Subsequently, the actual immunoprecipitations for MS 
analysis were upscaled and chromatin prepared from around 5*109 cells. For 
immunoprecipitation, soluble input chromatin was incubated with the GFP-
Trap affinity resin for 2 hours. After extensive washes to remove unspecifically 
associating proteins, co-precipitated material was eluted from beads by 
boiling ten minutes in 2x Laemmli buffer. The prolonged heating time as well 
as the high concentration of SDS (4 % end-concentration) were chosen to 
ensure a complete protein release from the resin. To evaluate whether the 
immunoprecipitation reaction successfully enriches for GFP-fusion proteins, a 
Western blot analysis with anti-GFP antibody was carried out of both MNase 
solubilized chromatin input material and proteins bound to the affinity matrix. 
Figure 2.5 shows this analysis with samples from one of the biological 
replicate. 
 
 
A similar GFP-variant abundance in input material is detected as in figure 2.2 
and the Western blot signal intensity of GFP-tagged variants in the eluate 
fraction (beads) is indicative of a successful affinity chromatography reaction.  
For the mass spectrometry analysis of immunoprecipitated material, the 
eluted proteins were separated on a denaturing 15 % polyacrylamide gel. The 
gel was then stained with either Coomassie Brilliant Blue or silver nitrate to 
Figure 2.5: Enrichment of 
GFP-tagged histone 
variants on GFP-Traps. 
Western Blots of input 
fractions before affinity 
purification and proteins 
eluted from beads after IP. 
The appropriate size of 
tagged variants is indicated. 
An amount corresponding to 
4% (CID), 6% (H3.2) or 8% 
(H3.3) of the total material 
used for IP reactions is 
loaded as input. Samples 
were taken from the 
replicate SID1392.  
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check for protein amounts and quality of the affinity purification. Finally, the 
individual lanes were evenly cut in eight fractions for downstream mass 
spectrometric analysis. Figure 2.6 represents one example of a silver stained 
SDS-PAGE from such a purification. The histone proteins (H3, H2A, H2B and 
H4, highlighted in figure 2.6) are abundant in the immunoprecipitated 
fractions, indicating that chromatin is enriched on the beads. The GFP-tagged 
variants, as marked by asterisks, can be identified due to their sample-specific 
appearance at the expected running height in the gel. The identity of the 
proteins corresponding to these bands was also confirmed by MS analysis 
(figure 1 of the appendix for CID, figure 2.7 for H3.2/H3.3).  
 
 
The intensities of the histone variants H3.2 and H3.3 present in the band of 
tagged protein from figure 2.7 can be determined by MS analysis. These two 
H3 variants only differ in four residues: position 31, 87, 89 and 90. With the 
treatment applied for analyzing histone modifications by mass spectrometry 
(explanation in methods chapter 4.2.5.3, chapter 2.4.1), the positions 87, 89 
and 90 lie within a peptide ranging from residue 84-116, which is not well 
detectable by MS analysis. Therefore, the peptide containing amino acids 27 
to 40 of histone H3 was used for discrimination of the two isoforms. H3.2 
harbors an alanine residue and H3.3 a serine on position 31, differing by 16 
atomic mass units (amu). The ionized peptides can thus be distinguished by 
mass spectrometry due to their different mass-to-charge ratios (m/z ratios). 
Figure 2.7 shows that, as expected, in the band cut from H3.2-GFP 
expressing cells, H3.2 is contained and vice versa for H3.3, proving that the 
proteins in excised bands from figure 2.6 indeed correspond to the H3.2-GFP 
or H3.3-GFP variants, respectively.  
 
Figure 2.6: Protein gel of proteins eluted 
from beads in different 
immunoprecipitations. A representative, 
silver stained gel of affinity purifications 
from the different cell lines is shown. 
Asterisks mark the GFP-tagged variants 
(confirmed by MS analysis). H3: histone 
3, H2B: histone 2B, H2A: histone 2A, 
H4: histone 4.  
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With the established workflow, it is possible to precipitate chromatin 
containing different GFP-tagged H3 variants. As the correct GFP-tagged 
variants are enriched on beads, (figure 2.5, 2.6 and 2.7), MS analysis of the 
chromatin proteins co-purifying with different variant proteins was carried out.  
2.4 Analysis of mass spectrometry data 
2.4.1 Histone posttranslational modifications of H3 variant chromatin as 
determined by LC-MS/MS analysis 
Centromeric chromatin consists of CID-containing nucleosomes as CID is the 
centromeric histone H3 variant. CID and H3 are incorporated as dimers with 
histone H4 and centromeric chromatin is also interspersed by H3-containing 
nucleosomes. Earlier studies of histone PTMs using antibody-based detection 
indicated that histone H3 and H4 are hypoacetylated in centromeric regions 
(chapter 1.4).  
The presence of the characteristic pattern of core histones on protein gels of 
the different IPs enabled MS-based analysis of histone posttranslational 
modifications (PTMs) on cutout histone bands (figure 2.6). Histone H4 can be 
acetylated on four different residues in its N-terminus: lysine 5, 8, 12 and 16 
(Sung and Dixon 1970). The treatment for MS analysis generates one peptide 
ranging from amino acids four to seventeen spanning all four of these lysines. 
It was therefore interesting to see whether this peptide carries different 
modification patterns in purifications associated with the respective H3 
variants.  
Histones co-purifying with chromatin from each IP were excised from the 
SDS-polyacrylamide gel and analyzed individually with a different protocol 
Figure 2.7: Enrichment 
of histone variant H3.2 
and H3.3 in the isolated 
protein bands marked 
with asterisks in figure 
2.6 as determined by 
mass spectrometry 
analysis. The values of 
unmodified peptide 27-
40, which differs in mass 
for both variants, were 
taken for calculation.  
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specific for histone PTM mass spectrometry analysis (chapter 4.2.5.3). Figure 
2.8 shows the analysis of a histone H4 peptide (residues 4 to 17) containing 
four lysines that can be acetylated: lysine 5, 8, 12 and 16. For display, values 
from all five different modification states (completely unmodified peptide or 
peptide carrying between 1 and 4 acetylations) were added up to 100 % and 
percentages of the respective modification in either of the affinity purifications 
are depicted.  
 
 
 
 
 
 
 
 
 
 
 
H4 of CID-GFP containing chromatin contains more monoacetylation and 
almost 2.5-fold more diacetylation, whereas the H4 molecule co-purifying with 
H3.3-GFP does not show a clear trend. In contrast to previous reports 
(Sullivan and Karpen 2004), these results indicate a slightly higher H4 
acetylation in nucleosomes containing CID-GFP.  
2.4.2 Identification and quantification of proteins in purified fractions by LC-
MS/MS analysis  
The application of mass spectrometry analysis to the immunoprecipitated 
material as produced for figure 2.6 results in identification and quantification of 
factors associated with the respective GFP-tagged histone H3 variants. The 
Figure 2.8: Modification status of histone H4 peptide 4-17 co-purified in different affinity 
purifications. Percentages of the occurrence of different modifications are displayed. Un: 
unmodified peptide, ac: peptide carrying one acetylation, 2ac: peptide carrying two 
acetylations, 3ac: peptide carrying 3 acetylations, 4ac: peptide carrying 4 acetylations. 
Values derived from 3 (wildtype, H3.3-GFP) or 4 (CID-GFP) biological experiments, 
respectively. Error bars represent standard deviations.  
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raw files of the MS runs are deposited in ProteomeXchange with identifier 
PXD000758 (http://proteomecentral.proteomexchange.org/dataset/PXD000758) 
and a MaxQuant output list of all identified proteins is published 
(http://onlinelibrary.wiley.com/doi/10.1002/pmic.201400052/suppinfo, table S1). An 
extended description about how protein abundances can be measured 
quantitatively by MS analysis can be found in chapter 4.2.5.2. Briefly, the 
peptide sequences detected in the spectra are compared to a database 
containing all theoretical tryptic peptides of the Drosophila proteome. If an 
identified peptide is unique, it can be assigned to a certain protein and its 
abundance can be determined. Abundance values come from extracted ion 
chromatograms (XICs, figure 4.7). The software MaxQuant provides an iBAQ 
value, which stands for intensity based absolute quantification. A feature of 
the value is taking into account that larger proteins may generate more tryptic 
peptides that can be detected. In the case of larger proteins, this also 
translates into higher total intensities. As the iBAQ value is corrected for this 
issue, its value correlates well with the abundance of a protein contained in 
one sample irrespective of its size.  
To detect differences in protein abundance in the immunoprecipitated 
proteins, the result files of biological replicates of control purifications 
(wildtype L2-4 cells, experiments SID1275, SID1341, SID1392), CID-GFP 
purifications (SID1275, SID1341, SID1392) and H3.3-GFP purifications 
(SID1341, SID1392, SID1508) were analyzed. Proteins only identified in CID-
GFP IPs were defined as specific to CID-GFP containing chromatin. Figure 
2.9 shows the number of proteins for which an iBAQ value could be calculated 
in at least one of the three biological replicates and the overlap of the 
respective proteins between the different immunoprecipitations. 149 proteins 
were identified exclusively in at least one CID-GFP purification and in none of 
the six other purifications (3x wildtype, 3x H3.3-GFP). A list with names of 
these potentially interesting factors is attached in table 1 in the appendix. 
Control centromeric proteins like CENP-C and Cal1 are contained therein, 
demonstrating the specificity of this purification.  
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Since the analysis provided quantitative values for all different affinity 
purifications, it allowed for the calculation of enrichments of factors in CID-
GFP versus wildtype IP and CID-GFP versus H3.3-GFP IP, which eliminates 
proteins binding to the affinity matrix and general chromatin binding factors, 
respectively. This strategy should retain the most specific factors of 
centromeric chromatin. Statistical analysis was performed by Dr. Andreas 
Schmidt.  
The log2-transformed iBAQ values obtained by MaxQuant analysis exhibited 
a Gaussian distribution, which is a prerequisite to many statistical tests 
(chapter 4.2.5.5, figure 4.9), thus enabling statistical analysis of this dataset. 
Therefore, iBAQ values of identified proteins in the CID-GFP purification and 
corresponding values in the control or H3.3-GFP sample were transformed by 
applying the logarithm to the basis of two. Zero values, occurring if a protein is 
not identified in a given sample, were replaced by imputation with values 
taken from a random distribution centered around one third of their lowest 
value. The imputation was repeated three times and the average value 
employed for subsequent calculations. These repetitions help reducing false 
positive or false negative assignations by imputation. ANOVA (analysis of 
variance) test was applied to compare protein abundances between different 
Figure 2.9: Venn diagram giving proportions of all identified proteins and their overlap in 
different purifications. Proteins are counted if they got identified at least in one of the three 
biological replicates. Percentages and numbers indicate the portion of the total proteins that 
were either identified in all different purifications (middle) or in one specific IP. Diagram 
created with BioVenn (http://www.cmbi.ru.nl/cdd/biovenn/).  
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affinity-purification experiments in the three biological replicates and calculate 
p-values (see table 2, appendix). P-values were corrected for multiple 
hypothesis testing by the method of Benjamini-Hochberg (Benjamini and 
Hochberg 1995) which is the preferred method for large proteomics datasets.  
The average enrichment in protein abundance of all three biological replicates 
is plotted in figure 2.10. Proteins with a more than 16-fold enrichment over 
both controls (log2 ratios of more than four) were considered as potential CID-
GFP interactors (green dots, protein names included in inlet). A complete list 
of candidate proteins including average ratios and their standard deviations as 
well as p-values for both controls is included in table 2 (appendix). This table 
furthermore includes information about expression vectors for Drosophila cells 
created and used in this work as well as a summary of the cytological 
experiments that were conducted. 
Among the candidate proteins were the two different isoforms of CAF-1, CAF-
1-PA and CAF-1-PB. The PA-isoform contains one additional amino acid, an 
alanine in position 8. Apart from that, the two isoforms are completely 
identical. Since the peptide covering the differing amino acid was identified by 
MS analysis for both isoforms, it is possible to distinguish them by mass 
spectrometry (figure 2.10, table 1 and 2, appendix). MaxQuant analysis to 
determine iBAQ values was set to only quantitate unique peptides – in this 
case, only the one spanning amino acid 8 (4-18 in CAF-1-PA). Therefore, 
individual quantification of the both isoforms is indicated for example in figure 
2.10 and tables in the appendix.  
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Figure 2.10: Plot of all proteins identified by MS analysis. Shown are log2 values of average 
ratios of iBAQ values in CID-GFP purifications versus control purifications (wt, x-axis) or 
versus H3.3-GFP purifications (y-axis). Each dot represents one identified protein. The inset 
on the right shows a magnification of the upper right quadrant and the lower one another 
magnification as indicated by boxes in the figure. Blue dots and protein names: Proteins only 
enriched over the wildtype control. Green dots and green and black protein names: average 
log2 value in both controls bigger than 4. Green protein names (see also table 2, appendix): 
Candidates further tested for cellular localization (chapter 2.5).  
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In total, 1871 proteins were identified in all experiments. Grey dots in figure 
2.10 represent factors whose enrichment in CID-GFP purifications was less 
than 16-fold (log2 ratio < 4) compared to both controls. These proteins were 
therefore classified as unspecific affinity-matrix binders (background binders). 
Only 85 proteins passed the arbitrary threshold (table 2, appendix). They are 
labeled with green dots and their names are written in black and green in 
figure 2.10. As expected, the bait protein CID is the most enriched protein and 
GFP is highly enriched only over the wildtype control, but not over H3.3-GFP 
(thus labeled in blue in figure 2.10). CG30390 is a factor that is enriched in 
CID-GFP IP versus both H3.3-GFP and wildtype precipitation and thus 
locates to the upper right quadrant in figure 2.10. Hence, it is one of the 85 
enriched factors that are also listed in table 2 (appendix). Its enrichment in 
CID-GFP purifications was also verified by Western blot analysis (figure 2.11). 
Similar to figure 2.5, input and bead material from another replicate was 
loaded on a 15 % SDS-polyacrylamide gel and analyzed by anti-GFP 
antibody, indicating that the right GFP-tagged H3 variant is present on the 
beads. Subsequently, the membrane was probed with CG30390-specific 
antibody. It only gives a signal in purification of the CID-GFP containing cells, 
meaning that CG30390 interacts with CID-GFP. 
 
 
 
 
 
 
Reanalysis of the primary data uncovered that some factors, which repeatedly 
and exclusively co-purified with CID-GFP chromatin, did not pass the initial 
filtering. Consequently, the process of imputation might create false negative 
assignments by replacing zero for higher values in non-CID chromatin 
purifications. Thereby, the calculated enrichment of bona fide centromere 
associated proteins might drop below the threshold. Thus, based on their 
specificity of interaction with CID, additional factors were included that could 
also be involved in centromere biology. For these factors, at least 90 % of all 
iBAQ values from the nine replicates (3x wildtype, 3x CID-GFP, 3x H3.3-GFP) 
Figure 2.11: CG30390 specifically associates with CID-GFP containing chromatin. Western 
blot probed with a CG30390 specific antibody and GFP antibody. Loaded are 0.3 % of the 
input and 80 % of the immunoprecipitated material. 
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must have originated from the three CID-GFP purifications, reflecting their 
specific presence in CID-containing chromatin. Thereby, nine proteins were 
included (Hcf, asp, CG6227, CG32343, CG1399, RhoGAP54D, CG8478, 
Top3beta, Ge-1), elevating the number of potential centromeric proteins to 94 
(85 passing the threshold plus nine additional factors, see table 2, appendix).  
After determining 94 potential centromere proteins (table 2, appendix), the 
current literature was searched for prior knowledge about these factors. This 
can help to categorize the factors in order to define future directions of 
research. The STRING database (Franceschini, Szklarczyk et al. 2013) 
provides a collection of information on proteins and genes from different 
curated databases (MINT, HPRD, BIND, DIP, BioGRID, KEGG, Reactome, 
IntAct, EcoCyc, NCI-Nature Pathway Interaction Database, GO) and model 
organisms and can automatically connect a number of factors via these data. 
The 94 candidates were fed into the algorithm and information with at least 
medium confidence (confidence score 0.4) about coexpression, experiments, 
databases and text mining in Drosophila melanogaster and other species was 
included in the analysis. Figure 2.12 represents the output of the STRING 
database analysis.  
Figure 2.12: STRING database network indicating known relations of proteins that were 
enriched with CID-GFP. Black lines: Coexpression in D. mel or other species. Pink lines: 
Interactions based on experimental data. Blue lines: Information gained from curated 
databases. Green lines: Information obtained from text mining.  
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Different clusters can be recognized (for example, centromeres: Cal1, CID, 
CENP-C, CAF-1, bottom left; HATs: Hcf, YL-1, CG30390, CG32343, middle 
right; RNA-associated clusters like CG3335, CG9630, CG32344, CG6769, top 
left; REG, CG14480, Ard1 and CG9418, middle; Rrp4, Spt6 and Mtr3, middle; 
potential cytoplasmic factors: CG6084, CG6776, CG6180, Jheh2, upper right) 
indicating the co-purification of complex protein assemblies. However, many 
factors have not been referred together with any other of these proteins. This 
could be due to a lack of centromere proteome studies in D. mel prior to this 
work. 
To confirm the centromeric association of candidate factors, 
immunolocalization was used as a complementary technology allowing single 
cell analysis of physiological states. Candidates to test by immuno-
fluorescence were chosen from the pool of 94 proteins (table 2, appendix) that 
were at least identified in two out of three CID-GFP biological replicate 
purifications and show a high specificity for CID-GFP purifications. Of the top 
40 factors fulfilling these criteria, 32 were selected and further tested (chapter 
2.5). They are labeled in green in table 2 (appendix) and in figure 2.10. The 
remaining eight factors were not investigated since expression constructs 
were not available and molecular cloning from cDNA templates failed 
(CG32344, SRPK, qkr58E-2, CG32069, CG6151, CG13117, RhoGAP54D, 
and CG8478). 
2.5 Cellular localization analysis of selected candidate proteins by 
fluorescence microscopy 
As explained in chapter 2.4.2, 32 proteins enriched in CID-GFP containing 
chromatin were selected for further analysis. Whether they truly localize to 
centromeres in vivo was investigated by immunolocalization experiments. 
Therefore, colocalization of candidate proteins with CID was investigated in 
cells that were either transiently or stably transfected (indicated in the figure 
legends) with expression constructs encoding for either GFP- or FLAG/HA-tag 
fusion proteins. Immunofluorescence experiments were carried out by both 
Georg Schade and me. 
For two of the most enriched factors on CID-containing chromatin, CG2051 
and CG14480 (figure 2.10, table 2, appendix), stably transfected cell lines 
were established by selecting cells with hygromycin for at least four weeks. 
Stable cell lines are preferred to transiently transfected cells as they 
frequently display more moderate transgene expression levels. In the cases of 
monitoring fusion protein localization in transiently transfected cells, only low 
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level expressing cells were chosen to avoid overexpression-driven 
mislocalization. Figure 2.13 shows localization of the GFP-tagged proteins in 
the stable cell lines either as maximum intensity projections of all optical 
sections or single optical sections (indicated as "z="). This figure emphasizes 
the need of assessing potential colocalization of CID and the putative 
centromere protein in single section images. In maximum intensity projections 
of all sections, spatial information about localization gets lost. Signals of both 
CG2051-GFP and CG14480-GFP are present in euchromatic areas in the 
whole nucleus. In single sections, however, presence at the centromere is 
clearly visible.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14 summarizes all factors found to colocalize with CID in this 
analysis. Single sections were chosen to highlight colocalizations as 
illustrated in figure 2.13. For better visibility of signal distributions in different 
channels, line profiles are added in figure 2.14 and 2.15. Here, lines can be 
drawn in the merged picture and a software (RGB profiler) plots the intensities 
Figure 2.13: Localization of CG14480-GFP or CG2051-GFP, respectively, in stable cell 
lines. The pictures are maximum intensity projections unless the single optical section 
displayed (z) is indicated. Pictures were deconvoled. Scale bar represents 5 µm. Blue: DAPI, 
green: GFP signal, red: CID antibody stain.  
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of the different channels (y-axis) versus the distance on the drawn line (x-
axis). The centromere signals (red peaks) can then be overlaid with 
information from the channel corresponding to the detection of tagged 
candidate protein (green signal).  
In this work, the proteins CG2051, CG14480, CG3548, CG9293, CG9418, 
CG6227, gfzf, MED30 and REG were shown for the first time to localize to 
centromeres. CG3548 is found on centromeres only during M-phase of the 
cell cycle and not during interphase (figure 2.14). Colocalization of Subito 
(sub) and CID has already been demonstrated in larval brain tissue (Cesario, 
Jang et al. 2006).  
 
 
Figure 2.14, part 1. Continued on next page.  
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Figure 2.15, part 1. Continued on next page.  
Figure 2.14: Candidates colocalizing with CID. Single optical sections of deconvolved 
images are shown. Scale bars represent 3 µm. The line profile plots depict the distribution of 
signals in the three channels along the line drawn in the merge panel. Blue: DNA stained 
with DAPI, green: epitope-tagged candidate protein, red: CID. Images for CG2051, 
CG14480 and CG3548 are obtained from stably transfected cell lines, the others from 
transient transfections. Immunofluorescence images have been acquired by both Georg 
Schade and me. 
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Despite their biochemical association with CID-containing chromatin, a 
number of factors exhibited nuclear localization without enrichment at 
centromeres (figure 2.15). One of these factors is CAF-1. As an antibody was 
available, no overexpression had to be performed. CAF-1 localizes to 
euchromatin and the line profile reveals no enrichment at CID foci. Still, 
CAF-1 has been shown to bind to CID (Furuyama, Dalal et al. 2006). Thus, 
the category of nucleus-localizing proteins can potentially also be implicated 
in centromere biology. Other factors of this class comprise Rbcn-3A, RagC, 
YL-1, CG12343, asp, Cdk12, hyd, su(hw), Hcf, ATAC3, CG11076, CG4972 
Figure 2.15: Candidates exhibiting nuclear localization. Single optical sections of 
deconvolved images are shown. Scale bars represent 3 µm. The line profile plots show the 
distribution of signals in the three channels on the location of the line drawn in the merge 
panel. Blue: DNA stained with DAPI, green: epitope-tagged candidate protein except CAF-1 
(anti-CAF-1 antibody signal), red: CID. Images recorded on transiently transfected cells 
except CG11076-GFP (stable cell line). Immunofluorescence images have been acquired by 
both Georg Schade and me. 
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and CG30390. As CG11076 displayed a distinct localization to regions of low 
DAPI intensity, its colocalization with the nucleolar factor Fibrillarin was tested 
(figure 2.16). Indeed, a good overlap of the two signals can be observed, 
indicating that CG11076 localizes to nucleoli.  
 
 
 
 
 
Thus, 24 out of 32 tested factors were found to localize to nuclei. Other eight 
proteins showed signals outside of nuclei (figure 2.17): either in the 
cytoplasm, like Fmr1, CG7518, infertile crescent (Ifc), CG1265, CG1091, and 
Hsp70Ab, or in the cell membrane, like CG1399 and Tsp42Ed. Hsp70Bbb is 
the heat shock protein isoform contained in the 94 enriched proteins; 
however, Hsp70Ab and Hsp70Bbb share 99 % of identity on protein level (five 
different amino acids in 641 amino acids). Both proteins were identified 
exclusively in CID-GFP purifications (table 1, appendix); but only Hsp70Bbb 
passed the threshold of an enrichment bigger than 16 (figure 2.10; table 2, 
appendix). For reasons of construct availability, figure 2.17 shows 
immunolocalization of Hsp70Ab only. Presumably, localization of Hsp70Bbb is 
similar to the one of Hsp70Ab.  
 
 
 
Figure 2.16: CG11076 colocalizes with Fibrillarin. Single optical sections of deconvolved 
images are shown. Blue: DNA stained with DAPI, green: CG11076-GFP, red: Fibrillarin. 
Scale bar represents 3 µm. A stable cell line expressing CG11076-GFP was used. Figure 
created by Georg Schade. 
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Figure 2.17: Candidates exhibiting localizations outside nuclei. Single optical sections are 
shown, images were deconvolved. Scale bars represent 3 µm. Blue: DNA stained with DAPI, 
green: epitope-tagged candidate protein, red: CID. Images obtained from transiently 
transfected cells except CG1091 (stable cell line). Immunofluorescence images have been 
acquired by both Georg Schade and me. 
RESULTS 
52 
 
It was surprising to detect not only centromeric or nuclear proteins, but 
additionally also some that were located in the cytosol. This might be due to 
mixing of cytosolic and nuclear fractions during preparation of extracts (see 
also chapter 3.2). Alternatively, centromere association of candidate proteins 
may be cell cycle regulated, which was not investigated systematically for all 
32 candidates. Nevertheless, different localization patterns were observed for 
the factor CG3548 (figure 2.14) which did not overlap with CID-stained 
regions in interphase, but on metaphase chromosomes. Therefore, its 
localization was also investigated on mitotic chromosome spreads (figure 
2.18). As observed in asynchronous, fixed cells, CG3548 colocalizes with CID 
on mitotically condensed chromosomes with some prominent additional extra-
centromeric foci. CG2051 and CG14480 are also bound to metaphase 
chromosomes, but are mostly distributed on chromosome arms without 
specific centromere enrichment (figure 2.18).  
 
 
In sum, CG3548 is present at centromeres only during mitotic phase of the 
cell cycle (figure 2.14, 2.18), indicating that it possibly constitutes a 
kinetochore component. Adversely, the two highly enriched factors CG14480 
Figure 2.18: Mitotic chromosome spreads of CG2051, CG14480 and CG3548-GFP 
constructs in stable cell lines. Blue: DNA stained with DAPI, green: GFP signal from tagged 
candidate protein, red: CID. Yellow arrows point out bright red spots (CID signal), orange 
arrows green ones (GFP signal). Scale bar represents 3 µm. Images are deconvolved and 
maximum intensity projections are shown. Figure created by Georg Schade.  
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and CG2051 can be found in euchromatin and centromeres during interphase 
and not during mitosis (figure 2.13, 2.14, 2.18). Other six factors were found 
as colocalizing with CID in interphase: CG9293, CG9418, CG6227, gfzf, 
MED30 and REG (figure 2.14). Fourteen more factors are localizing to the 
nucleus (figure 2.15) and could be involved in centromere biology just like 
CAF-1.  
2.6 Influence of candidate proteins on CID-GFP incorporation in 
centromeres  
One possible function of a centromeric protein is to promote the incorporation 
of CID at each round of cell division. To test if this hypothesis is true for some 
of the determined factors, the amount of candidate proteins was reduced by 
RNAi-mediated knockdown and the impact on centromeric CID amount was 
analyzed. 
2.6.1 Influence of factors on centromeric incorporation of newly synthesized 
CID 
An elegant way to measure incorporation of newly synthesized CID into 
centromeres is the use of the so-called SNAP technology (Keppler, 
Gendreizig et al. 2003). This technology is based on a suicide reaction of the 
enzyme O6-alkylguanine-alkyltransferase, usually responsible for DNA 
damage repair involving guanine adducts. The SNAP-tag is a 20 kDa mutant 
form of this enzyme that reacts specifically with the substrates benzylguanine 
and benzylchloropyrimidine. An ether bond in the substrate is cleaved and a 
covalent bond with the enzyme is generated, with the reaction being 
irreversible. If the substrate is coupled to a fluorophore, the dye is conjugated 
to the SNAP-tag, making the technology suitable for fluorescence microscopy 
(Keppler, Pick et al. 2004). The scheme for the experiment is depicted in 
figure 2.19. D.mel Kc167 cells, a cell line derived from a female Drosophila 
embryo, coexpressing GFP-tagged CID as well as CID fused to the SNAP-
tag, were obtained from the group of Gary Karpen (UC Berkeley). The CID-
SNAP fusion can be reacted to the cell-permeable TMR-Star substrate 
(tetramethylrhodamine fluorophore coupled to benzylchloropyrimidine). 
Thereby, SNAP-CID can be visualized by fluorescence microscopy (figure 
2.19, panel A). Alternatively, the cell-permeable drug BTP 
(bromothenylpteridine) can be added to cells expressing SNAP-CID. It will 
also be conjugated to SNAP-CID, but does not give a signal when analyzed 
by fluorescence microscopy (panel B). Hence, BTP treatment of cells will 
render all present SNAP-CID molecules unavailable for the conjugation of a 
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fluorophore, a process referred to as quenching. However, as soon as BTP is 
removed (chase), newly synthesized SNAP-CID can again react with a 
fluorophore (pulse). Quench-chase-pulse experiments were performed using 
the following scheme (panel C): Cells in different knockdown situations 
expressing SNAP-CID were incubated with BTP to block all SNAP enzymes 
(quench). After 24 hours of chase, corresponding to approximately one 
complete cell cycle in Drosophila Kc cells, TMR was added (pulse) and 
thereby exclusively SNAP-CID synthesized during the last 24 hours was 
detected by confocal microscopy. If this workflow is combined with RNAi 
treatment of cells before the quench, it allows screening for effects on 
incorporation of newly synthesized CID in the absence of a given centromeric 
factor.  
 
 
 
 
 
 
Figure 2.20 displays a TMR-stain of unblocked Kc cells (upper panel), 
demonstrating that the TMR signal colocalizes with the CID signal as 
expected. A quench-chase-pulse experiment with control (GST) knockdown is 
displayed in the lower panel. 
Figure 2.19: Schematic presentation for SNAP quench-chase-pulse experiment as 
performed in figure 2.21. A: CID is expressed with a SNAP tag. This enzyme can conjugate 
the benzyl and fluorophore part of an added TMR-Star substrate. B: Alternatively, the SNAP 
enzyme can also conjugate BTP to itself. C: For quench-chase-pulse experiments, cells in a 
knockdown situation are subjected to BTP, thereby quenching all preexisting SNAP tags. 
After 24 hours chase, TMR is added (pulse). The fluorophore then marks all SNAP-CIDs 
synthesized in the last 24 hours of the chase.  
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Although colocalization of TMR-labeled SNAP-CID with CID-GFP is observed 
after BTP block and a 24 hour release, the high background of the TMR-Star 
signal in cytoplasm and nucleus hampered reliable measurement of CID-TMR 
signals in centromeres.  
Figure 2.21 shows one quench-chase-pulse experiment series using the 
SNAP technology combined with knockdowns of known centromeric factors 
as well as selected candidate factors. An additional control was included to 
demonstrate that the BTP quench was successful (uppermost panel). 
Therefore, upon quenching and removal of BTP, cells were directly pulsed 
with TMR-Star without a chase. As expected, the CID-GFP signal is still 
visible, but no TMR-Star signal, since the cells were not allowed to newly 
synthesize SNAP-CID available for TMR-Star conjugation. This demonstrates 
that the BTP block was successful. A knockdown of cid itself as well as 
knockdown of cal1, which encodes the CID deposition chaperone (Mellone, 
Grive et al. 2011), served as positive controls, RNAi against GST as negative 
control. While control experiments produced the anticipated results (for 
reduction of CID and CID-GFP levels in cid knockdown, see also figure 2.23 
lanes 9 and 10), REG and CG14480 knockdowns do not lead to obvious 
defects in centromere loading of newly synthesized CID (figure 2.21, lowest 
two panels).  
Figure 2.20: Stain of SNAP-CID in a stable cell line by TMR with or without BTP block. Blue: 
DNA stained with DAPI, green: CID (upper panel: antibody stain, lower panel: CID-GFP 
signal), red: SNAP-CID. Maximum intensity projections, images not deconvolved. Scale bar 
represents 3 µm. 
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Figure 2.21: SNAP quench-chase-pulse experiment. Cells were treated with different 
dsRNAs (kd) for five days before the experimental scheme as indicated in figure 2.19C was 
applied (total knockdown time: 6 days). Blue: DNA stained with DAPI, green: CID-GFP, red: 
TMR-Star labeled SNAP-CID. Maximum intensity projections of non-deconvolved images 
are shown. Scale bars represent 5 µm.  
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When looking closer to the CAF-1 knockdown images, there is a signal visible 
for TMR-Star labeled SNAP-CID at each centromere as determined by the 
CID-GFP channel. However, such faint signals can get masked by the high 
nuclear and cytosolic background staining. If a knockdown influences CID 
incorporation at centromeres, the signal in both the CID-GFP as well as the 
SNAP-CID channel are decreased. This, together with a problem of variable 
TMR-Star staining backgrounds, complicates automatic detection of 
centromeres and reliable quantification of SNAP-CID intensity therein. A 
quantitative statement about incorporation of newly synthesized CID in 
centromeric regions by automated analysis was thus not possible with this 
method. Therefore, CID-GFP fluorescence in centromeres upon candidate 
knockdown was measured to study their effect on CID deposition.  
2.6.2 Quantification of CID-GFP signal intensities in centromeres  
Knockdowns of different factors in the CID-GFP cell line also used for the AP-
MS experiments were performed for six days before cells were analyzed by 
quantitative fluorescence microscopy. For this, fixed cells were imaged with 
constant hardware settings on a confocal laser scanning microscope. 
Deconvolved maximum intensity projections of these images were analyzed 
automatically with a pipeline in the software CellProfiler. The pipeline was 
developed by Dr. Andreas Thomae (see chapter 4.2.6.3 for a more detailed 
description). First, nuclei are detected using the DAPI staining. Second, 
centromeres are defined by a GFP signal in the nuclei. Third, average 
centromeric GFP intensity per cell was determined and multiplied with the 
detected number of centromeres to obtain the total centromeric CID-GFP 
intensity per cell. This value is plotted in the upper panel of figure 2.22. The 
pipeline also detects the number of centromere clusters present in one 
nucleus, an interesting variable since centromere declustering phenotypes are 
observed when knocking down another recently described centromere factor 
termed NLP (Padeken, Mendiburo et al. 2013) (see chapter 1.4). The number 
of centromere foci per cell is plotted in the lower panel of figure 2.22.  
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As expected, control knockdowns, like cid, cal1 and CENP-C (two different 
dsRNA constructs, 1 and 2) lead to a decrease in intensity of GFP in 
centromeres and less centromere clusters per cell as compared to a GST 
control knockdown. No other knockdown resulted in a decrease of intensity, 
but surprisingly, hyd, REG and CG6227 depletion in cells led to increased 
CID-GFP intensity in centromeres and higher centromere cluster numbers. 
Whether more CID-GFP results in more centromere clusters or the other way 
round cannot be deduced from this analysis. All other proteins analyzed here 
did not show any effect, indicating that they do not influence incorporation or 
maintenance of CID at centromeres.  
 
Figure 2.22: Quantification of CID-GFP in stably transfected cells in different knockdown 
conditions. Upper panel: Intensity of GFP signal in centromeres, arbitrary units. Lower panel: 
number of centromere foci measured per cell. The results are plotted in a box plot. The blue 
line indicates the median value of GST knockdown as a comparison. n: number of analyzed 
cells. Kd: knockdown of different genes. Red crosses show maximal outliers. Box plots 
created with Vertex42
TM
 Box and Whisker Plot Template. The median value is indicated by a 
horizontal black line surrounded by an upper and lower quartile, each comprising 25% of all 
values. Whiskers correspond to a maximum of 1.5 times of the inter-quartile range, meaning 
length of the box; maximum outliers are marked by a red cross.  
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2.7 Hyd or REG loss does not result in a global increase of CID-
GFP 
The RNAi-mediated reduction of hyd, REG and CG6227 levels resulted in an 
increase of centromeric CID amounts (chapter 2.6.2). Hyd is an E3 ubiquitin 
ligase and REG a proteasome activator, suggesting that these factors might 
be involved in regulation of CID turnover through the ubiquitin proteasome 
system. Therefore, the effect of hyd and REG knockdowns on CID levels and 
ubiquitination were investigated by Western blot analysis. In order to stabilize 
ubiquitination, Drosophila L2-4 cells stably expressing CID-GFP were treated 
with NEM (N-ethylmaleimide) and/or MG-132 six hours before harvest and 
both inhibitors were always included in the protein extraction buffers. NEM 
irreversibly inhibits deubiquitinases whereas MG-132 inhibits the 26S 
proteasome. Treatment with one or both inhibitors was performed to 
investigate CID ubiquitination and proteasomal degradation by anti-CID 
antibody immunoblotting (figure 2.23). As opposed to the microscopy-based 
assay, no clear effect on CID levels upon knockdown of hyd as compared to 
GST control RNAi was observed (figure 2.23, lanes 1 and 2). However, when 
treating cells for six hours with MG-132, a slower migrating anti-CID antibody 
reactive band, which could represent mono-ubiquitinated CID (CID-ub), is 
appearing. This band is weaker in a hyd knockdown (compare lanes 3 and 4). 
The same is true when the MG-132 incubation is combined with NEM (lane 5 
and 6), even though the CID-ub band is less pronounced here. With NEM 
treatment only, a difference between control and hyd knockdown is not 
detected, suggesting that MG-132 is the effective agent to visualize the 
shifted band and that it could indeed be ubiquitinated CID (lanes 7 and 8). cid 
knockdown reduces the levels of endogenous CID as well as GFP-tagged 
CID, as expected (lanes 9 and 10) and as observed earlier by fluorescence 
microscopy analysis (figure 2.21, 2.22). Furthermore, in cid knockdowns, the 
slower migrating band is also lost, underlining that this band corresponds to a 
modified form of CID. Comparable to the hyd knockdown, REG knockdown 
does not lead to a global increase in CID levels; however, here, the size-
shifted CID band that could correspond to CID-ub is also present (lanes 11 
and 12, compare to lane 3 and 5). Whether or not REG has an influence on 
the turnover of ubiquitinated CID cannot be deduced from this experiment. 
Since REG is an activator of the proteasome, it would be interesting to 
investigate if MG-132 addition is still required to stabilize ubiquitinated CID in 
a REG knockdown situation. To conclude, this preliminary experiment 
suggests an involvement of Hyd in CID ubiquitination, potentially thereby 
influencing its stability.  
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2.8 Influence of selected candidate proteins on cell cycle 
progression 
The correct establishment of the kinetochore is dependent on centromeric 
CID and is a key step for cell cycle progression in mitosis. Hence, cell cycle 
state distribution analysis represents an additional readout to investigate 
whether a factor contributes to centromere functionality. Therefore, 
perturbations in cell cycle distribution upon factor knockdown were assessed 
by flow cytometry. After six days of knockdown, the DNA content in cells was 
measured by fluorescence-activated cell sorting (FACS) analysis of propidium 
iodide signals. Figure 2.24 comprises representative plots. G1-phase 
corresponds to a DNA content of 1 chromatid per DNA copy, G2 and M-phase 
have double the DNA amount and S-phase is the fraction between those two 
states. Panel A reassures that GST knockdown does not lead to a cell cycle 
defect as compared to untreated asynchronous cells. Interestingly, cal1 and 
Figure 2.23: Western blot analysis of CID levels in CID-GFP expressing cell lines upon 
knockdown of hyd, REG or cid in combination with NEM and/or MG-132 treatment as 
indicated by the scheme. Anti-CID (short and long exposure) and anti-tubulin western blots 
are shown. Asterisks indicate unspecific bands. CID-ub: band probably corresponding to 
mono-ubiquitinated CID.  
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cid knockdown lead to an increased amount of cells in S-phase (panel D). 
This effect is even more pronounced when CENP-C levels are reduced (two 
different dsRNA constructs: CENP-C 1/2, panel D). However, reduction of the 
two proteins strongly enriched in centromeric chromatin, CG2051 and 
CG14480 (figure 2.10), does not influence the cell cycle distribution (panel E). 
Depletion of Prod, a protein known to bind to pericentromeric heterochromatin 
on chromosome 2 and 3 of D. mel, and gfzf knockdown lead to slightly 
decreased number of cells in G2/M-phase (panel G and J). CG6227 
knockdown shows an enrichment of cells in G2/M-phase (panel K), an effect 
that is even more pronounced in CAF-1 knockdown (panel H, 2 different 
dsRNA constructs). Nevertheless, none of the centromeric factors as 
determined by the biochemical purification assay shows similar cell cycle 
phenotypes as knockdown of CENP-C, the only known CCAN protein in 
Drosophila.  
As histone H3 is known to be phosphorylated on serine 10 (H3S10ph) during 
mitosis by Aurora B kinase (Hsu, Sun et al. 2000), H3S10ph staining was 
used as a mitotic marker in addition to the propidium iodide staining of DNA 
and analyzed by FACS. This analysis reveals that in asynchronously cycling 
Schneider L2-4 cells, around 1.8 % of cells are in M-phase (Figure 2.24B and 
C). In the cases of CAF-1 and CG6227 knockdowns, where G2/M-phase is 
increased, the amount of cells in mitosis actually is decreased (panel I and L), 
indicating that in these knockdowns, cells are arresting in G2-phase. CG2051 
and CG14480 knockdowns show no changes in portion of mitotic cells (only 
shown for CG2051, panel F. Value for CG14480 was 1.76 %.). Mitotic indexes 
for prod and gfzf knockdowns were not determined.  
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Figure 2.24: DNA content and number of mitotic cells in asynchronous cells after different 
knockdowns. Kd: knockdown. The x-axis displays measured DNA amount representing 
different cell cycle phases as indicated in the figure. Either DNA content is plotted versus cell 
number as histogram (percent of maximum to compare different cell numbers from different 
knockdowns) or DNA content versus signal from H3S10ph stain as density plot to distinguish 
mitotic cells. Percentages in panels B, C, F, I and L indicate the number of living, single cells 
positive for the mitotic marker H3S10ph.  
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In sum, depletion of none of the factors interacting with CID-GFP (chapter 
2.4.2) induces defects as severe in cell cycle progression as observed upon 
knocking down the centromeric factors CENP-C, cal1 and cid. This finding is 
in line with the missing effects of candidate knockdowns on CID-GFP 
incorporation in centromeres (chapter 2.6.2). Finally, the observed S-phase 
arrest of cells with reduced levels of cid, cal1 and CENP-C is an interesting 
new finding.  
2.9 Depletion of selected candidates leads to mitotic defects upon 
knockdown 
The main function of the centromere and kinetochore is to ensure correct 
microtubule attachment and chromosome segregation during mitosis. Any 
failure in assembling these vital structures can therefore directly be assessed 
by monitoring mitotic defects. It was thus screened for lagging chromosomes, 
multipolar spindles and multinucleated cells in cells with reduced levels of 
proteins of interest by fluorescence microscopy (figure 2.25). Knockdown 
efficiency as measured by qPCR on mRNA level is indicated in the figure and 
always above 70 %, thus leading to a significant decrease of the target gene 
expression. A control knockdown targeting the white gene results in 15-20 % 
of mitotic errors in L2-4 cells, indicated with a red line in the figure. Thus, 
triggering an RNAi response in Schneider L2-4 cells alone leads to a quite 
high number of mitotic errors. Prod depletion, a protein localizing to pericentric 
heterochromatin, involved in centric chromatin condensation and cell 
proliferation and implicated in centromere function (Torok, Harvie et al. 1997), 
increases the number of cells displaying mitotic errors to 36 %. CG2051, 
CG14480 and hyd knockdowns are in the same range. CAF-1 reduction, 
however, shows the strongest effect with 54 % of errors, potentially mirroring 
the observed cell cycle defects (figure 2.24H and I). Thus, some of the 
strongest enriched candidates of the biochemical screen for centromeric 
proteins are indeed required for proper mitotis. 
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2.10  General centromere architecture is not impaired by CG2051 
and CG14480 knockdown 
CG2051 and CG14480 reduction results in elevated mitotic errors (figure 
2.25) while CID incorporation in centromeres is not influenced (figure 2.22). 
Another possible consequence of their knockdown might be erroneous 
incorporation of other centromere and kinetochore proteins leading to 
defective centromere architecture. Therefore, localization of the proteins 
CENP-C, Rod, INCENP, Ndc80 and Polo was investigated by fluorescence 
microscopy in a knockdown situation of the factors CG2051 and CG14480 
(figure 2.26). CENP-C is the only known Drosophila CCAN protein; INCENP is 
part of the inner centromere layer; Ndc80, Polo and Rod are located in the 
outer kinetochore and thus only present at centromeres in mitosis. Their 
proper localization was assessed by verifying their colocalization with or their 
proximity to CID foci in knockdowns of CG14480, CG2051 and control 
knockdowns targeting the white gene.  
However, no differences of localizations between control and factor 
knockdowns were observed. This, together with the fact that neither CG2051 
nor CG14480 knockdown affects CID-GFP levels in centromeres, suggests 
that these factors are not involved in the establishment and maintenance of 
the basic centromere architecture. In addition, no influence on the cell cycle 
distribution was observed upon their depletion. (figure 2.24E). It will be 
Figure 2.25: RNAi-mediated depletion of centromere associated proteins causes mitotic 
defects. Given is the frequency of mitotic defects (multipolar spindles, multinucleated cells 
and lagging chromosomes) as analyzed by fluorescence microscopy. The horizontal red line 
indicates the maximal percentage of defects observed in control knockdowns (white RNAi). 
Data collected by Georg Schade.  
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interesting to unravel their functions in Drosophila centromere biology in future 
experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.26: Loss of CG2051 and CG14480 does not impair the localization of known 
centromere and kinetochore proteins. Experiment performed by Georg Schade. Blue: DNA 
stained with DAPI, red: CID, green: centromere/kinetochore protein. Maximum intensity 
projections of deconvolved images are shown. Scale bar represents 3 µm.  
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3 DISCUSSION 
The aim of this work was to better understand centromere composition and 
function in Drosophila melanogaster. It comprises the first published 
proteomic screen to identify novel Drosophila centromeric proteins. 
Immunolocalization analysis of selected candidate factors was performed as 
an independent assay to investigate the biochemically predicted centromeric 
association in vivo. By that means, at least nine novel factors were found to 
localize to centromeres. Further assays were performed to unravel possible 
functions in Drosophila centromere biology. In the following sections, the 
rationale of the methodology, the obtained datasets as well as the strategy for 
the analysis will be discussed. Some of the newly identified centromeric 
factors like acetyltransferases are able to modify proteins or are involved in 
protein turnover whereas the molecular function of others is completely 
unknown. The significance of these findings is considered below. Last, this 
work offers a first description of cell cycle defects upon knockdowns of 
centromeric proteins. The surprising finding of an intra S-phase block and its 
possible role in centromere biology is also discussed below.  
3.1 (Dis)advantages of the applied AP-MS strategy  
In order to determine centromeric proteins, a strategy was needed to isolate 
and enrich centromeric chromatin. Since centromeres are not a distinct 
compartment in a cell, this is not possible via centrifugation or size isolation 
strategies. Furthermore, centromeric chromatin needs to be solubilized from 
the confining nucleus and then affinity-purified. This could be done via the 
underlying DNA sequence by using the PICh (proteomics of isolated 
chromatin segments) method (Dejardin and Kingston 2009). However, as the 
exact DNA sequence is not known for Drosophila centromeres, this was not a 
feasible approach. Thus, a remaining strategy involved usage of a 
centromere-specific protein as a bait to fish for interactors.  
As described in the introduction (chapter 1.4), only a few centromere proteins 
are known in Drosophila. Cal1 is the homolog of the centromeric H3 
chaperone HJURP and therefore is also binding to CID in soluble nuclear 
fractions (Mellone, Grive et al. 2011). CENP-C as well as CID are 
constitutively binding to centromeres, but CID is present in the layer of 
centromeric chromatin and thought to confer identity to centromeric regions 
(chapter 1.2). Therefore, it is the best bait for identifying centromeric proteins. 
Some CID-specific antibodies exist; however, in order to provide a sufficiently 
high specificity, the centromeric chromatin has to be compared to chromatin 
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present in other regions of chromosomes. Therefore, the H3 variant H3.3 
present in active, transcribing chromatin, was used to filter out generic 
chromatin binding factors in the proteomic screen. The possibility to compare 
the protein content associated with both H3 variants is only given if the same 
antibody is used for both. Thus, the variants were tagged so that they could 
be purified in the same manner. GFP was the tag of choice since it can be 
visualized by microscopy and GFP-Trap agarose resins are commercially 
available and can be used for immunoprecipitation.  
The workflow described in chapter 2.1 was modeled after the methodology 
used by Foltz et al. who successfully applied AP-MS to identify ten novel 
proteins implicated in centromere biology in human HeLa cells (Foltz, Jansen 
et al. 2006). In order to prepare chromatin for affinity purification, it needs to 
be solubilized. This could be done by shearing chromatin using sonication. It 
is a quick way to obtain chromatin fragments that can be extracted from the 
nuclei. Sonication, however, may cause protein degradation and results in 
undefined DNA fragment sizes ranging from 100-500 basepairs. The MNase 
digestion applied in this work yields soluble chromatin with fragments 
corresponding to mainly mono- and dinucleosomes (figure 4.4), similar to the 
previous study in human cells. Upon MNase digestion, chromatin still needs to 
be separated from the unsoluble nuclear material. When different ways to 
release chromatin fragments were tested, neither detergent nor EDTA 
treatment or mild sonication resulted in detectably released DNA (figure 4.5). 
The only means of extraction was addition of 300 mM sodium chloride, which 
is consistent to the data from Foltz et al. (Foltz, Jansen et al. 2006). 
Subsequently, the IPs were also performed in these high salt conditions. This 
might lead to disruption of certain protein interactions and a loss of bona fide 
centromere proteins during the affinity purification steps. This might explain 
why some centromeric proteins of Drosophila like HMR, LHR, NLP or Umbrea 
(Ross, Rosin et al. 2013, Thomae, Schade et al. 2013) were not recovered in 
this screen. To stabilize their interactions with centromere chromatin, 
crosslinking with formaldehyde (FA) can be performed before chromatin 
extraction. However, incomplete reversal of such crosslinks can hamper MS 
detection and analysis, as it leads to mass shifts of 12 or 30 Daltons on 
crosslinked amino acids like mainly lysine or tryptophan (Sutherland, Toews 
et al. 2008). Furthermore, trypsin cleavage at crosslinked lysines and 
arginines could be inhibited thereby impeding the quantitative MS analysis.  
A common problem of affinity purifications is the co-enrichment of proteins 
that unspecifically bind to the affinity matrix. Affinity purifications using the 
same affinity matrix on chromatin samples not containing the bait protein help 
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to identify those background binding proteins. In this work, mock GFP-Trap 
purifications on chromatin extracts from cells that do not express a GFP-
tagged protein served to identify these proteins (figure 2.6, wildtype). 
Furthermore, in this analysis, the washing steps after immunoprecipitation 
were carried out without addition of detergent in order to preserve as many 
CID-GFP containing chromatin interactions as possible. In future screens, 
washing could be more stringent, thereby reducing the number of detected 
proteins – both specific and unspecific ones. Another way to reduce the 
number of unspecifically binding proteins in the first place would be to apply 
native elution conditions that specifically release the bait and its co-associated 
proteins from the affinity matrix. FLAG-tagged proteins for example can be 
eluted from immobilized anti-FLAG M2 antibody agarose beads by FLAG 
peptide competition circumventing the need for denaturing elution conditions 
like the use of Laemmli buffer (an example is the work of Thomae et al. 
(Thomae, Schade et al. 2013)). By that means, a larger fraction of proteins 
will be recovered due to a specific association with the bait.  
Apart from unspecific matrix binders, general chromatin proteins may also be 
enriched in CID-GFP chromatin purifications compared to mock purifications. 
Therefore, quantitative comparisons of purifications of CID-GFP versus H3.3-
GFP containing chromatin were performed to discriminate centromere-
enriched factors from general chromatin components. However, proteins that 
are present in both centromeric as well as H3.3-containing chromatin would 
be filtered out by this calculation. Whether this type of filtering indeed 
increases the success rate or creates unreasonably frequent false negative 
assignments remains to be tested.  
Surprisingly, only a limited number of kinetochore components were 
recovered in this study. This may relate to the fact that asynchronous cells 
were used for preparing the input material. Only around 2 % of asynchronous 
Drosophila Schneider cells are in mitosis (figure 2.24), decreasing the 
probability to detect kinetochore proteins that are only temporarily associating 
with centromeres during mitosis. If kinetochore proteins are to be targeted, 
cells can be accumulated in mitosis for example by treatment of cells with 
colcemid, as performed by Blower et al. (Blower and Karpen 2001). In the 
work presented here, the focus lied more on proteins binding to centromeres 
during interphase of the cell cycle, as CENP-C was the only known 
constitutive centromere-binding protein.  
In summary, there are many possibilities to modify the workflow to potentially 
improve its overall performance. Still, the protocol used here already yielded 
new insights into the composition of the Drosophila centromere. 
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3.2 A critical view to the obtained AP-MS datasets 
The described workflow was repeated in triplicates starting from around 5*109 
cells as CID and also CID-GFP in the stable cell line are only expressed at 
very low levels. Since the localization of this variant is restricted to 
centromeric chromatin, which covers only a small region of chromosomes, 
upscaling is necessary and therefore, the replicate experiments have been 
conducted on different days. Before discussing the means of statistical 
analysis, the triplicate datasets are examined in more detail. 
At first glance, the protein content of the different affinity purifications is 
surprisingly similar. Almost half of the proteins (49 %) are at least once 
identified in all three conditions (wildtype, CID-GFP, H3.3-GFP) (figure 2.9). 
This underlines the common problem of unspecific binding in AP-MS 
approaches. Still, 149 proteins are identified exclusively in at least one of the 
CID-GFP purifications. These factors were considered as bona fide 
centromere proteins. However, there is an even larger number of proteins 
(261) exclusively identified in mock purifications. This larger number may 
result from the absence of a bait protein that competes for available binding 
sites on the affinity matrix resulting in a random binding of non-chromatin 
associated protein. Indeed, the similarity of the three replicates of mock 
purifications is less than in the CID-GFP precipitations (31.73 % versus 
40.94 %). Although this overlap of identified proteins in the different replicates 
seems to be low, the percentages of reproducibility obtained are typical for 
MS experiments (35-60 %, Tabb, Vega-Montoto et al. 2010) and might be 
challenged even more if, like in this study, replicates were generated and 
analyzed by MS on different days.  
When statistical analysis was performed as described in the results and 
methods section (chapter 2.4.2, 4.2.5.5), 94 potential centromere factors were 
determined and IF performed for 32 of them. Despite the fact that chromatin 
was used as input material, eight out of the 32 tested candidates enriched in 
CID-GFP containing chromatin showed a cytosolic localization (figure 2.17). 
Since chromatin isolation involved a disruption of cellular membranes, nuclear 
and cytosolic proteins might mix and form unspecific interactions. Another 
study also detected interactions of proteins that are separated by the 
compartmentalization in the cell and that are located in the nucleus and 
cytoplasm, for example latheo, a component of the origin recognition complex 
(ORC3), and Fmr1 (Guruharsha, Rual et al. 2011, cytoplasmic localization of 
Fmr1 was confirmed in figure 2.17). It is thus a common risk of biochemical 
isolation and purification procedures to detect non-physiological interactions. 
For that reason, immunolocalization studies are required to independently test 
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potential centromere association of candidates picked up by the CID-GFP 
interactome MS analysis. Another advantage of localization studies is that 
interactions can be monitored on single cell levels and capture distinct 
physiological states. The combined use of these complementary techniques is 
the strength of this study that aimed at finding novel Drosophila centromeric 
proteins.  
3.3 Statistical analysis allows a better selection of candidate 
centromeric proteins 
The MS dataset obtained in this work contains quantitative information about 
interactors of CID-GFP. The gained output is a long list of proteins with 
different iBAQ values. Therefore, a good way to extract the most confident 
candidates of true Drosophila centromeric proteins is needed. As mentioned 
in the results section (chapter 2.4.2, table 1, appendix), an easy way to extract 
factors from the identified proteins is to only consider proteins that were 
exclusively present in CID-GFP purifications. However, CID itself has been 
identified in three out of six control purifications (3x H3.3-GFP, 3x mock IPs), 
albeit to a lower level. Regarding only proteins never identified in any control 
purification would thus result in a false negative assignment of CID as a non-
centromeric protein. Therefore, and for reasons of better comparability 
between replicates and quantitative ratios, statistical analysis of the data was 
performed to extract proteins likely to be enriched in centromeric chromatin 
(described in chapter 2.4.2 and 4.2.5.5). Even though not many centromeric 
proteins are known so far in Drosophila, the most reliable controls Cal1 and 
CENP-C are present in the list of 85 proteins passing the set threshold 
(chapter 2.4.2, table 2, appendix). This underlines the feasibility of the 
approach to identify centromeric proteins. GFP is only enriched in CID-GFP 
affinity purification when compared to mock purifications (as cells do not 
express any GFP protein), but not when compared to H3.3-GFP purifications, 
since here another H3 variant is tagged with GFP. These features serve as 
quality control for the outcome of the screen.  
The statistical analysis resulted in 85 proteins with a rather stringent 
enrichment of 16-fold compared to the two different controls (wildtype- and 
H3.3-GFP purification). However, when manually revisiting the data, some 
factors that were identified repeatedly and almost exclusively in CID-GFP 
purifications were not included in this list as their enrichment factors were 
lower than sixteen. Therefore, nine additional factors were included in the list 
of centromeric factors (Ge-1, asp, CG6227, Hcf, Top3beta, CG8478, 
RhoGAP54D, ATAC3, CG1399) that were below the threshold due to the 
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imputation of zero values in control purifications needed for the statistical 
analysis (marked in grey in table 2, appendix). This generates a more 
complete picture of proteins present at Drosophila centromeres. Indeed, 
CG6227 was detected on centromeres (figure 2.14) and asp, Hcf and ATAC3 
were at least demonstrated to be nuclear (figure 2.15). Without inclusion of 
the nine additional factors, the centromeric localization of CG6227 would have 
gone unnoticed in this screen. Also, imputation may well be the reason why 
only Hsp70Bbb, and not the isoform Hsp70Ab, was sustained in the final 94 
candidates (chapter 2.5), even though they share most of the peptide 
sequences, since only unique peptides are taken into account. In the following 
chapters, CG6227 and other interesting factors will be discussed.  
3.4 Involvement of posttranslational modifications on centromeric 
proteins 
Cell cycle processes need to be well controlled, since the correct timing of 
events minimizes errors in DNA duplication that might otherwise be 
deleterious for a cell or even a whole organism. They often involve 
chronological cascades of protein complexes that need to interact in order to 
activate or inhibit each other (chapter 1.1). Posttranslational modifications like 
ubiquitinations and acetylations are involved in cell cycle regulation and it is 
thus worthwhile to screen potential centromeric proteins for protein modifiers. 
In this work, a number of acetyltransferases as well as proteins potentially 
involved in protein degradation were assigned to the Drosophila centromere 
proteome.  
3.4.1 Localization of acetyltransferases at centromeres in Drosophila 
One of the most strongly enriched factors identified in this screen is CG2051 
(figure 2.10, table 2, appendix). It is the homolog of the human histone acetyl 
transferase 1 (HAT1). HAT1 acetylates histone H4 on lysines 5 and 12 in the 
cytoplasm immediately after synthesis (Sobel, Cook et al. 1995) and is in a 
complex with the histone H3/H4 dimer and the chaperone Asf1 for this 
purpose (Alvarez, Munoz et al. 2011). Additionally, it can acetylate H2A on 
lysine 5 (Verreault, Kaufman et al. 1998, Tafrova and Tafrov 2014). Once 
imported into the nucleus, the histone H3/H4 dimers are transferred to the 
CAF-1 chaperone as a (H3/H4)2 tetramer, thus joining two dimers on CAF-1 
(Winkler, Zhou et al. 2012). CAF-1 is responsible for loading (H3/H4)2 
tetramers on replicating DNA (Kaufman, Kobayashi et al. 1995). Histone H4 
carries the two acetyl marks on lysine 5 and 12 when it is incorporated in 
chromatin; the marks are then rapidly removed (Annunziato and Seale 1983).  
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Despite the fact that the Drosophila HAT1 homolog is a nuclear protein, it is 
tempting to speculate that CG2051 cooperates with CAF-1 to ensure the 
correct acetylation status of H4 on CID/H4 dimers before or during their 
incorporation into centromere chromatin. Analysis of histone modifications 
associated with CID-GFP containing chromatin indeed showed a slight 
enrichment of acetylation marks on histone H4 as compared to control 
purification (figure 2.8). This finding is in contrast to earlier reports in which 
centromeric H4 was described to be devoid of acetylation (Sullivan and 
Karpen 2004); however, in contrast to this MS-based analysis, the mentioned 
study was performed using antibodies for different acetylations on histone H3 
and H4. Recently, it became clear that these antibodies might not be specific 
for distinct modifications, but rather bind preferably to multiply acetylated H4 
(Rothbart, Lin et al. 2012) which might explain the observed discrepancy 
between the two studies.  
Immunofluorescence analysis demonstrated that CG2051 is found in the 
nucleus and with a clear presence at centromeres in many cases (figure 2.13, 
2.14). For figure 2.13 and 2.14, prelysis was performed on cells before fixing 
them. By that means, most cytoplasmic proteins are washed out of the cell, 
increasing visibility of nuclear localization patterns. It can thus not be excluded 
that CG2051 is also present in the cytoplasmic fraction. However, cytoplasmic 
signal was also not detected in immunolocalization experiments performed 
without prelysis (figure 2.22, raw data not shown), suggesting that CG2051 
might acetylate histone H4 in the nucleus. 
Although the acetylation of K5 and K12 on newly synthesized histone H4 is 
highly conserved, it does not play a major role in chromatin assembly since its 
mutation or the total lack of H4-tails harboring K5 and K12 do not influence 
cell proliferation (reviewed in Parthun 2012). This might explain why CG2051 
depletion has no major influence on centromere architecture or cell cycle 
distribution (figures 2.22, 2.24 and 2.26) even though an increase in mitotic 
defects is observed (figure 2.25). Since asynchronous cells were analyzed, it 
is possible that CG2051 is only enriched at centromeres at the time of cell 
cycle when centromeric chromatin is replicated. Also, a redundant 
acetyltransferase might exist in D. mel cells, making it impossible to detect 
effects with knockdowns of just one HAT. It might therefore be interesting to 
combine knockdowns of different HATs and re-screen for cell cycle effects or 
increases in mitotic errors.  
Furthermore, the dataset contained members of different acetyltransferase 
complexes: for example the human YL-1 homolog is a member of the 
TRRAP/Tip60 complex (Cai, Jin et al. 2005) known to acetylate histone H2A 
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and H4 and to be involved in a number of cellular processes (reviewed in 
Squatrito, Gorrini et al. 2006). Additionally, the PHD (plant homeodomain) 
finger protein encoded by CG9293 that localizes to centromeres (figure 2.14) 
is the homolog of human ING5 (inhibitor of growth). ING5 is member of two 
different HAT complexes: p300/CBP and MYST-HATs (reviewed in Tallen and 
Riabowol 2014) which acetylate either H3 or H4 or the tumor suppressor p53, 
involving ING5 in cancer. It induces cell cycle arrest and associates with MCM 
(minichromosome maintenance) proteins that are part of the replicative 
helicase. Therefore, both of the HAT complex members might indeed directly 
contribute to centromere function or cell cycle control.  
Moreover, three components of the ATAC complex were enriched in 
centromeric chromatin, namely ATAC3, CG30390 and Hcf (see figure 3.1, 
Suganuma, Gutierrez et al. 2008). ATAC complex is named after AdaTwoA 
containing complex and comprises two histone acetyltransferase subunits: 
Gcn5 and ATAC2 (Suganuma, Gutierrez et al. 2008). The mammalian ATAC 
complex has been shown to acetylate Cyclin A/Cdk2, resulting in its 
degradation and thus being implicated in progression through M-phase 
(Orpinell, Fournier et al. 2010). This together with findings of this work 
indicates that ATAC complex might have a function in cell cycle regulation.  
 
 
 
 
 
 
 
 
 
 
 
Another study performed in human HeLa cells suggests an implication for 
histone acetylation and deacetylation in deposition of newly synthesized 
CENP-A. It was demonstrated that treatments with the histone deacetylase 
inhibitor Trichostatin A influences centromere priming (Fujita, Hayashi et al. 
Figure 3.1: Schematic of 
ATAC complex component 
quantifications in this work. 
The color code indicates the 
specificity of detection in 
CID-GFP samples – more 
blue means more specific for 
CID-GFP immuno-
precipitations. Green square: 
Trimethylation. Pink star: 
Acetylation. Modified after 
Spedale, Timmers et al. 
2012).  
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2007): A complex of three proteins, hMis18α, hMis18β, and M18BP1 binds to 
centromeres in telophase/G1-phase of the cell cycle, before the reduction of 
CENP-A levels caused by the previous round of DNA replication is adjusted. If 
levels of hMis18α are reduced by RNAi, incorporation of newly synthesized 
CENP-A is hampered. This effect can be suppressed by inhibiting HDACs by 
Trichostatin A in a concentration-dependent manner, indicating that histone 
acetylation is important for CENP-A incorporation to centromeres.  
Figure 3.2 sums up all potential implications of acetyltransferases on either 
centromere proteins in Drosophila or acetylations of proteins, like Cyclin A, 
important for cell cycle progression. Question marks indicate hypotheses 
made based on this work.  
 
 
Figure 3.2: Scheme of possible acetylation events at the centromere. CG2051 and ATAC 
are acetyltransferases that might be involved in acetylating histones associated with CID 
before chromatin incorporation or at the centromere; or non-histone proteins involved in cell 
cycle regulation as shown for Cyclin A (CycA). A possible cytosolic function of CG2051 is 
also illustrated since a potential minor cytosolic localization could not be fully excluded. 
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Taken together, the AP-MS dataset contains several acetyltransferases or 
acetyltransferase-associated proteins potentially regulating centromere 
biology in Drosophila melanogaster. This might be due to acetylation of 
histone proteins in the cytosol or nucleus before chromatin incorporation. 
Alternatively, histones incorporated in centromeres might get acetylated. 
Figure 2.8 however only shows a low increase of histone H4 acetylation in 
comparison to histones originating from the mock IP. All histones detected in 
mock IPs are unspecifically binding to the resin. It can therefore be assumed 
that a high amount of background-binding histones is also present in the CID-
GFP IPs. That is why a huge difference in histone modification patterns could 
not be detected. The acetylations of histone H3 peptides were not analyzable. 
Another possibility for the here identified histone acetyltransferases is that 
non-histone proteins are their targets.  
3.4.2 CID turnover might be regulated by Hyd, a ubiquitin ligase 
Additional to the importance of ubiquitination as degradation signal for cell 
cycle regulatory proteins as mentioned in chapter 1.1, this posttranslational 
modification might also be implicated directly in balancing levels of CID and/or 
other centromeric proteins. If CID is overexpressed in cells, it also covers the 
arms of condensed chromosomes (Olszak, van Essen et al. 2011). This 
ectopic incorporation can be deleterious to cells since CID alone can recruit a 
functioning kinetochore (Heun, Erhardt et al. 2006, Olszak, van Essen et al. 
2011) and needs to be prevented. The existence of a mechanism involving 
the proteasome to degrade erroneously incorporated CID has been found 
(Moreno-Moreno, Torras-Llort et al. 2006). Partner of paired (Ppa), which is a 
subunit of the E3 ubiquitin ligase SCF, was identified as responsible for CID 
level regulation in Drosophila (Moreno-Moreno, Medina-Giro et al. 2011). 
Here, Ppa was never identified in a MS run, suggesting that it is not well 
detectable by MS analysis or only low abundant. As supernumerary 
kinetochores on a chromosome can lead to chromosomal aberrations, a 
tightly controlled system to avoid aberrant CID incorporation must exist. 
Therefore, it is possible that additional factors besides Ppa regulate CID 
levels in vivo. Interestingly, a set of regulatory proteins found in this screen 
was predicted to be implicated in protein degradation: Hyd (hyperplastic 
discs), which is an E3 ubiquitin ligase, as well as REG, a proteasome 
regulator.  
Drosophila REG has been shown to increase the trypsin-like digestion activity 
of the 20S proteasome, whereas it decreases its chymotrypsin-like activity as 
determined by different fluorophoric peptides used as substrates (Masson, 
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Andersson et al. 2001). REG colocalizes with CID as determined by 
immunofluorescence analysis (figure 2.14). Its reduction leads to higher 
amounts of CID-GFP at centromeres (figure 2.22), which could be due to an 
accumulation of non-degraded CID-GFP in accordance with REG's 
stimulating function of the proteasome. Interestingly, the function of REG to 
control CID levels seems to be restricted to centromeres, as no alterations in 
global CID levels upon REG RNAi were observed in Western blot analysis 
(figure 2.23). Notably, STRING analysis (figure 2.12) suggests an interaction 
of the human homologs of REGγ and CG14480 (human homolog: FAM192A, 
41.9 % identity) (Doueiri, Anupam et al. 2012). Thus, the strong CID-GFP 
interactor CG14480 (figure 2.10, table 2, appendix), of which no information is 
published so far, may cooperate with REG to control CID levels. It remains to 
be established whether this hypothetical function could explain the observed 
increase in mitotic errors upon CG14480 RNAi.  
As mentioned earlier, Hyd is another predicted ubiquitin ligase found enriched 
with CID-GFP (table 2, appendix). Hyd is a putative E3 ubiquitin ligase and is 
required for regulation of cell proliferation in imaginal discs of Drosophila 
(Mansfield, Hersperger et al. 1994). In addition, Drosophila hyd mutant 
animals are sterile due to germ cell defects. In males, sterility may be caused 
by chromosome condensation and spindle attachment defects and thus may 
be linked to an impairment of centromere function or regulation (Pertceva, 
Dorogova et al. 2010). Hyd is also involved in the Hedgehog signaling 
pathway as its mutation causes accumulation of Cubitus interruptus, 
Hedgehog and Decapentaplegic in Drosophila eye discs (Lee, Amanai et al. 
2002). Allelic imbalances of EDD, the human ortholog of Hyd, are found in a 
number of human tumors (Clancy, Henderson et al. 2003). In flies, hyd 
reduction leads to elevated mitotic errors (figure 2.25) that might be due to a 
function in CID amount regulation at centromeres: In a hyd knockdown 
situation, more CID-GFP can be detected at centromeric foci (figure 2.22). 
Similar to REG loss, this increase of CID-GFP is not reflected in global 
changes of CID levels, arguing for a locally restricted mode of action (figure 
2.23). However, experiments employing RNAi-mediated depletion of hyd 
combined with proteasome inhibition revealed that Hyd is responsible for 
mono-ubiquitination of CID (figure 2.23). Mono-ubiquitination per se does not 
target proteins for proteasomal degradation, but it can be a substrate for 
another ubiquitin ligase in charge of adding additional ubiquitin residues. 
Thus, it is unclear how exactly Hyd could be involved in controlling CID 
amounts at centromeres.  
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Figure 3.3 displays a model of how turnover of centromeric proteins might be 
regulated by factors detected in this work. Hyd was found as a CID-GFP 
interactor; its localization was determined to be nuclear, not especially 
overlapping with CID signals (figure 2.15). Therefore, it might also be 
implicated in degradation of CID that was incorporated outside of centromeres 
by mistake. Other possibilities are that it also regulates CID levels at 
centromeres or it ubiquitinates some so far unknown factors besides CID that 
are implicated in centromere biology.  
 
 
 
 
 
Figure 3.3: Model of protein degradation factors involved in centromere biology. REG might 
interact with CG14480 as in humans and was found to stimulate the proteasome, maybe for 
degradation of CID protein. Hyd might be an ubiquitin ligase specific for CID mono-
ubiquitination and thereby trigger poly-ubiquitination and subsequent degradation of CID. 
This might regulate CID levels at ectopic localizations on chromosome arms or also at 
centromeres. Alternatively, Hyd might also ubiquitinate other proteins involved in centromere 
biology.  
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3.5 Immunolocalization proofs presence of additional proteins at 
Drosophila centromeres 
3.5.1 CAF-1, Subito and Proliferation disruptor were identified as centromeric 
proteins as expected 
Several proteins fished with the AP-MS strategy had already been reported to 
interact with CID. CAF-1, for example, was co-purified in Drosophila together 
with TAP-tagged CID (Furuyama, Dalal et al. 2006), suggesting that CAF-1 is 
responsible for centromeric histone deposition. CAF-1 is a chaperone 
involved in assembling nucleosomes on newly replicated DNA during S-phase 
of the cell cycle or DNA repair (Smith and Stillman 1989, reviewed in Loyola 
and Almouzni 2004). Indeed, CAF-1 knockdown provokes mitotic errors 
(figure 2.25) as well as a G2-phase block in the cell cycle (figure 2.24). 
CAF-1, however, is also implicated in other cellular processes besides 
chaperoning newly synthesized histones: It is part of the Polycomb group 
complex PRC2 that methylates H3 on lysine 27, a repressive histone 
modification. Furthermore, CAF-1 is present in the HAT1 complex, HDAC1 
complex and NuRD nucleosome remodeler complex (reviewed in Suganuma, 
Pattenden et al. 2008). Thus, the phenotypes observed in the assays 
performed here might originate from other functions of CAF-1.  
Another protein enriched in CID-GFP containing chromatin is Subito (table 2, 
appendix). Immunolocalization showed its colocalization with CID as well as 
binding to euchromatin (figure 2.14). Subito has been described before as a 
kinesin motor protein that colocalizes with CID in early metaphase (Cesario, 
Jang et al. 2006). Together with the chromosomal passenger complex, it is 
needed for the bipolar orientation of homologous chromosomes (Radford, 
Jang et al. 2012). The colocalization of CID and Subito was also confirmed 
here, together with a euchromatic signal in nuclei (figure 2.14). This proofs 
that also factors like Sub, which might not be interacting with CID during the 
whole cell cycle, can be enriched with the applied experimental strategy.  
Furthermore, Proliferation disruptor (Prod) is enriched on CID-GFP containing 
chromatin (table 2, appendix). It is here regarded as control since it was 
published to be localized at centric heterochromatin of the second and third 
Drosophila chromosome (Torok, Harvie et al. 1997). It is implicated in 
condensation of centric heterochromatin. When determining mitotic errors in a 
prod knockdown, as expected, the values are increasing (figure 2.25), yet not 
as strong as in CAF-1 knockdown. This argues that CAF-1 knockdown, as 
discussed above, might comprise also centromere biology-unspecific effects. 
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Prod might also have additional effects as it has been found to bind to 
telomeric retrotransposons in Drosophila (Torok, Benitez et al. 2007). Apart 
from binding centric heterochromatin, it has around 400 additional binding 
sites on euchromatin of polytene chromosomes (Torok, Harvie et al. 1997).  
3.5.2 CG3548 is a potential component of the outer kinetochore 
As discussed in chapter 3.1, the AP-MS workflow was not specially set to trap 
proteins transiently bound to kinetochores in M-phase. Yet, CG3548 seems to 
localize to centromeres in a cell cycle dependent manner, as can be seen in 
figure 2.14: CG3548 exhibits euchromatic localization during interphase and is 
bound to centromeres during mitosis (figure 2.18). In addition to the 
centromeric foci, it is also enriched at a few spots on the chromosome arms, 
arguing for kinetochore-independent functions of CG3548. Based on the very 
strong focal enrichment, CG3548 might bind and regulate highly repetitive 
DNA sequences on chromosome arms.  
CG3548 has been found to interact with Prod (Guruharsha, Rual et al. 2011), 
a centromeric protein discussed in chapter 3.5.1. The CG3548 protein 
contains a Myb/SANT domain (Tweedie, Ashburner et al. 2009) which is 
predicted to be implicated in nucleosome remodeling as well as reading 
histone posttranslational modifications (Boyer, Latek et al. 2004), giving a hint 
about CG3548 functions in chromatin biology. Furthermore, evidence has 
been found in mouse that M18BP1, a protein required for centromere priming 
before its regeneration during the cell cycle, also contains such a SANT 
domain that mediates its interaction with CENP-C (Dambacher, Deng et al. 
2012). Unlike loss of M18BP1, CG3548 RNAi does not change CID-GFP 
signals at centromeres (figure 2.22), suggesting that CG3548 function in 
Drosophila is not related to centromere priming.  
3.5.3 CG9418, GFZF, MED30, CG6227 and CG11076 could be involved in 
centromere biology in Drosophila 
Apart from proteins discussed so far, other centromeric localizations have 
been determined in this work by the combination of AP-MS and 
immunolocalization analysis (figure 2.14). One of these factors is CG9418, 
also known as high mobility group protein 2 (HMG-2). It contains a high 
mobility group box domain, which usually mediates DNA binding or protein-
protein interactions (Stros, Launholt et al. 2007). In high-throughput screens, 
CG9418 has been found to interact with RhoGAP54D (Giot, Bader et al. 
2003), a protein contained in the list of 94 centromeric proteins listed in table 
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2, appendix, as well as with REG, which is also enriched at centromeres seen 
by both AP-MS (table 2, appendix) and immunolocalization (figure 2.14, 
discussed in chapter 3.4.2) (Guruharsha, Rual et al. 2011). It might therefore 
build a complex with REG and CG14480.  
GFZF stands for GST-containing FLYWCH zinc finger protein. It contains four 
FLYWCH domains at its N-terminus and shares a 46 % homology with GST at 
its C-terminus (Dai, Sun et al. 2004). FLYWCH domains are zinc finger 
domains responsible for binding nucleic acids or for protein-protein 
interactions. They were originally found in the Mod(mdg4) proteins that 
interact with Su(hw) insulator proteins (Dorn and Krauss 2003). The 
localization of GFZF has been previously determined as mostly cytoplasmic in 
Drosophila Schneider cells and embryos (Dai, Sun et al. 2004); however, the 
protocol used in this work, as opposed to the earlier results, contains a 
prelysis step designed to pre-extract the soluble cytoplasmic pool thereby 
revealing a potential nuclear localization of the protein. Thus, most of the 
GFZF molecules might reside in the cytoplasm while a small fraction localizes 
to centromeres in Drosophila Schneider cells (figure 2.14). Its depletion by 
RNAi reduces the number of cells in G1-phase (figure 2.24). The insulator 
protein Su(hw) also biochemically co-purified with centromere chromatin 
(table 2, appendix), however, it localizes at distinct foci in the nucleus that do 
not overlap with centromeric foci (figure 2.15) (Roseman, Pirrotta et al. 1993). 
The implication of insulator elements to centromere biology is appealing as 
insulators could make up the border between centromeric and pericentromeric 
chromatin domains. Whether GFZF is involved in this process remains to be 
investigated.  
Another protein colocalizing with centromere foci in immunofluorescence 
analysis is MED30 (figure 2.14). MED30 is a subunit of the mediator complex 
needed for transcription regulation (reviewed in Carlsten, Zhu et al. 2013). 
Transcription at centromeres is a feature found in many organisms such as 
Schizosaccharomyces pombe, Saccharomyces cerevisiae, mouse and 
humans (reviewed in Chan and Wong 2012). Studies in S. pombe unraveled 
that subunits of the mediator complex at centromeric regions are in fact 
required for incorporation of CENP-A via regulation of heterochromatin 
formation by inhibiting transcription of non-coding RNAs (Carlsten, Szilagyi et 
al. 2012). In Schneider cells, reducing amounts of MED30 by RNAi does not 
seem to induce CID incorporation defects (figure 2.22). Still, the presence of 
MED30 at centromeres of Schneider cells might be the first indication of 
transcriptional regulation of (peri)centromeric chromatin in Drosophila 
melanogaster.  
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In analogy to loss of hyd and REG, CG6227 knockdowns translate into higher 
centromeric CID-GFP levels (figure 2.22). The human homolog of CG6227 is 
DDX46, a DEAD box protein, so it contains the amino acid sequence 
aspartate-glutamate-alanine-aspartate (DEAD). DEAD box proteins are 
usually RNA helicases (Linder 2006) and DDX46 was found to act in pre-
mRNA splicing (Will, Urlaub et al. 2002). It is thus a component of the 
spliceosome. Interestingly, in S. pombe, components of the spliceosome are 
implicated in centromere biology since they regulate formation of siRNA from 
centromeric repeats needed to establish centromeric heterochromatin to 
silence underlying DNA repeats (Bayne, Portoso et al. 2008). Spliceosome 
proteins interact with both members of the RNAi machinery as well as 
centromeric DNA repeats. No such connection has been made to date in 
Drosophila; however, chromosome segregation defects result if the amount of 
splicing genes is reduced (Somma, Ceprani et al. 2008). Therefore, CG6227 
might be a splicing factor in Drosophila implicated in regulation of centromeric 
(hetero)chromatin.  
CG11076, a factor enriched with CID-GFP as determined by AP-MS (table 2, 
appendix), did not exhibit centromeric localization in immunofluorescence 
analysis (figure 2.15). Rather, when costaining CG11076-GFP transfected 
cells with antibodies against Fibrillarin, a typical protein of nucleoli (Ochs, 
Lischwe et al. 1985), a colocalization of both signals was observed (figure 
2.16). The nucleolus is involved in centromere biology since centromere 
clustering and tethering is taking place at its surface. It has recently been 
shown that the Nucleoplasmin-like protein (NLP), Modulo, a nucleolar protein, 
as well as the insulator protein CTCF are required for proper establishment of 
centromere clusters (Padeken, Mendiburo et al. 2013). It might be possible 
that CG11076 is involved in this process. However, reducing protein amounts 
does not lead to a centromere declustering (figure 2.22).  
3.6 Only previously identified centromeric proteins cause cell 
cycle defects 
Since the centromere is the assembly platform for the kinetochore, its integrity 
should be vital for cell cycle progression. It can be envisioned that disturbance 
of any of the involved factors leads to differences in the cell cycle distribution. 
Therefore, FACS analysis was employed which measures the DNA content in 
individual cells that linearly correlates with the different cell cycle phases.  
Interestingly, RNAi-mediated depletion of the centromeric factors CID or Cal1 
led to an increase in cells with an S-phase like DNA content (figure 2.24, 
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panel D). This effect is even stronger when levels of the constitutive 
centromere-associated network protein CENP-C are reduced (figure 2.24, 
panel D). The fact that Schneider cells depleted of centromeric factors arrest 
in S-phase is surprising, since these proteins fulfill their functions in mitosis. 
The findings here suggest the existence of an intra-S phase checkpoint that 
monitors centromere protein levels or centromere integrity. Biologically, the 
existence of such a checkpoint is plausible as it prevents the amplification of 
aneuploid cells which otherwise might lead to cancer. Of course, the precise 
nature and key molecules contributing to this pathway need to be resolved. It 
will be interesting to see whether CENP-C functions upstream of CID and 
Cal1 given the stronger S-phase arrest phenotype its loss causes.  
RNAi-mediated depletion of selected novel centromere associated factors 
identified in this work did not result in a similar S-phase arrest phenotype. 
However, as knockdown of neither of the factors causes reduction of CID 
levels at centromeres (figure 2.22), this result is not unexpected. In this 
respect, it is probable that no additional bona fide CCAN protein was found in 
this screen. It remains unclear whether this is due to technical challenges or if 
Drosophila harbors a less complex centromere with the little number of 
already known proteins taking over tasks that are necessary for functional 
centromeres. As discussed above, this question can potentially be resolved 
by employing alternative experimental settings. Hence, the future challenges 
will be to further improve the AP-MS strategy in order to find more centromere 
or kinetochore proteins in Drosophila; and to unravel the precise centromeric 
functions of the novel centromeric factors discovered in this work. As the 
classical assays to study centromere biology failed to reveal mechanistic 
details, their task is not related to CCAN maintenance or kinetochore 
formation. Still, the list of proteins co-purifying with CID-GFP determined in 
this work offers a repository for scientists investigating centromere biology in 
Drosophila. As mentioned earlier, findings from Drosophila have already been 
transferred also to other model organisms and thus can lead to future insights 
into novel centromeric functions. It will be interesting to follow future 
discoveries based on the results obtained here. 
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4 MATERIAL AND METHODS 
4.1 Material 
4.1.1 Stable cell lines and vectors 
4.1.1.1 Stable cell lines expressing GFP-tagged H3 variants 
The histone H3 variants CID, H3.2 and H3.3 tagged with GFP were 
transfected in L2-4 cells, a derivative line of Drosophila Schneider SL2 cells 
(Schneider 1972) (karyotype: two X-chromosomes, four 2nd chromosomes 
plus 2L, four 3rd chromosomes, two 4th chromosomes; phenotype male) and 
transfectants were selected based on the hygromycin resistance encoded by 
the vector (figure 4.1). Stable cell lines possess similar expression levels of 
tagged proteins and thus offer more comparable conditions than transiently 
transfected cells. The tagged variants are under control of a metallothionein 
promoter (pMT) with basal expression that can be induced 30 to 100 fold by 
addition of copper sulfate (Bunch, Grinblat et al. 1988). For all mass 
spectrometry and immunofluorescence experiments, the basal promoter 
activity without copper sulfate induction was used to avoid overexpression 
and thereby the formation of potential unspecific interactions. Figure 4.3 
shows that upon copper sulfate induction of the CID-GFP transfected cell line, 
CID-GFP in many cells localizes throughout the whole nucleus instead of 
being restricted to the characteristic centromeric foci usually seen (for 
example, figure 2.3). Instead of inducing CID-GFP expression in cells, a larger 
amount of cells was taken for immunoprecipitations.  
 
 
 
 
Figure 4.1: Outline of vector used to 
establish stable cell lines of histone H3 
variants with GFP-tags. The gene of 
interest expression is driven by an inducible 
pMT promoter. The GFP tag is added on 
the C-terminus. Hygro: Hygromycin 
resistance gene. pUC ori: origin of 
replication. Amp: Ampicillin resistance 
gene. SV40 pA: polyadenylation signal from 
SV40 virus.  
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4.1.1.2 Other GFP-fusion constructs  
Based on statistical analysis, 94 factors were assigned centromeric and 32 of 
these were checked additionally by immunolocalization (chapter 2.5). To do 
so, their cDNA sequences were cloned in an expression vector suitable for 
Drosophila tissue culture expression and supplied with a tag. Three different 
tags were used: Either a GFP-tag as for the stable H3-variant cell lines 
(chapter 4.1.1.2), N-terminal (chapter 4.1.1.3) or C-terminal FLAG/HA-tag 
(chapter 4.1.1.4), or v5-tag (for CG6227 and CG1399). All coding sequences 
of vectors utilized in this work were confirmed by sequencing. Table 4.1 lists 
GFP-tagged factors and also indicates if the construct was used to develop a 
stable cell line. In that case, all figures shown in the results section were 
obtained from the stable cell lines. The plasmid used here is indicated as 
“GFP Invitrogen” in table 2 of the appendix. Stable cell lines were established 
by Georg Schade (chapter 4.2.1).  
 
Table 4.1: Other GFP-fusion constructs.  
Construct Stable cell line 
CG1091-GFP available 
CG11076-GFP available 
CG14480-GFP available 
CG2051-GFP available 
CG3548-GFP available 
Gfzf-GFP  
Hcf-GFP  
MED30-GFP  
su(hw)-GFP  
 
4.1.1.3 N-terminal FLAG/HA-tagged candidates 
Figure 4.2 illustrates the schematic organization of the expression vector into 
which cDNAs of different factors were cloned. This vector was established by 
Dr. Andreas Thomae. It allows expression of an N-terminally tagged protein in 
Drosophila cells. Table 4.2 gives an overview about potential centromeric 
factors cloned in this vector for this work. The hygromycin resistance gene 
contained in the vector allowed for selection of transfected cells while for 
transient transfections in immunolocalization studies, the pMT promoter could 
be induced by addition of copper sulfate, as indicated above. This vector is 
denoted as “pMT-hyg-FLAG-HA-Nterm” in table 2 of the appendix. 
Immunolocalization was then performed using an anti-FLAG antibody.  
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Table 4.2: Constructs with N-terminal FLAG/HA-tag.  
Construct Construct 
FH-hyd FH-Cdk12 
FH-CG4972 FH-CG7518 
FH-Hsp70Ab FH-asp 
FH-CG30390 FH-ATAC3 
FH-Rbcn-3A  
 
4.1.1.4 Expression vectors from BDGP  
If available, cDNAs were ordered in expression vectors from the Berkeley 
Drosophila Genome Project (BDGP). They were then integrated in the 
pMK33-CFH-BD expression vector which encodes the coding sequence plus 
a C-terminal FLAG/HA(FH)-tag. Table 4.3 gives an overview about ordered 
factors used in this work. Immunolocalization was performed with anti-FLAG 
antibody. 
 
Table 4.3: Constructs ordered from BDGP containing a C-terminal FLAG/HA-tag.  
Construct Construct 
CG14480-FH CG12343-FH 
REG-FH CG9418-FH 
Ifc-FH Fmr1-FH 
CG9293-FH RagC-FH 
Tsp42Ed-FH YL-1-FH 
CG1265-FH Sub-FH 
Figure 4.2: Vector map of 
FLAG/HA(FH)-tag expression vector. 
The vector was established by Dr. 
Andreas Thomae. The expression of 
the gene of interest is driven by an 
inducible pMT promoter. A FLAG/HA-
tag is added at the N-terminus. Amp: 
Ampicillin resistance. Hygro: 
Hygromycin resistance, driven by 
pCopia promoter. SV40 pA: 
polyadenylation signal from SV40 virus.  
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The following cDNAs (table 4.4) were received from BDGP in other vectors 
and recloned to expression vectors as indicated above. CG1399 and CG6227 
were cloned into a pIB-v5 expression vector (Invitrogen). Also here, all coding 
sequences were verified by sequencing.  
 
Table 4.4: Non-expression vectors ordered from BDGP.  
Construct Vector 
CG1091 pFlc-1 
Su(hw) pBS SK- 
CG6227 pOT2 
gfzf pOT2 
CG3548 pOT2 
CG1399 pFlc-1 
MED30 pOT2 
4.1.2 Reagents 
Reagent Provider 
1 kb DNA ladder New England Biolabs 
100 bp DNA ladder New England Biolabs 
ACN (acetonitrile) Roth 
Ambion® MEGAscript® RNAi kit Life Technologies 
Ammoniumhydrogencarbonate Roth 
Ampicillin Roth 
Aprotinin Genaxxon 
BSA (bovine serum albumin) Sigma 
Coomassie G250 Serva 
CuSO4 Sigma 
DAPI Life Technologies 
DMSO (dimethyl sulfoxide) Sigma 
DTT (dithiothreitol) Roth 
FCS (fetal calf serum) Sigma 
Formaldehyde methanol –free VWR 
Glycine VWR 
HEPES VWR 
Hygromycin B Invitrogen 
Image-iT FX signal enhancer Invitrogen 
In-Fusion® HD cloning plus Clontech 
Leupeptin Genaxxon 
NGS (normal goat serum) Dianova 
Nitrocellulose membrane (Amersham® 
Protran) 
GE Healthcare 
Penicillin/Streptomycin PAA 
Pepstatin A Genaxxon 
PMSF Sigma 
Propidium iodide Sigma 
Propionic anhydride VWR 
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Protein assay Dye Reagent Concentrate 
(Bradford assay) 
Biorad 
Protein marker V Peqlab 
Proteinase K Roche 
PVP (Polyvinylpyrrolidone) Sigma 
QiaQuick Gel Extraction Kit Qiagen 
RNase A Sigma 
Schneider cell medium Life technologies 
Silver nitrate Sigma 
SlowFade Invitrogen 
SNAP-cell® TMR-star New England Biolabs 
TFA VWR 
TopTip Carbon Glygen 
Triton X-100 Sigma 
Vectashield mounting medium Vector Labs 
X-tremeGENE HP DNA transfection reagent Roche  
4.1.3 Enzymes 
Enzyme Provider 
AvrII New England Biolabs 
Bsp120L Thermo Scientific 
EcoRV New England Biolabs 
HindIII New England Biolabs 
KpnI New England Biolabs 
MNase Sigma 
NotI New England Biolabs 
Q5® high-fidelity DNA polymerase New England Biolabs 
SuperScript® III reverse transcriptase Life technologies 
T4 DNA ligase New England Biolabs 
Taq polymerase VWR 
Trypsin Promega 
XbaI New England Biolabs 
  
4.1.4 Antibodies and beads 
Antibody Provider Dilution Comments 
Primary: 
Chicken anti-CID Patrick Heun IF: 1:100 Raised against full-
length CID fused to 
a his-tag 
Chicken anti-Ndc80 Tom Mareska IF: 1:100  
GFP-Trap® agarose 
beads 
ChromoTek  IP 
Mouse anti-GFP Roche WB: 1:1000 Clones 7.1 and 3.1 
Mouse anti-Polo Claudio Sunkel IF: 1:50  
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Mouse anti-Tubulin Sigma IF: 1:100  
Protein A-coupled 
sepharose beads 
GE Healthcare  Preclear Sepharose 
4, fast flow 
Rabbit anti-CAF-1 James Kadonaga IF: 1:250  
Rabbit anti-CENP-C Christian Lehner and 
Stefan Heidmann 
IF: 1:100  
Rabbit anti-CG30390 Jerry Workman WB: 1:1000  
Rabbit anti-CID Active Motif IF: 1:250 
WB: 1:500 
Immunoblot grade 
Rabbit anti-FLAG Sigma IF: 1:500 Polyclonal 
Rabbit anti-H3 Abcam WB: 1:5000  
Rabbit anti-H3S10ph Abcam FACS: 1:2000  
Rabbit anti-ROD Roger Karess IF: 1:100  
Rat anti-CID 7A2 and 
4F8 
Elisabeth Kremmer IF 7A2: 1:100 Rat IgG2a 
Rat anti-INCENP Patrick Heun IF: 1:100 N-terminal fragment 
cloned by Mar 
Carmena 
Secondary:   
Donkey anti-rabbit 
Alexa 647 
Jackson Immuno 
Research 
IF: 1:1000 Preabsorbed 
Donkey anti-rat Alexa 
488 
Jackson Immuno 
Research 
IF: 1:200 Not preabsorbed 
Donkey anti-rat Cy3 Jackson Immuno 
Research 
IF: 1:500 Preabsorbed 
Goat anti-mouse 
Alexa 488 
Molecular Probes IF: 1:2000 Preabsorbed 
Goat anti-mouse 
Alexa 647 
Life technologies IF: 1:500 Preabsorbed  
ECL anti-mouse IgG, 
HRP-linked whole 
antibody 
Amersham WB: 1:5000  
ECL anti-rabbit IgG, 
HRP-linked whole 
antibody  
Amersham WB: 1:5000  
 
To test the different subclones of the rat-anti-CID antibodies provided by 
Elisabeth Kremmer from the antibody facility at the Helmholtz Center in 
Großhadern/Munich, cells stably transfected with CID-GFP were used (figure 
4.3). Expression of CID-GFP controlled by the pMT-promoter was induced by 
adding 250 µM CuSO4 for 24 hours before fixation of cells and performing the 
immunolocalization. Figure 4.3 indicates that the 7A2 antibody specifically 
binds to untagged endogenous CID, and not to CID-GFP, since only 
centromeric patterns are visible even when CID-GFP is overexpressed and 
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exhibits localization throughout the nucleus (second panel). This is not true for 
the 4F8 subclone which gives a similar localization pattern to GFP and also 
seems to be less sensitive.  
 
 
 
 
4.1.5 Primers for generating dsRNAs for knockdowns 
The website SnapDragon (www.flyrnai.org/cgi-bin/RNAi_find_primers.pl) was 
used for assistance with primer design. dsRNA length was defined to be 
around 500 bp. Custom oligos were ordered via Sigma-Aldrich.  
Oligo specificity Sequence 
CAF-1 1 fw 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGACCGTTCCTGTACGATCTGGTCAT  
CAF-1 1 rev 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGAATCAGAGGCTGACAGCAAATAGCC 
CAF-1 2 fw 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGAGACGTGGCTTGGCATCTGCTAC 
CAF-1 2 rev 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGAGAGAAATCGCTAATCTTGGCAGTGTG 
CAF-1 fw 
(mitotic defects) TAATACGACTCACTATAGGGCGCGTGATCAATGAGGAGTA 
CAF-1 rev 
(mitotic defects) TAATACGACTCACTATAGGGAACGCTGGCGATGAGTAGAT 
Cal1 fw TTAATACGACTCACTATAGGGAGACGGTGGTGGACGAGGAAACACT 
Cal1 rev TTAATACGACTCACTATAGGGAGACGACGACTCTGCTGGATGTAGCG 
Figure 4.3: Test of reactivity of monoclonal rat antibodies upon copper-induction of stable 
CID-GFP expressing cells. Either the monoclonal with the number 7A2 or 4F8 was used as 
primary antibody and the same secondary antibody in both cases. Single plane images are 
shown, pictures not deconvolved. Scale bar represents 3 µm. 
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CENP-C 1 fw TTAATACGACTCACTATAGGGAGACAAGCTTGCCGAAAATAAGCCGG 
CENP-C 1 rev TTAATACGACTCACTATAGGGAGATTTCTCTGTGCAAGGTGTGCTGCTTATTTC 
CENP-C 2 fw TTAATACGACTCACTATAGGGAGAATCCCTTGGCCTGAGTACCTTGACGTG 
CENP-C 2 rev TTAATACGACTCACTATAGGGAGATTCGCTTGTTTCATGCTACGTTTTTGGTATG 
CG11076 fw TTAATACGACTCACTATAGGGAGAGAGCGAGGCACTGGGCTATTTG 
CG11076 rev TTAATACGACTCACTATAGGGAGAGAATTAAATTTTTTCTTGCGCATTTTG 
CG14480 fw TTAATACGACTCACTATAGGGAGAATGAGTTCGGGCTTTGTGACTGAAGC 
CG14480 rev TTAATACGACTCACTATAGGGAGAGTCTTCTGAGTGCTACGCCCGACC 
CG2051 fw   
(CID loading) TTAATACGACTCACTATAGGGAGAACACCACCGTATACGAGTACTACGCCTATC 
CG2051 rev 
(CID loading) TTAATACGACTCACTATAGGGAGACAGGCGAGCACGCAGCATTTC 
CG2051 fw  
(mitotic defects) TAATACGACTCACTATAGGGTCCACGAACCACAAGATGAA 
CG2051 rev  
(mitotic defects) TAATACGACTCACTATAGGGCATCTACTTGGGCGTCGATT 
CG3548 fw TTAATACGACTCACTATAGGGAGAGAAACGCTCCCTTAACTGGGAG 
CG3548 rev TTAATACGACTCACTATAGGGAGACTCGCTGGCGTTCGTAGAGTTG 
CG6227 fw TTAATACGACTCACTATAGGGAGAGTCGATAAGCAGGAGAACGCTGAC 
CG6227 rev TTAATACGACTCACTATAGGGAGAGATGTCCTCCTCATCATCGGAATC 
CID fw TTAATACGACTCACTATAGGGAGACCGTCGGCGAACAACTCAAAGT 
CID rev TTAATACGACTCACTATAGGGAGAAGCCGCTGCGTCAAGTACATCTC 
Gfzf fw TTAATACGACTCACTATAGGGAGACATCAATGTGGACTTTTGCGCC 
Gfzf rev TTAATACGACTCACTATAGGGAGAATGTGTGACATATCCGGTGGGTTC 
GST fw TTAATACGACTCACTATAGGGAGAAGTTTGAATTGGGTTTGGAGTTTCC 
GST rev TTAATACGACTCACTATAGGGAGATCGCCACCACCAAACGTGG 
hyd fw  TTAATACGACTCACTATAGGGAGACCATGCATTCTTTGCTCGATCTG 
hyd rev TTAATACGACTCACTATAGGGAGACTATGATAACCTCTGGTCGTGTGGC 
MED30 fw TTAATACGACTCACTATAGGGAGACTATCTCGCAGCAAAATCCTCACAAG 
MED30 rev TTAATACGACTCACTATAGGGAGACAGCATGGTGTTGATCTCCCAG 
prod fw 
(mitotic defects) TAATACGACTCACTATAGGGGCTGCACAGTACAAAGCTGG 
prod rev    
(mitotic defects) TAATACGACTCACTATAGGGGCTAATGCTGATCCTTTCGC 
prod fw 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGAACGAGGACATGATGGAGGAG 
prod rev 
(CID loading/FACS) TTAATACGACTCACTATAGGGAGATATAAGGACGGCGGATCGTA 
Rbcn-3A fw TTAATACGACTCACTATAGGGAGACTAGCACACAAAGTGCTTCGCAAT 
Rbcn-3A rev TTAATACGACTCACTATAGGGAGAGTTGTCTCACATCGAAGACGCAA 
REG fw TTAATACGACTCACTATAGGGAGACGTTGATCCTCAAGGCAGAGC 
REG rev TTAATACGACTCACTATAGGGAGAATAATCATCGATGTGCGGATACTTG 
White fw TTAATACGACTCACTATAGGGACTGCTCAATGGCCAACCTGTGGAC 
White rev TTAATACGACTCACTATAGGGCCTCGGCCATCAGAAGGATCTTGTC 
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4.2 Methods 
4.2.1 Tissue culture 
Cell maintaining: 
If not mentioned otherwise in the text, the Drosophila Schneider S2 cell line 
subclone L2-4 has been used in this work (exception: Kc167 cells for SNAP 
experiments). Cells were maintained in Schneider medium (Life technologies) 
supplemented with 10 % FCS (Sigma) and Penicillin and Streptomycin (PAA) 
in order to avoid bacterial contaminations. Cells were kept in Greiner flasks at 
26 °C and split to 1-2*106 cells per milliliter every two to three days. For 
harvesting cells, they were spun down at 1000 g for 20 minutes.  
Cell freezing and thawing:  
To freeze cells, logarithmically growing cultures at 100 % confluency were 
spun at 170 g for six minutes and diluted in 50 % FCS/10 % DMSO/40 % 
Schneider cell medium. The solution was put in cryovials (Thermo Scientific) 
in freezing racks (Fisher Scientific) with a cooling rate of 1 °C per minute over 
night at -80 °C and then transferred to liquid nitrogen tanks for long-term 
storage. Thawing was performed quickly in 15 mL Schneider medium, cells 
seeded in a Greiner flask and after settling of the cells (approx. 1 hour), the 
medium was replaced with fresh one in order to avoid cell damage by DMSO.  
Knockdowns:  
For performing knockdowns, 1*106 cells in log-phase were seeded in six well 
plates in 1 mL serum-free medium. 10 µg dsRNA were added. Plates were 
carefully shaken for 10 minutes at room temperature and subsequently 
incubated 50 minutes at 26 °C. Each well was then supplied with 2 mL serum-
containing medium. Knockdowns were generally carried out for six days total 
incubation time. dsRNA was generated using the Ambion MEGAscript® RNAi 
kit according to manufacturer's instructions.  
Transient transfections and stable cell lines:  
For transfections, 3*106 cells were seeded in six well plates in 1.5 mL 
Schneider medium. 2 µg of plasmid DNA diluted in 100 µL medium were pre-
mixed with 5 µL transfection reagent (X-tremeGENE HP DNA Transfection 
Reagent, Roche) in an Eppendorf tube, incubated for 10 minutes, 500 µL of 
Schneider medium added and carefully pipetted under the surface of the 
medium. Transfections were incubated for 24 hours before 250 µM copper 
sulfate was added to induce transcription of the transfected gene. The 
protocol for immunofluorescence was performed 24 hours later. To create 
stable cell lines, cells were selected after transfection and without induction 
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for four weeks in Schneider medium supplemented with 100 µg/mL 
Hygromycin B (Invitrogen).  
4.2.2 DNA methods 
Cloning: 
The open reading frames of hyd, CG7518, Rbcn-3A and asp were PCR 
amplified from Drosophila cDNA and cloned into the expression vector 
described in chapter 4.1.1.3 using the in-Fusion HD cloning kit (Clontech). 
Since they comprise very long sequences, they were first subcloned in two 
pJet1.2 vectors by the in-Fusion strategy, excised with respective restriction 
enzymes (see below) and ligated into the expression vector. Additionally, 
Cdk12, ATAC3 and CG4972 were PCR amplified from cDNA, cloned into 
pJet1.2 vector by in-Fusion reaction and inserted in the vector by restriction 
and ligation. CG30390 and Hsp70Ab were directly cloned into the vector after 
PCR amplification from cDNA.  
 
Restriction sites added by PCR reaction to the different cDNAs for cloning:  
Target gene Added restriction sites 
Asp  1
st
 Bsp120L/HindIII, 2
nd
 HindIII/XbaI 
ATAC3 XbaI/NotI 
Cdk12 XbaI/NotI 
CG30390 XbaI/NotI 
CG4972 XbaI/NotI 
CG7518 1
st
 Bsp120L/KpnI, 2
nd
 KpnI/XbaI 
Hsp70Ab NotI/AvrII 
Hyd 1
st
 NotI/XbaI, 2
nd
 XbaI 
Rbcn-3A 1
st
 NotI/HindIII, 2
nd
 HindIII/XbaI 
1
st
 and 2
nd
 denote insertions in two individual pJet1.2 intermediate vectors 
 
Other constructs were ordered from BDGP and served as template for PCR-
based amplification and subsequent cloning into the pMT-hyg-FLAG-HA-
Nterm, pIB-v5 or a pIB-GFP expression vector (see tables 4.1/4.2/4.3/4.4). All 
sequences obtained by cloning or ordering were verified by sequencing. 
Cloning into pIB-GFP/v5 vectors was performed by Georg Schade. The 
vectors containing H3.2-GFP, H3.3-GFP and CID-GFP used to generate 
stable cell lines were cloned by Patrick Heun (H3.2-GFP and CID-GFP cell 
lines described in Heun, Erhardt et al. 2006).  
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Generation of cDNA from Drosophila L2-4 cell mRNA:  
cDNA was generated using SuperScript III reverse transcriptase (Life 
technologies) with random as well as oligo-dT primers according to 
manufacturer's instructions in 40 µL reaction volume. RNase H digestion was 
performed afterwards.  
In-Fusion reaction:  
For in-Fusion reactions, the pJet1.2 vector was linearized using EcoRV 
enzyme and supplied with the PCR amplified inserts in a ratio determined by 
the Clontech ratio calculator. The exact concentration of inserts as well as 
pJet1.2 vector was determined by gel electrophoresis and comparison with 
the 2log-ladder (New England Biolabs, see below). The end volume of the in-
Fusion reaction was 5 µL. After the in-Fusion reaction, the resulting vectors 
were transformed into competent Stellar cells (Clontech): 20 µL of competent 
cell solution plus DNA were kept on ice for 30 minutes, heat shocked for 45 
seconds at 42 °C in a waterbath, 250 µL of SOC medium added and kept at 
37 °C shaking before plating on an ampicillin-containing medium plate. 
Restriction digests:  
For restriction digests of DNA, the DNA was mixed with water and 10x buffer 
4 of New England Biolabs, BSA added to a concentration of 1 mg/mL and the 
ideal unit amount for the enzymes calculated. The reaction was carried out at 
the required temperature (mostly 37 °C) until 2–10 fold overdigestion as 
determined by calculation was achieved.  
Ligations:  
For ligation of an insert into a digested vector, 40 ng of the plasmid were used 
and three times more moles of the insert added. The ligation was performed 
for 30 minutes at room temperature using 320 U T4 DNA ligase (New England 
Biolabs) and supplemented with the required volume of 10x ligation buffer.  
PCR protocol: 
PCRs were performed with the Q5 polymerase from New England Biolabs 
since it offers a low error rate.  
The reaction was separated in three aliquots of 25 µL and run in a gradient 
thermocycler at different annealing temperatures between 60 °C and 66 °C 
(step 3 in the PCR conditions) 
 
For difficult amplifications from the whole cDNA-pool, the following exemplary 
protocol was applied:  
 
 
MATERIAL AND METHODS 
96 
 
15 µL  5x Q5 reaction buffer 
1.5 µL  10 mM dNTPs (final concentration: 200 µM) 
3.75 µL  forward primer 10 µM, final concentration 0.5 µM 
3.75 µL  reverse primer 10 µM, final concentration 0.5 µM 
1.25 µL  template cDNA, corresponding to 250 ng dsRNA used for 
cDNA synthesis 
0.75 µL  Q5 high-fidelity DNA polymerase (final concentration 0.02U/µL) 
15 µL  5x Q5 high GC enhancer 
34 µL  nuclease-free water 
final volume:   75 µL 
 
PCR conditions:  
1. 98 °C 30 seconds 
2. 98 °C 10 seconds 
3. 60 ° to 66 °C 20 seconds 
4. 72 °C 40 seconds per kb  
5. 72 °C 5 minutes 
6. 4 °C 
Steps 2-4 were repeated 35 times.  
 
Amplified DNA was size separated by electrophoresis using a 1 % (w/v) 
agarose gel (Bio&SELL) in TBE (0.9 M Tris, 0.9 M Boric acid, 32 mM EDTA) 
buffer. The DNA band at the right size was excised from the gel and purified 
using the Qiagen QiaQuick Gel extraction kit.  
DNA quantification: 
DNA quantification was either carried out with a Nanodrop device (ND-1000 
UV Spectrophotometer, Peqlab) at a wavelength of 260 nm or 1 µL of the 
DNA was applied on a 1 % agarose gel and 10 µL of the 2log-ladder (New 
England Biolab) which enables good estimation of DNA amounts.  
Preparation of DNA for gel electrophoresis:  
For RNA digestion, 50 µg/mL RNase A (Sigma) and 0.5 % (w/v) SDS were 
added to nuclear pellets for 30 minutes at 37 °C and subsequently, proteins 
were digested by adding 0.5 mg/mL proteinase K (Roche) for two hours at 
65 °C. For ethanol precipitation, 1/10 volume of 3 M sodium acetate pH 5.2 
was added followed by 2.5 volumes of ice-cold ethanol. Precipitation was 
performed at -20 °C for at least 30 minutes. Precipitated DNA was collected in 
a pellet by 30 minutes of centrifugation at maximum speed. The pellet was 
washed in 70 % ethanol and the DNA finally redissolved in TE (10 mM 
Tris/1 mM EDTA) buffer. 
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4.2.3 Protein methods 
SDS-PAGE: 
To distinguish proteins by size, SDS-PAGE analysis was performed. Either 
pre-cast polyacrylamide gradient gels from 4-20 % PAA (Expedeon, RunBlue) 
were used or self-cast 15 % PAA gels for MS analyses (polyacrylamide 
solution: Rotiphorese, 37.5:1 acrylamide/bisacrylamide (Roth), separation gel 
buffer (375 mM Tris/HCl pH 8.8), stocking gel buffer (125 mM Tris/HCl pH 
6.8), 0.05 % TEMED: Roth, 0.1 % APS: Roth). Protein samples were mixed 
with Laemmli buffer (final concentration: 50 mM Tris/HCl, pH 6.8, 2 % SDS, 
10 % glycerol, 0.05 % bromophenol blue, 0.15 M β-mercaptoethanol; except 
for elution from GFP-Traps for which all concentrations were doubled) and 
boiled for 5 minutes (elution: 10 minutes) at 95 °C before application for 
electrophoresis. Gel chambers were XCell Sure Lock from Invitrogen and gels 
were run at 130 V to 180 V for varying times.  
To stain proteins with Coomassie Brilliant Blue, the gels were shaken for 20 
minutes in staining solution (50 % methanol, 10 % acetic acid, 0.25 % 
Coomassie G-250 (Serva)) directly after size separation electrophoresis. 
Destaining was performed in 10 % acetic acid at room temperature until 
protein bands were visible. Silver staining was performed according to the 
protocol of Blum et al. (Blum, Beier et al. 1987).  
Western Blotting: 
Western blot analysis was performed using a wet blot chamber (Mini-Protean 
Tetra System, Biorad). Proteins were transferred to a nitrocellulose 
membrane (Protran®, Amersham, GE Healthcare) at 300 mA for two hours at 
4 °C in a transfer buffer containing 15 % (v/v) methanol, 0.02 % (w/v) SDS, 
25 mM Tris, 192 mM glycine. Before incubation with the primary antibody, the 
membrane was blocked with 5 % (w/v) milk powder (Heirler) in PBS for 30 
minutes. Incubation with the primary antibody was performed at 4 °C over 
night. The membrane was then washed with PBS/0.1 % (v/v) Tween 20 
(Sigma) three times for 10 minutes and blocked again in 5 % (w/v) milk/PBS 
for 30 minutes before the secondary antibody was added (usually diluted in 
1 % (w/v) milk/PBS or 3 % (w/v) BSA/PBS). The secondary antibody was 
coupled with horseradish peroxidase. It was used in a 1:5000 dilution in 1 % 
(w/v) milk/PBS and incubated for one hour at room temperature. The 
membrane was washed in PBS/0.1 % (v/v) Tween 20 again three times for 10 
minutes, incubated in enhanced chemiluminescence solution (Amersham ECL 
Prime Western Blotting Detection Reagent, GE Healthcare) for five minutes 
and chemiluminescence signals were visualized with Fuji X-ray films (Röntgen 
Bender) on an Agfa Curix 60 developer machine.  
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Protein quantification: 
To determine concentration of proteins in a solution, a Bradford assay was 
conducted using the Protein assay Dye Reagent Concentrate (Biorad). For 
this purpose, 800 µL of ddH2O were mixed well with 1.5 µL of protein solution 
and 200 µL of the dye added. After five minutes of incubation, absorption at 
595 nm was measured on a UV Visible Spectrophotometer (Ultrospec 2000, 
Pharmacia Biotech) and compared to a standard curve of five known BSA 
concentrations.  
Protease inhibitors and reducing agent: 
 
Name 
 
Stock 
Working 
concentration 
Aprotinin 1 mg/mL in H2O 1 µg/mL 
Leupeptin 1 mg/mL in H2O 1 µg/mL 
Pepstatin 0.7 mg/mL in ethanol 0.7 µg/mL 
PMSF 0.2 M in isopropanol 0.2 mM 
DTT 1 M in 10 mM sodium acetate pH 5.2 1 mM 
4.2.4 GFP affinity purifications 
A purification of centromeric chromatin has to be performed on soluble 
chromatin material as an input. Digestion of chromatin by MNase is a well-
established method to generate such chromatin fragments. The aim was to 
not overdigest chromatin during MNase treatment, but still release as much 
CID-GFP as possible. Overdigestion might lead to loss of interactions as 
nucleosomal proteins and their binding partners might fall apart. The packing 
degree and structure of centromeric chromatin is not yet clear, so the MNase 
conditions had to be adjusted for this work. Therefore, different conditions for 
the MNase digest were assayed on the nuclear pellet of CID-GFP expressing 
cells, resulting in a nucleosomal array of mostly mononucleosomes to higher 
chromatin sizes (figure 4.4A). The respective fractions were tested for CID-
GFP amounts in either the supernatant after MNase digestion and 
centrifugation or the remaining non-soluble protein in the pellet (figure 4.4B). 
No strong difference of released CID-GFP was observed with different 
concentrations of MNase. An MNase concentration corresponding to 1x in 
figure 4.4B was chosen, as small chromatin fragments of mostly mono- and 
dinucleosomes were generated here (figure 4.4A). This may also increase the 
specificity of purifying centromere chromatin, as larger chromatin fragments 
bear the risk of reaching into neighbouring non-centromeric chromatin. Still, 
one experiment with longer arrays of nucleosomes (SID1508), prepared with 
an MNase concentration corresponding to 1/10 dilution (figure 4.4B), was 
performed to compare MS results to the ones of shorter arrays. However, the 
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most enriched factors of CID-GFP versus wildtype purification were the same 
in both MNase conditions, indicating that the MNase digestion degree does 
not influence detection of these CID-GFP interactors.  
Since there seemed to be a degradation of CID-GFP in the titration 
experiment (figure 4.4B), all chromatin preparations actually used for mass 
spectrometry experiments were checked by GFP Western blot (figure 4.4C). 
No degradation in the experiments used for identification and quantitation was 
detected. The conclusion was that the degradation did not result from the 
applied MNase conditions. Figure 4.4D shows the DNA fragment size 
distribution of solubilized chromatin from one actual replicate experiment, 
SID1392, where chromatin is mostly mononucleosomal. 
 
 
MNase digestion was performed in Ex100 buffer containing 100 mM sodium 
chloride (NaCl). The standard protocol for extracting MNase digested 
chromatin from nuclei is to apply a so-called resuspension buffer for one hour. 
Figure 4.4: Preparation of chromatin for immunoprecipitation. A: Ethidium bromide stained 
agarose gel demonstrating the digestion degree of chromatin prepared from CID-GFP 
expressing cells using different concentrations of MNase. B: Corresponding Western blot 
depicting levels of CID-GFP released by different degrees of MNase digestion (supernatant) 
and insoluble levels remaining in the pellet. C: Western blot of input samples analyzed by 
mass spectrometry. D: Representative DNA gel showing lengths of chromatin elements used 
for immunoprecipitations. Appropriate sizes of mono-, di- and trinucleosomes (mono-, di- and 
trinuc.) are indicated.  
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This buffer consists of PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.4 mM K2HPO4) plus 150 mM sodium chloride, 2 mM EDTA and 0.1% (v/v) 
Triton X-100 to efficiently extract chromatin. However, such high 
concentrations of salt can disrupt interactions of complexes and might lead to 
less efficient immunoprecipitation as well as loss of binding partners. 
Therefore, it was tested whether also single conditions contained in the 
resuspension buffer were sufficient to extract chromatin (figure 4.5). 
Chromatin was either not digested with MNase (first lane) or it was digested 
with MNase (same batch for lanes 2-6) and afterwards incubated for one hour 
with either the complete resuspension buffer (lane 6) that was known to 
release digested chromatin from nuclear pellets, or with PBS plus only 
300 mM salt conditions (lane 2), 3 mM EDTA (lane 3), PBS and sonication 
(lane 4, Branson Sonifier 250-D, sonication for two times 60 seconds at 22 % 
power) or PBS plus 0.1 % (v/v) Triton X-100 (lane 5). After extraction and 
centrifugation at 5000 g for 10 minutes to remove unsoluble fractions, RNA of 
the supernatant was removed by RNase A treatment (chapter 4.2.2), proteins 
by proteinase K digestion and the DNA precipitated by addition of ethanol. 
The DNA gel picture (figure 4.5) indicates that the most efficient way to extract 
chromatin is indeed by high salt conditions as only there, the bands 
corresponding to mono- and dinucleosomes and larger chromatin sizes are 
visible. Thus, chromatin in this workflow was extracted in around 300 mM salt 
solution and subsequent affinity purification performed in the same conditions.  
 
 
To determine amounts of GFP-Traps required to quantitatively precipitate the 
GFP-fusion proteins from a given amount of starting material, a titration was 
performed using increasing volumes of affinity matrix (beads). Increased 
depletion of CID-GFP or H3.3-GFP from input samples could be observed 
Figure 4.5: DNA gel 
indicating effectiveness to 
release digested chromatin 
from nuclei. Except in the first 
lane, material from the same 
batch of MNase digested 
L2-4 nuclear pellets was 
extracted for one hour on a 
rotating wheel at 4°C with the 
conditions indicated on top. 
Resuspension buffer 
contains roughly 300 mM 
NaCl, 2 mM EDTA and 0.1 % 
triton X-100.  
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after affinity purification when using increasing bead volumes (figure 4.6). For 
further experiments, a volume of beads was used that would correspond to 
between 1-5 µL of bead volume from the experiment shown in figure 4.6. 
Under these conditions, inputs were considerably depleted of the GFP-tagged 
protein, but no full saturation of the beads was obtained yet. This should 
ensure the recovery of interactors of lower abundance and at the same time 
limit the association of factors that unspecifically bind to the affinity matrix.  
 
 
 
 
 
 
 
The whole protocol for affinity purifications was performed as follows: For 
GFP affinity purifications, stable cell lines expressing H3.2-GFP, H3.3-GFP or 
CID-GFP were upscaled in roller bottles to around 5*109 cells per cell line. 
Cells were harvested by centrifugation at 1000 g for 15 minutes at 15 °C in a 
Heraeus centrifuge. Cell pellets were washed once with 10 mL PBS per 109 
cells, centrifuged at 1000 g for 10 minutes and the pellet then resuspended in 
hypotonic buffer (10 mM HEPES-KOH pH7.6, 15 mM NaCl, 1.5 mM MgCl2, 
0.1 mM EDTA, plus freshly added protease inhibitors plus DTT). Cells were 
left swelling in the hypotonic buffer on ice for 20 minutes. To disrupt cell 
membranes, the same volume of hypotonic buffer plus 0.2 % (v/v) Triton X-
100 was added and cells spun at 4 °C for 10 minutes. Volumes of hypotonic 
buffer were chosen such that the end volume including cell volume plus 
hypotonic buffer plus hypotonic buffer supplemented with Triton X-100 
reached 2 mL per 109 cells. One tenth of this volume of 1 M NaCl was added 
after preparing nuclei in order to reestablish more physiological salt conditions 
and thereby stabilize interactions that only exist under these conditions. 
Nuclear pellets resulting from that treatment were washed once in 4 mL per 
109 cells of EX100 buffer (10 mM HEPES-KOH pH7.6, 100 mM NaCl, 1.5 mM 
Figure 4.6: Titration of GFP-Trap amounts for immunoprecipitation. Western blot with inputs 
before binding to beads and unbound fractions after incubation with beads. The same 
amount of total protein between CID-GFP and H3.3-GFP immunoprecipitations as 
determined by Bradford assay is loaded.  
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MgCl2, 0.1 mM EDTA, plus freshly added protease inhibitors plus DTT). 
Nuclei were then resuspended in 1-2 mL per 109 cells of EX100 for MNase 
digestion. CaCl2 of a 100 mM stock solution was added to a final 
concentration of 2 mM as calcium is a requirement for MNase activity. 2000 
Becker units of MNase per 109 cells were added and the reaction incubated at 
26 °C for 20 minutes. Becker units result if 500 units of MNase from Sigma 
are diluted in 850 µL EX50 buffer – the resulting solution contains 50 Becker 
units per microliter. The reaction was stopped on ice by adding the calcium 
chelator EGTA to 10 mM final concentration. Chromatin was further extracted 
by adding NaCl to an end-concentration of 300 mM and homogenized with ten 
strokes in a Dounce homogenizer with a tight fit pestle. Afterwards, the 
solution was rotated at 4 °C for one hour, followed by centrifugation at 5000 g 
to remove debris and harsh centrifugation at top speed for 20 minutes to 
further clear the protein solution. Aliquots were kept as input samples.  
Before performing affinity purification, this solution was further pre-cleared by 
rotation at 4 °C for 30 minutes using equilibrated Sepharose beads coupled 
with protein A (GE Healthcare). At the same time, GFP-Traps, after 
equilibrating them in EX100 containing 300 mM NaCl end-concentration, were 
pre-blocked by adding 0.5 % (w/v) PVP/0.5 % (w/v) BSA in EX100 also for 30 
minutes rotating at 4 °C. The pre-cleared MNase digested chromatin was 
added to the GFP-Traps and incubated with rotation at 4 °C for two hours. 
After immunoprecipitation, beads were washed three times with EX100 
containing 300 mM NaCl for 5 minutes while rotating at 4 °C. Beads were 
then diluted in 2x Laemmli solution (final concentration: 100 mM Tris/HCl, pH 
6.8, 4 % (w/v) SDS, 20 % (v/v) glycerol, 0.1 % (w/v) bromophenol blue, 0.3 M 
β-mercaptoethanol) and boiled at 95 °C for 10 minutes. The proteins released 
from beads under these conditions were then directly applied for SDS-PAGE.  
4.2.5 Mass spectrometry 
4.2.5.1 In-gel tryptic digestion 
After separating bead-binding proteins by size by SDS-PAGE and Coomassie 
staining, each lane was evenly divided in eight subfractions using a 
disposable gridcutter (Gel company). Each of the eight fractions was 
subjected to in-gel tryptic digestion and then loaded individually on the mass 
spectrometer (chapter 4.2.5.2). In-gel tryptic digestion was performed by Marc 
Wirth. To identify and measure proteins in different elution fractions of 
immunoprecipitation experiments, bottom-up, "shotgun" mass spectrometry 
analysis was carried out. In bottom-up analysis, peptides instead of proteins 
are measured as they bear smaller masses, occupy lower numbers of charge 
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states upon ionization and produce less complex fragment spectra. Trypsin is 
commonly employed for this proteolysis as it specifically cleaves peptide 
bonds C-terminal to arginines and lysines.  
All chemicals used for MS treatment were MS/HPLC grade. The excised 
bands were first washed two times with water and two times with 20 mM 
ammonium bicarbonate for pH adjustment. To remove the Coomassie dye, 
which could cause problems during subsequent MS measurement, gel pieces 
were incubated with 10 mM ammonium bicarbonate/50 % (v/v) acetonitrile 
(ACN) for 60 minutes at 37 °C. Afterwards, the gel pieces were again washed 
three times with 20 mM ammonium bicarbonate. Gel pieces were dehydrated 
by application of ACN until they appeared white. They were rehydrated with 
10 mM DTT in 20 mM ammonium bicarbonate and incubated for one hour at 
room temperature to reduce bisulfite bonds between cysteines. Cysteines 
were then alkylated by adding 55 mM iodoacetamide (IAA) in 20 mM 
ammonium bicarbonate for 30 minutes at room temperature in the dark. Gel 
pieces were then washed with 20 mM ammonium bicarbonate once and 
dehydrated by addition of ACN until they appear white. Gel pieces were 
rehydrated in trypsin solution: 25 ng/µL trypsin (Promega) in 20 mM 
ammonium bicarbonate were added and the supernatant not aspirated by the 
gel pieces removed after 30 to 45 minutes incubation. 20 mM ammonium 
bicarbonate was added to cover the gel pieces and digestion was performed 
over night at 37 °C. Before loading the resulting peptide solution on the mass 
spectrometer, it was acidified with trifluoroacetic acid (TFA) to an end-
concentration of 0.1 % (v/v), a prerequisite for peptide ionization.  
4.2.5.2 Analysis by LC-MS/MS  
The peptides were fractionated by reversed phase - liquid chromatography 
(RP-LC) where peptides are bound to a hydrophobic C18 resin column and 
eluted by a gradient of increasing acetonitrile, a hydrophobic compound. In 
RP-LC, more hydrophilic peptides are eluting earlier. By applying a high 
voltage in a process called electrospray ionization (ESI), peptides are 
changing from liquid phase into gas phase and subsequently enter the mass 
spectrometer at different times during the upstream chromatography step 
(retention time). This reduces complexity of the sample and thus increases 
the number of identified peptides.  
In the mass spectrometer, first a survey spectrum to detect abundant signals 
and their mass-to-charge (m/z) ratios at a given retention time is measured 
(MS1 spectrum). Based on the intensity of the signals in the MS1 spectrum, 
the six most intense peaks (Top6-method) are subjected to fragmentation. In 
peptide fragmentation, the peptide is dissociated upon collision with an inert 
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gas which in most cases breaks a single peptide bond within the peptide 
sequence. Bond breakage relies on the dissociation energy of the peptide 
bond. By breakages at different positions within a peptide, fragment products 
after ideally each single amino acid of the parental peptide result. Thus, the 
fragmentation spectrum (MS2 or MS/MS spectrum) can be used to read the 
amino acid sequence of the peptide and to determine the location of 
posttranslational modifications, if present. Raw data of MS1 and MS2 spectra 
over the retention time of the whole LC run thus comprise m/z values of 
survey as well as several fragmentation spectra. 
MS1 overview spectra are recorded every few seconds, leading to several 
measurements during the retention time of one peptide (peak width 0.5-2 
minutes). In the meantime, the six MS2 spectra are obtained (figure 4.7). 
When searching the MS data for the m/z ratio of a certain peptide in form of 
an extracted ion chromatogram (XIC, see figure 4.7), it is first eluting to a low 
intensity, which increases over time and decreases thereafter.  
 
 
 
 
 
 
 
The area under such a peak can be integrated and this gives quantitative 
information about the abundance of a protein in a sample. This absolute 
intensity though can differ between different peptides due to factors like 
feasibility of ionization or binding to the column. To improve comparison 
between different proteins, the MaxQuant software used here (chapter 
Figure 4.7: Quantification of protein intensities by mass spectrometry. A: Extracted ion 
chromatogram (XIC) of a certain m/z-ratio. Every few seconds, a MS1 overview spectrum is 
generated (violet, vertical line), in the time between the MS1 spectra, six MS2 spectra are 
recorded. The peptide of interest is starting to elute from the column at a certain retention 
time (x-axis), its eluted amount is increasing over time and then again decreasing. The 
intensity of detection in the mass spectrometer mirrors this phenomenon. B: In order to 
obtain quantitative values of peptide intensities, the MS1 intensities are combined to form a 
peak and the area under the peak is calculated (grey).  
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4.2.5.4) calculates a value called iBAQ (intensity based absolute 
quantification, (Schwanhausser, Busse et al. 2011). This value puts the 
theoretical detection probability for different proteins into account – the bigger 
a protein is, the higher the probability to measure one of its peptides, thus 
minimizing detection differences and facilitating comparison of protein 
abundances. In general: a high iBAQ value stands for high protein 
abundances.  
To analyze samples by LC-MS/MS, 50 % of the in-gel digested peptides of 
one fraction of a lane were injected into an Ultimate 3000 HPLC system 
(Thermo Fisher Scientific). Samples were desalted on-line by a C18 micro 
trap column (5 mm x 300 µm inner diameter, packed with C18 PepMapTM, 
5 µm, 100 Å, Thermo Fisher Scientific), and peptides were separated by a 
gradient from 5 % to 60 % (v/v) acetonitrile in 0.1% (v/v) formic acid over 40 
minutes at 300 nL/minute on a C18 analytical column (10 cm x 75 µm, packed 
in house with C18 PepMapTM, 3 µm, 100 Å, Thermo Fisher Scientific). The 
effluent from the HPLC was directly infused into the LTQ Orbitrap XL mass 
spectrometer (Thermo Fisher Scientific) via a nano-electrospray ion source. 
The MS instrument was operated in the data-dependent mode to 
automatically switch between full scan MS and MS/MS acquisition. Survey full 
scan MS1 spectra (m/z 350-2000) were acquired in the Orbitrap with 
resolution 60.000 at m/z 400. For all measurements with the Orbitrap 
detector, three lock-mass ions from ambient air (m/z=371.10123, 445.12002, 
519.13882) were used for internal calibration as described (Olsen, de Godoy 
et al. 2005). The six most intense peptide signals with charge states between 
two and five were sequentially isolated applying a 1 Dalton (Da) window 
centered on the most abundant isotope to a target value of 10.000 and 
fragmented in the linear ion trap by collision-induced dissociation. Fragment 
ion spectra were recorded in the linear trap of the instrument. Typical mass 
spectrometric conditions were: spray voltage 1.4 kV; no sheath and auxiliary 
gas flow; heated capillary temperature 200°C; activation time 30 ms and 
normalized collision energy 35 % for collision-induced dissociation in the 
linear ion trap.  
4.2.5.3 Protocol to analyze histone modifications 
As described in chapter 1.3 and 2.4.1, histone proteins are vastly modified 
mainly on their N-termini, which consist of a high number of lysines and 
arginines. Trypsin digests after lysines and arginines which for histones 
results in very small peptides that are not convenient for MS analysis (figure 
4.8). That is why in order to detect as many peptides carrying histone 
posttranslational modifications as possible, the trypsin digestion is combined 
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with a propionylation treatment that modifies unmodified and monomethylated 
lysines so trypsin only cuts after arginines – that is, because trypsin anyways 
cannot digest after di- or trimethylated or acetylated lysines. It results in the 
peptides indicated in figure 4.8.  
 
Histone proteins at a size between 11 and 17 kDa were excised from gels and 
in-gel tryptic digestion was performed. First, the bands were destained from 
Coomassie essentially as described for proteomics analysis in chapter 
4.2.5.1. Instead of treatment with DTT and IAA, 1 µL propionic anhydride in 
10 µL 100 mM ammonium bicarbonate was added to the gel pieces followed 
by 30 µL 1 M ammonium bicarbonate, to keep the pH during the 30 minutes 
incubation at room temperature between 7 and 8. Gel pieces were washed 
carefully afterwards three times with 100 mM ammonium bicarbonate to avoid 
over-propionylation events that result in unspecific mass shifts. Afterwards, 
trypsin digestion over night was performed similar to the description in chapter 
4.2.5.1. Here, 200 ng of trypsin were used per sample. To get a high 
sequence coverage, histone peptides were desalted using Carbon ZipTips 
(Glygen) according to manufacturer's instructions and the desalted peptides 
loaded directly onto the LC column without the use of a trap column. 
Otherwise, LC-MS/MS analysis was carried out essentially as described in the 
previous chapter for proteomics analyses.  
Figure 4.8: Propionylation inhibits trypsin digestion after lysines and therefore creates typical 
tryptic peptides of histone H3 and H4. Blue arrow: trypsin cutting site. Red cross: cutting site 
inhibited by propionylation. Orange arrow: residue protected from trypsin cleavage because 
of the following proline. Numbers indicate amino acids of analyzed tryptic peptides.  
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4.2.5.4 MaxQuant analysis for protein identification and quantification 
A large amount of data is acquired in the eight LC-MS/MS runs resulting from 
the eight chopped gel pieces containing information about identity and 
abundance of detected proteins. This information should be compared to a 
theoretical database of a Drosophila proteome. MaxQuant is a software that 
searches peptide sequences obtained from MS2 spectra versus an annotated 
proteome as in this case the one from the flybase database for Drosophila 
melanogaster. The software correlates the measured sequences with 
theoretical sequences with a certain probability. Actually measured peptide 
sequences that can be assigned to a protein or protein isoforms from the 
database then results in identification of that protein in the MS run.  
For protein identification, the raw data were analyzed with the Andromeda 
algorithm of the MaxQuant protein analysis package (version 1.2.2.5) against 
the Flybase dmel-all-translation-r5.24.fasta database including reverse 
sequences to determine false discovery rates and contaminants. Trypsin/P 
was selected as protease and maximum two missed cleavages allowed. Fixed 
modifications were carbamidomethylation of cysteines resulting from IAA 
treatment, while methionine oxidation and N-terminal acetylation of proteins 
were set as variable modifications. The mass tolerance of the initial search 
was 20 ppm; after recalibration, 6 ppm mass error were applied for the main 
search. Fragment ions were searched with a mass tolerance of 0.5 Da using 
the six most intense signals within 100 Da. Searching for secondary peptide 
hits within already assigned MS/MS spectra was enabled. The search results 
were filtered with a peptide and protein false discovery rate of 0.01 and a 
minimum peptide length of six amino acids. Protein identifications with at least 
one unique peptide were accepted. For quantification, the intensity based 
absolute quantification (iBAQ) values were calculated from peptide intensities 
and the protein sequence information of unmodified and modified unique 
peptide species with a minimum of two identified peptides per protein. 
4.2.5.5 Statistical analysis to determine centromeric proteins 
Statistical analysis was carried out by Dr. Andreas Schmidt. The output of the 
MaxQuant search was used for further statistical analysis. First, protein 
identifications from reverse sequences or contaminants as well as 
identifications without MS1 quantification values were removed. IBAQ values 
were log2-transformed. If a protein did not get identified in one out of nine 
samples (3x mock purification, 3x CID-GFP and 3x H3.3-GFP IPs), the iBAQ 
value in this sample is zero. Since for ratios, division by zero errors would 
occur, the zeros need to be replaced. This was done by imputing values by a 
random distribution centered at 1/3*log2 of the lower distribution of the 
complete iBAQ dataset. In order to avoid huge deviations by imputation, it 
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was repeated three times and the average value was further used. ANOVA 
(analysis of variance) was applied in DanteR (vs 0.2, PNNL, Richland, USA) 
as statistical means to calculate protein enrichment factors and p-values (see 
table 2, appendix) and obtained p-values were corrected for multiple 
hypothesis testing by the Benjamini-Hochberg method (Benjamini and 
Hochberg 1995). 
An important prerequisite for performing ANOVA analysis is that the obtained 
experimental values show Gaussian distribution. Figure 4.9 displays on one of 
the analyzed replicates that this is the case here: The log2-value of all iBAQ 
values of one run (from eight gel fractions) is plotted. A high log2-value 
probably stands for specific enrichment of one protein and consistently, 
especially in the purifications with CID-GFP and H3.3-GFP, a slight second 
peak in the area of log2 of twenty and more is appearing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A cutoff of a 16 times enrichment (log2 of four) over both H3.3-GFP samples 
and mock purifications was chosen in order to determine potential centromeric 
proteins. The outcome was 85 proteins plus nine proteins that were added 
because of their specificity of detection in CID-GFP purifications (see table 2, 
appendix): 90 % of all their determined iBAQ values had to arise specifically in 
CID-GFP IPs. Furthermore, they had to be identified in at least two out of 
Figure 4.9: Distribution of log2-
transformed iBAQ values of 
experiment SID1341. X-axis: all log2 
iBAQ values of one experiment. Y-
axis: number of proteins harboring a 
given log2 iBAQ value. The Gaussian 
distribution allows subsequent 
statistical analysis.  
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three CID-GFP purifications. The nine proteins with the highest average iBAQ 
values were added. To select around one third of factors to be checked by 
immunofluorescence analysis, the resulting 94 proteins were sorted by the 
following criteria: 1. The protein had to be detected in at least two out of three 
CID-GFP purifications. 2. The sum of iBAQ values originating from the three 
CID-GFP purifications out of the nine purifications (including 3x mock and 3x 
H3.3-GFP purifications) had to exceed 90 %. 3. Factors were sorted 
according to their average iBAQ values in the three CID-GFP purifications 
with the highest iBAQ values on top. The top third of proteins were chosen for 
IF analysis. Because of missing construct availability, the following proteins 
were not checked by IF: CG32344, SRPK, qkr58E-2, CG32069, CG6151 
(fwe), CG13117, RhoGAP54D, and CG8478. 
4.2.6 Microscopy methods 
4.2.6.1 Methods for microscopic analyses 
 
Immunolocalization protocol:  
For immunolocalization in Schneider L2-4 cells, transiently transfected and 
copper-induced cells (or uninduced, stable cell lines as indicated in figure 
legends) were settled on poly-L-lysine (Sigma) coated coverslips for minimum 
one hour, prelysed with PBS/0.1 % (v/v) Triton X-100 (PBT) for 40 seconds 
and gently washed with PBS before fixation with PBS/3.7 % (v/v) 
formaldehyde (10 min at room temperature). The prelysis step removes 
soluble proteins of the nucleoplasm which might otherwise cover centromeric 
signals. Cells were permeabilized for six minutes on ice with PBS/0.25 % (v/v) 
Triton X-100, subsequently washed twice with PBS for ten minutes and 
blocked for 45 minutes with Image-iT® FX signal enhancer (Invitrogen). 
Primary antibodies were diluted in PBS/5 % (v/v) normal goat serum (NGS) 
(Dianova) and incubated with the coverslips over night at 4 °C. After two ten 
minute washes with PBT, fluorophore coupled-secondary antibodies in diluted 
in 5 % (v/v) NGS/PBS were added for 45 min to one hour at room 
temperature. Cells were washed two times for ten minutes with PBT and then 
stained with PBS/DAPI (200 ng/mL) for six minutes, washed again with PBS 
and mounted in Vectashield (Vector Labs) or SlowFade (Invitrogen). 
Mitotically condensed chromosome analysis:  
For cytospins, performed by Georg Schade, 1-2*105 stably transfected cells 
were enriched in metaphase by colcemid treatment (1 μg/mL) for 30 minutes. 
Cells were resuspended in 500 μl 0.5 % sodium citrate, incubated for seven 
minutes and then spun using a single-chamber cytospin funnel in a Shandon 
MATERIAL AND METHODS 
110 
 
Cytospin 4 (10 minutes; 900 g; high acceleration). Cells were fixed for 9 
minutes in 3.7 % (v/v) formaldehyde in PBS solution, washed once with PBT 
for 5 minutes, then blocked with Image-iT® FX signal enhancer (Invitrogen) for 
1 hour. Subsequent steps for staining DNA and mounting cells were 
performed as described above. 
Analysis of mitotic defects: 
The protocol to determine mitotic defects was carried out by Georg Schade. 
RNAi experiments were essentially performed as described above (chapter 
4.2.1). Tubulin stainings in order to visualize the mitotic spindle and detect 
aberrant phenotypes and staining against the mitotic marker H3S10ph (see 
also chapter 2.8) were conducted. Two replicates of the experiment with 50 
imaged cells in each replicate were carried out.  
SNAP protocol: 
Kc167 cells obtained from Gary Karpen's lab (UC Berkeley) expressing 
SNAP-CID and CID-GFP were used for the SNAP protocol. The SNAP 
protocol is modeled after the publication from this lab by Mellone et al. 
(Mellone, Grive et al. 2011). RNAi was performed as described above 
(chapter 4.2.1). Conditioned medium was produced by growing cells in 
Schneider medium for 2-3 days, spinning down the cells for five minutes at 
600 g and the supernatant mixed 1:1 with fresh Schneider medium.  
To block SNAP-CID with BTP (quench), cells were treated with 12 µM BTP in 
conditioned medium for 30 minutes, washed three times with 1 mL of fresh 
medium for three minutes, once with conditioned medium for 30 minutes and 
afterwards released to progress in cell cycle (0h timepoint). The chase was 
performed for 24 hours. Then, cells were stained with 3 µM TMR in 
conditioned medium for 45 minutes in the dark (pulse). Cells were washed 
three times for five minutes with fresh medium, once 30 minutes with 
conditioned medium and twice for ten minutes with conditioned medium. After 
the quench-chase-pulse method, cells were treated as described above 
(fixation, permeabilization, DAPI stain and embedding).  
4.2.6.2 Analysis by confocal microscopy 
The microscopy setup used by me was a Leica TCS SP5 II confocal 
microscope with a 63x glycerol immersion objective (NA = 1.3). Z-stacks were 
deconvolved using the Huygens Essential Software (SVI) and further 
analysed with ImageJ software. Georg Schade used a DeltaVision RT 
microscope with 100x oil immersion objective. Pictures were deconvolved and 
analysed using SoftWorx Explorer Suite (Applied Precision). Line profiles for 
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both cases were produced using RGB profiler plugin for ImageJ 
(http://rsb.info.nih.gov/ij/plugins/rgb-profiler.html) 
4.2.6.3 Quantitative determination of GFP amounts in centromeres  
The CellProfiler pipeline described here was established by Dr. Andreas 
Thomae. Maximum intensity projections of deconvolved immunolocalization 
images were loaded into a pipeline of the CellProfiler software. First, nuclei 
were identified as primary objects with Otsu Global two classes thresholding 
method with the option to manually remove mitotic cells or misrecognized 
nuclei to avoid false quantifications. CID-GFP images were then enhanced as 
speckles. The enhanced CID-image was masked with nuclei to later only 
identify nuclear CID-GFP intense foci (centromeres). Next, centromeres were 
identified as primary objects with Otsu Global two classes thresholding 
method using the enhanced and masked CID-GFP image. Centromere 
objects (child objects) were related to the respective nucleus (parent object), 
and the per-parent mean integrated centromeric CID-GFP intensity was 
determined. The per-parent mean integrated intensity value was multiplied by 
the number of centromeres determined per nucleus to calculate total 
centromeric CID-GFP intensities per nucleus. Data were plotted using the 
Vertex42TM Box and Whisker Plot Template. Box plot shows upper and lower 
quartile and median values. Whiskers indicate upper and lower boarders of 
the 1.5-fold IQR (interquartile range) and contain more than 90 % (or more 
than 80 % in case of CENP-C 1 knockdown) of data points.  
4.2.7 FACS analysis 
Around 5*106 cells were harvested, washed with PBS and fixed in 70 % 
methanol/30 % PBS. Fixed cell pellets were kept at -20 °C for at least one 
hour and maximum one week. Pellets were then washed twice with PBS and 
then supplemented with 100 µg/mL RNase A in 200 µL PBS and incubated for 
ten minutes on ice. 10 µL of propidium iodide stock solution (1 mg/mL, Sigma) 
with 2 µL of EDTA in PBS were added and the samples directly measured on 
the FACSCanto device. Cell appearance was measured with forward and side 
scatter (FSC/SSC) indicating cell size or granularity, respectively. Propidium 
iodide was measured in the PE channel and the signal corresponding to Alexa 
488 in the FITC channel. Per condition, 100.000 cell events were measured. 
Results were analyzed using the FlowJo software. Gating on cells was 
performed as shown in figure 4.10: Cells were separated from debris by a plot 
of FSC versus SSC. Single cells were obtained by plotting PE-A (area) versus 
PE-W (width). In FACS analysis, the DNA content per cell is determined and if 
two cells in G1-phase stick together, the DNA content resembles the one of 
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cells in G2/M-phase. Therefore, this second gating event is applied. If an 
event harbors the same area, but double the width, it probably results from 
two cells sticking together. The histograms and density plots shown in figure 
2.24 result from single cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Gating of raw FACS data. Pink shapes are self-drawn gates that are kept the 
same for all conditions. Upper panel: forward scatter versus side scatter (FSC vs. SSC) 
density plot identifies living cells for GST knockdown (left) or CID knockdown (right). Middle 
panel: Single cells are determined by plotting PE-A versus PE-W. Numbers in plots indicate 
percentages contained in gates. Lower panel: Histograms obtained from only single cells of 
PE-A signal versus cell number as shown in the results part (figure 2.24).  
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APPENDIX 
Table 1: Proteins only identified in CID-GFP pulldowns. Listed are proteins that were 
identified at least in one of the three biological replicates of CID-GFP pulldown and never in 
control pulldowns (wildtype, H3.3-GFP). Blue: Proteins present in final list of CID-GFP 
enriched proteins after statistical analysis (see table 2).  
asp CG17187 CG4289 CHKov1 MED4 Src42A 
Baldspot CG17202 CG4679 CLIP-190 MEP-1 Stim 
Bap60 CG17293 CG4699 coil mge su(Hw) 
Brd8 CG17544 CG4887 CycB mip120 Su(var)3-7 
CAF-1-PB CG17660 CG4972 dream mit(1)15 sub 
Cal1 CG17768 CG5004 ec Mlf swm 
Cdk12 CG2186 CG5009 Edem1 mRpL12 Synd 
CENP-C CG2469 CG5664 eIF2B-gamma NAT1 Taf12 
CG10131 CG30390 CG6151 enok ncm Tango1 
CG10320 CG3056 CG6227 Ets97D Orc1 Tango5 
CG10420 CG31048 CG6230 Fatp Orc2 tex 
CG10600 CG31510 CG6525 Ge-1 pch2 Top3beta 
CG1091 CG31650 CG6766 gfzf pea torp4a 
CG1092 CG32069 CG6904 Gint3 phr tou 
CG11076 CG3209 CG7338 hay prod Trap1 
CG11200 CG32243 CG7518 Hsp70Ab qkr58E-2 Trp1 
CG11577 CG32343/ATAC3 CG8478 Hsp70Bbb Rae1 Tsp42Ed 
CG12104 CG32549 CG8525 hyd RagC v(2)k05816 
CG12343 CG32554 CG9293 ifc Rbcn-3A VhaM9.7-2 
CG1265 CG32699 CG9302 Jheh1 Rcd5 vimar 
CG1399 CG33691 CG9418 Klp3A RhoGAP54D Vsx1 
CG14722 CG3548 CG9601 l(1)G0230 Rlb1 wapl 
CG14480 CG3625 CG9609 LSm1 RN-tre YL-1 
CG15012 CG3714 CG9776 MED17 SF1 ZnT63C 
CG17153 CG41519 Chd1 MED30 Spn4 
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Table 2: Proteins enriched in CID-GFP pulldown as determined compared to wildtype and 
H3.3-GFP pulldowns by statistical analysis. The list is sorted due to enrichment of CID-GFP 
over control pulldown with the highest enriched proteins on top. Names, average log2 
enrichment values of three biological replicate experiments plus standard deviations and p-
values, experimental evidence from this work and constructs created for analyses in this work 
are indicated. Factors tested by immunolocalization analysis in this work are highlighted in 
green.  
name CID-GFP/control CID-GFP/H3.3-GFP 
Experimental 
evidence Construct 
 
log2 p-value log2 p-value 
 
  
CID 15.9 ±1.1E-01 1,60E-02 11.1 ±4.5E-05 5,80E-02 Control   
CG14480 11.8 ±8.7E-02 1,70E-05 11.6±7.4E-02 1,40E-05 
Centromeric and 
euchromatic, on 
chromosome 
arms during 
mitosis, 
elevated mitotic 
errors in 
knockdown 
pMK33-
CFH-BD 
Cal1 11.3 ±9.1E-02 1,60E-05 11.2 ±7.6E-02 1,70E-05 Control   
CG2051 10.8 ±1.0E-05 5,40E-02 8.3 ±3.1E-07 1,10E-01 
Centromeric and 
euchromatic, on 
chromosome 
arms during 
mitosis, 
elevated mitotic 
errors in 
knockdown 
GFP 
Invitrogen 
CG13117 9.2 ±1.1E-01 7,60E-04 9.6 ±2.6E-02 6,50E-04     
CG34191 9.2 ±1.8E-01 3,50E-04 9.5 ±1.3E-01 3,00E-04     
CG6769 8.6 ±9.2E-02 2,20E-04 8.4 ±7.2E-02 2,60E-04     
Vps4  8.0 ±4.3E-01 9,20E-02 7.5 ±4.0E-01 1,00E-01     
CG4972 7.7 ±1.6E-01 6,20E-05 7.6 ±4.7E-02 5,30E-05 Nuclear 
pMT-hyg 
FLAG-
HA-Nterm 
CAF-1-
PB  
7.6 ±8.6E-03 1,90E-04 7.5 ±1.1E-02 1,70E-04 
Control, 
elevated mitotic 
errors in 
knockdown, 
nuclear 
(antibody stain)   
LSm3  7.5 ±7.6E-02 3,90E-04 7.7 ±5.4E-02 2,50E-04     
Kap-
alpha1 
7.5 ±4.4E-01 1,10E-02 8.3 ±2.5E-01 4,60E-03   
  
REG 7.3 ±1.1E-04 4,00E-01 13.4 ±3.8E-02 6,40E-02 
Centromeric and 
euchromatic, 
higher CID-GFP 
levels in cells 
after knockdown 
pMK33-
CFH-BD 
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name CID-GFP/control CID-GFP/H3.3-GFP 
Experimental 
evidence Construct 
 
log2 p-value log2 p-value 
 
  
       
ifc 7.3 ±9.8E-02 2,20E-04 7.1 ±6.8E-02 2,60E-04 Cytoplasmic 
pMK33-
CFH-BD 
CG11985 7.2 ±7.5E-02 7,10E-04 7.5 ±6.7E-02 3,50E-04     
CG9293 7.1 ±1.7E-01 3,70E-05 7.1 ±6.2E-02 4,30E-05 
Centromeric and 
euchromatic 
pMK33-
CFH-BD 
CG8891 7.1 ±1.2E-01 7,70E-03 7.4 ±1.2E-01 5,00E-03     
CG3548 7.0 ±1.0E-01 2,00E-04 7.0 ±4.9E-02 2,50E-04 
At centromeres 
and 
euchromatin in 
mitosis, nuclear 
in interphase 
GFP 
Invitrogen 
Hsp70 
Bbb 
7.0 ±2.1E-02 1,40E-03 6.9 ±6.0E-02 1,50E-03 
Hsp70Ab: 
cytoplasmic 
pMT-hyg 
FLAG-
HA-Nterm 
SRPK 7.0 ±6.1E-01 2,60E-02 7.6 ±2.8E-01 1,40E-02     
Unc-76 7.0 ±9.5E-02 8,80E-03 6.3 ±8.1E-02 1,20E-02     
CG6776 6.9 ±2.1E-01 8,40E-02 7.8 ±9.1E-02 4,30E-02     
Srp54k 6.9 ±5.0E-01 1,90E-01 6.4 ±5.3E-01 1,30E-01     
CG32069 6.7 ±1.7E-01 1,60E-04 6.6 ±6.5E-02 1,70E-04     
alphaTub
85E 
6.7 ±7.2E-02 1,80E-03 7.1 ±1.0E-01 9,20E-04   
  
MED30 6.6 ±7.5E-02 1,40E-04 6.6 ±6.6E-02 1,80E-04 
Centromeric and 
euchromatic 
GFP 
Invitrogen 
CG6151 6.6 ±9.6E-02 1,60E-04 6.4 ±8.1E-02 1,30E-04     
Rrp4 6.4 ±1.1E-01 1,70E-03 6.3 ±6.4E-02 1,30E-03     
CG1789 6.3 ±2.1E-02 1,10E-03 6.8 ±2.7E-02 7,30E-04     
qkr58E-2 6.3 ±9.7E-02 1,80E-04 6.1 ±6.8E-02 2,10E-04     
Prod 6.3 ±1.4E-01 1,20E-04 6.2 ±1.1E-01 1,50E-04 
Control, 
elevated mitotic 
errors in 
knockdown   
Tsp42Ed 6.3 ±1.0E-01 2,00E-04 6.1 ±8.1E-02 1,90E-04 
Membrane 
protein 
pMK33-
CFH-BD 
CG6180 6.3 ±1.4E-01 9,20E-04 6.6 ±2.8E-02 6,70E-04     
CG7945 6.3 ±4.2E-01 1,80E-01 5.1 ±1.0E+00 2,80E-01     
CG14695 6.2 ±1.9E-01 2,30E-03 6.5 ±1.1E-01 1,80E-03     
CG3731 6.2 ±6.5E-02 4,00E-04 6.0 ±5.0E-02 5,00E-04     
ATPsyn-
Cf6 
6.2 ±2.2E-01 1,20E-05 6.2 ±5.0E-02 1,30E-05   
  
BEAF-32 6.1 ±5.9E-02 5,30E-04 6.2 ±7.5E-02 5,70E-04     
CG5021 6.1 ±6.2E-01 1,90E-01 4.9 ±1.2E+00 3,10E-01     
PH4alpha
EFB  
6.0 ±1.0E-01 1,70E-03 6.3 ±9.6E-02 1,50E-03   
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name CID-GFP/control CID-GFP/H3.3-GFP 
Experimental 
evidence Construct 
 
log2 p-value log2 p-value 
 
  
ns3  6.0 ±9.2E-02 2,60E-01 6.0 ±7.1E-02 2,10E-01     
CG1265 6.0 ±1.5E-01 9,70E-04 6.0 ±5.0E-02 1,10E-03 Cytoplasmic 
pMK33-
CFH-BD 
CG12343 6.0 ±6.5E-02 1,20E-04 6.0 ±6.7E-02 1,10E-04 Nuclear  
pMK33-
CFH-BD 
CG11030 5.9 ±3.8E-01 3,00E-01 5.6 ±4.3E-01 2,40E-01     
CG9418 5.9 ±8.6E-02 1,80E-04 5.7 ±9.0E-02 2,50E-04 
Centromeric and 
euchromatic 
pMK33-
CFH-BD 
Prx5  5.9 ±1.2E-01 2,00E-02 6.1 ±4.6E-02 1,60E-02     
Jheh2 5.9 ±6.5E-02 8,40E-04 5.9 ±1.1E-02 8,20E-04     
Pcd 5.9 ±6.6E-02 4,70E-03 6.3 ±1.1E-01 3,50E-03     
Caz 5.7 ±1.3E-01 2,10E-05 6.0 ±6.1E-02 8,70E-06     
CG30390 5.7 ±1.9E-01 1,80E-04 5.6 ±8.5E-02 2,40E-04 Nuclear 
pMT-hyg 
FLAG-
HA-Nterm 
Ard1 5.6 ±4.8E-02 1,80E-03 6.0 ±1.4E-01 1,40E-03     
Dbp45A 5.6 ±2.3E-01 1,30E-03 6.0 ±3.1E-02 1,00E-03     
Uch-L3 5.5 ±1.4E-01 7,70E-04 5.7 ±6.9E-02 6,00E-04     
Fmr1  5.5E±4.5E-02 2,00E-01 5.4 ±1.2E-01 1,70E-01 Cytoplasmic 
pMK33-
CFH-BD 
Gfzf 5.5 ±9.0E-02 2,70E-04 5.5 ±1.1E-01 2,50E-04 
Centromeric and 
euchromatic 
GFP 
Invitrogen 
su(Hw)  5.4 ±8.7E-02 6,00E-04 5.3 ±8.2E-02 4,10E-04 
Non-centromeric 
foci in nucleus 
and cytoplasm 
GFP 
Invitrogen 
CG6084 5.4 ±9.2E-02 7,80E-03 5.6 ±4.8E-02 6,70E-03     
Nup50  5.4 ±2.8E-02 1,10E-01 4.1 ±3.3E-01 2,10E-01     
RagC  5.4 ±1.5E-01 5,40E-04 5.3 ±1.6E-01 4,00E-04 Nuclear  
pMK33-
CFH-BD 
CG17271 5.4 ±6.9E-01 2,50E-01 4.3 ±1.2E+00 1,80E-01     
CAF-1-
PA 
5.3 ±1.7E-07 7,20E-03 5.3 ±6.8E-07 6,50E-03 
Control, 
elevated mitotic 
errors in 
knockdown, 
nuclear 
(antibody stain)   
CG1091 5.3 ±1.2E-01 7,20E-04 5.3 ±1.3E-01 9,30E-04 Cytoplasmic 
GFP 
Invitrogen 
Bor 5.1 ±1.2E-01 2,80E-02 4.2 ±4.1E-01 6,80E-02     
Spt6 5.1 ±3.9E-02 1,90E-01 4.8 ±7.6E-02 1,90E-01     
YT521-B 5.0 ±3.5E-01 3,50E-01 5.0 ±9.7E-02 3,20E-01     
CG5482 5.0 ±9.0E-02 3,40E-04 5.3 ±5.3E-02 2,20E-04     
CG1309 4.9 ±7.4E-03 8,90E-03 5.1 ±3.7E-02 4,00E-03     
APPENDIX 
117 
 
name CID-GFP/control CID-GFP/H3.3-GFP 
Experimental 
evidence Construct 
 
log2 p-value log2 p-value 
 
  
Hyd 4.9 ±1.6E-01 1,80E-03 4.8 ±4.4E-02 2,30E-03 
Nuclear, 
excluded from 
heterochromatin 
higher CID 
levels in 
knockdown, 
elevated mitotic 
errors in 
knockdown 
pMT-hyg 
FLAG-
HA-Nterm 
CG32344 4.9 ±5.8E-06 4,20E-01 11.1 ±4.1E-02 3,10E-02     
CG11820 4.9 ±2.9E-01 6,90E-02 5.8 ±2.5E-01 3,30E-02     
Oscp 4.8 ±1.0E-01 2,30E-02 5.1 ±7.6E-02 1,90E-02     
CG4858 4.8 ±1.5E-01 6,70E-01 6.5 ±5.8E-02 3,30E-01     
CG3335 4.8 ±9.8E-02 5,80E-03 5.0 ±7.8E-02 4,20E-03     
CG11076 4.8 ±4.3E-02 2,30E-03 4.7 ±1.0E-01 2,10E-03 Nucleolar 
GFP 
Invitrogen 
YL-1 4.7 ±8.9E-02 6,90E-04 4.7 ±5.9E-02 7,10E-04 Nuclear 
pMK33-
CFH-BD 
Sub  4.6 ±1.0E-01 5,30E-03 4.6 ±1.3E-01 6,70E-03 Control 
pMK33-
CFH-BD 
Rbcn-3A  4.6 ±1.4E-01 3,60E-04 4.5 ±7.8E-02 4,10E-04 Nuclear 
pMT-hyg 
FLAG-
HA-Nterm 
eIF-4B 4.6 ±8.0E-02 1,90E-02 4.8 ±8.2E-02 1,30E-02     
Pgi 4.5 ±9.7E-02 9,70E-03 4.7 ±1.6E-02 7,20E-03     
CG9630 4.5 ±7.3E-02 2,80E-03 4.8 ±1.6E-01 1,20E-03     
CENP-C 4.5 ±1.3E-01 3,00E-03 4.4 ±7.0E-02 2,90E-03 Control   
Mtr3 4.5 ±1.1E-01 5,20E-01 5.8 ±6.4E-02 2,70E-01     
CG2943 4.5 ±7.7E-02 6,10E-01 4.4 ±5.5E-02 5,10E-01     
Cdk12  4.4 ±2.2E-01 5,00E-04 4.2 ±7.5E-02 5,70E-04 
Nuclear, 
excluded from 
heterochromatin 
pMT-hyg 
FLAG-
HA-Nterm 
CG7518 4.3 ±1.2E-01 5,40E-04 4.4 ±7.4E-02 6,00E-04 Cytoplasmic  
pMT-hyg 
FLAG-
HA-Nterm 
CG5198 4.2 ±3.8E-02 3,20E-02 4.6 ±1.2E-01 1,10E-02     
CG1399 3.8 ±8.4E-02 1,73E-03 3.8 ±5.0E-02 1,64E-03 Cytoplasmic pIB-v5 
CG6227 
4.0 ±2.8E-02 3,29E-03 4.0 ±9.8E-02 2,29E-03 
Centromeric and 
euchromatic 
GFP 
Invitrogen 
asp 
1.9 ±5.0E-02 7,49E-02 1.8 ±8.8E-02 6,59E-02 Nuclear  
pMT-hyg 
FLAG-
HA-Nterm 
CG32343
/ATAC3 
3.8 ±1.5E-01 7,13E-03 3.7 ±6.5E-02 8,38E-03 Nuclear  
pMT-hyg 
FLAG-
HA-Nterm 
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name CID-GFP/control CID-GFP/H3.3-GFP 
Experimental 
evidence Construct 
 
log2 p-value log2 p-value 
 
  
RhoGAP
54D 3.5 ±1.8E-01 1,51E-03 3.4 ±4.7E-02 9,81E-04   
CG8478 3.8 ±8.1E-02 1,85E-02 3.6 ±3.3E-02 1,81E-02   
Top3beta 3.4 ±6.5E-02 3,40E-02 3.4 ±9.4E-02 3,17E-03   
Ge-1 3.0 ±7.0E-02 2,53E-02 2.8 ±7.1E-02 2,03E-02   
Hcf 
3.5 ±2.7E-02 2,44E-01 2.7 ±3.1E-02 3,21E-01 Nuclear  
GFP 
Invitrogen 
Grey: factors not contained in 85 initially identified CID-chromatin co-purifiers and selected 
based on their high and CID-GFP specific iBAQ values  
 
 
 
 
 
 
 
  
Figure 1: Identification of CID-GFP in the band excised from the gel in figure 2.6. MS2 
spectrum of a proteotypic peptide of CID (parent mass: 479.24948, z=3). The peptide 
sequence is shown in the inlet. ox: oxidated methionine. pr: propionylated lysine. The b- and 
y-ions assigned in the spectrum are indicated in the inlet. The complete b- and y-ions series 
was detected by the software Proteome Discoverer. 
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ABBREVIATIONS 
5-mC 5-methylcytosine 
ACN Acetonitrile 
amu Atomic mass unit 
ANOVA Analysis of variance 
AP-MS Affinity purification – mass spectrometry  
APC/C Anaphase promoting complex/cyclosome 
Asf1 Anti-silencing function protein 1 
BDGP Berkeley Drosophila Genome Project 
bp Basepair(s) 
CAF-1, p55 Chromatin assembly factor 1  
Cal1 Chromosome alignment defect 1 
CCAN Constitutive centromere-associated network 
Cdc20 Cell division cycle protein 20 
CDK Cyclin-dependent kinase  
CENP Centromeric protein 
CID Centromere identifier 
CID-ub Monoubiquitinated band of CID 
CPC Chromosomal passenger complex 
CREST calcinosis, Raynaud's phenomenon, esophageal 
dysmotility, sclerodactyly, and telangiectasias 
D. mel Drosophila melanogaster 
Da Dalton 
DAPI 4',6-diamidino-2-phenylindole 
DNA Deoxyribonucleic acid 
dsRNA Double stranded RNA 
DTT Dithiothreitol 
ESI Electrospray ionization 
Ezh1/2 Enhancer of zeste homolog ½ 
FA Formic acid 
FACS Fluorescence-activated cell sorting 
fw Forward 
GFP Green fluorescent protein 
H1 Histone 1 
H2A Histone 2A 
H2B Histone 2B 
H3 Histone 3 
H3S10ph Histone 3 serine 10 phosphorylation 
H4 Histone 4 
HAT Histone acetyl transferase 
HJURP Holliday junction recognition protein 
IAA  Iodoacetamide  
iBAQ Intensity based absolute quantification 
IF Immunofluorescence 
ING Inhibitor of growth 
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IP Immunoprecipitation 
kb Kilobase(s) 
kDa Kilodalton  
KMN Knl1 complex, Mis12 complex and Ndc80 complex 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
m/z Mass-to-charge 
Mb Megabase(s) 
MCM Minichromosome maintenance 
min Minute(s) 
mL Milliliter 
MNase Micrococcal nuclease 
MS Mass spectrometry 
MT Microtubule 
MTOC Microtubule organizing center 
NaCl Sodium chloride 
ncRNA Non-coding RNA 
NEM N-ethylmaleimide  
NLP Nucleoplasmin-like protein 
ORC3 Origin recognition complex 
PAGE Polyacrylamide gel electrophoresis  
PHD Plant homeodomain 
PLK Polo-like kinase 
pMT Metallothionein promoter 
ppa Partner of paired  
ppm Parts per million 
PRC1/2 Polycomb repressive complex 
prod Proliferation disruptor 
PTM Posttranslational modification 
rev Reverse 
RNA Ribonucleic acid 
RNAi RNA interference 
RP-LC Reversed phase – liquid chromatography 
SAC Spindle assembly checkpoint  
SDS Sodium dodecyl sulfate 
SID Sample identifier 
siRNA Small interfering RNA 
TAP Tandem affinity purification 
TET Ten-eleven-translocation 
TFA Trifluoroacetic acid 
TFIID Transcription factor II D 
wt Wildtype 
XIC Extracted ion chromatogram 
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